matchedPattern,context,lineNumber,columnNumber,publicationName
4269A > G,"...> G, 3303C > T in the tRNALeu (UUR) gene (MTTL1); 4269A > G, 4295A > G, 4300A > G, 4317A > G, 4320C ...",48,736,Acta_Myol_2011_Jul_30(1)_9-15.txt
4269A > G,"...> G, 3303C > T in the tRNALeu (UUR) gene (MTTL1); 4269A > G, 4295A > G, 4300A > G, 4317A > G, 4320C ...",48,736,Acta_Myol_2011_Jul_30(1)_9-15.txt
4317A > G,"...R) gene (MTTL1); 4269A > G, 4295A > G, 4300A > G, 4317A > G, 4320C > T in the tRNAIle gene (MMTI); 8...",48,769,Acta_Myol_2011_Jul_30(1)_9-15.txt
4320C > T,"...TL1); 4269A > G, 4295A > G, 4300A > G, 4317A > G, 4320C > T in the tRNAIle gene (MMTI); 8348A > G in...",48,780,Acta_Myol_2011_Jul_30(1)_9-15.txt
9997T > C,"...ene (MMTI); 8348A > G in the tRNALys gene (MTTK), 9997T > C in the tRNAGly gene (MTTG), 12297T > C i...",48,856,Acta_Myol_2011_Jul_30(1)_9-15.txt
3303C > T,...usually associated to the mutations 3260 A > G or 3303C > T in the tRNALeu (UUR) gene (MTTL1),50,226,Acta_Myol_2011_Jul_30(1)_9-15.txt
3243A > G,"MTTL1 3243A > G(80%), 3271, 329",133,8,Acta_Myol_2011_Jul_30(1)_9-15.txt
9957T > C,"...308T > C, various MT-ND5 gene mutations, MTCOXIII 9957T >",135,59,Acta_Myol_2011_Jul_30(1)_9-15.txt
3308T > C,"... position 3271 and 3291 in the MTTL1 gene, MT-ND1 3308T > C mutation, various MTND5 gene mutations, ...",193,909,Acta_Myol_2011_Jul_30(1)_9-15.txt
14487T > C,"14487T > C (M63V, ND6) and 12297T > C (tRNA Leu) i...",398,1,Acta_Myol_2011_Jul_30(1)_9-15.txt
12297T > C,"14487T > C (M63V, ND6) and 12297T > C (tRNA Leu) in a Leig",398,28,Acta_Myol_2011_Jul_30(1)_9-15.txt
-511 G>A,IL1B	2q14	-511 G>A	rs16944,38,11,Acta_Naturae_2011_Jan-Mar_3(1)_116-122.txt
-511 G>A,IL1B	2q14	-511 G>A	rs16944,38,11,Acta_Naturae_2011_Jan-Mar_3(1)_116-122.txt
-511 G>A,IL1B	2q14	-511 G>A	rs16944,38,11,Acta_Naturae_2011_Jan-Mar_3(1)_116-122.txt
-590 C>T,IL4	5q31.1	-590 C>T	rs2243250	Decreasing the level of anti-in...,39,12,Acta_Naturae_2011_Jan-Mar_3(1)_116-122.txt
13145A>G,"...ngle nucleotide polymorphisms, -1123G>C, 1858C>T, 13145A>G, 14943C>T, and 20628A>G, were genotyped. ...",4,1418,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
13145A>G,"...ngle nucleotide polymorphisms, -1123G>C, 1858C>T, 13145A>G, 14943C>T, and 20628A>G, were genotyped. ...",4,1418,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
-1123G>C,"...ed five SNPs of the PTPN22 gene, one in promoter (-1123G>C), one in exon (1858C>T) and three in intr...",22,180,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
-1123G>C,"...ed five SNPs of the PTPN22 gene, one in promoter (-1123G>C), one in exon (1858C>T) and three in intr...",22,180,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,"... in exon (1858C>T) and three in intron (13145A>G, 14943C>T and 20628A>G), based on previous reported...",22,244,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,"...=0.047; Fig. B). Similarly, the CT/TT genotype at 14943C>T was associated with a significantly highe...",29,483,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,"...ound significant associations of 2 intronic SNPs, 20628A>G and 14943C>T, with the prevalence of seru...",32,371,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
-1123G>C,"...za et al.5 recently reported that a promoter SNP, -1123G>C, was associated with CU susceptibility in...",34,176,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1858C>T,... It was also found that PTPN22 gene polymorphism (1858C>T) was not associated with responses to ASST...,41,451,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
1858C>T,... It was also found that PTPN22 gene polymorphism (1858C>T) was not associated with responses to ASST...,41,451,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,"...n conclusion, intronic polymorphisms of PTPN22 at 20628A>G and 14943C>T enhances serum specific IgE ...",43,52,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
14943C>T,...nce of serum specific IgE to SEA according to the 14943C>T polymorphism,50,353,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
20628A>G,20628A>G (rs1217407)	AA	178 (43.5%)	168 (43.3%)	0....,102,1,Allergy_Asthma_Immunol_Res_2015_May_15_7(3)_290-294.txt
677 C>T,...tions are known to modulate disease risk in MTHFR 677 C>T individuals (31). It may be important to c...,189,1161,Am_J_Clin_Nutr_2015_Mar_7_101(3)_646-658.txt
677C->T,MTHFR 677C->T genotype is associated with folate and hom...,386,7,Am_J_Clin_Nutr_2015_Mar_7_101(3)_646-658.txt
22 G > A,"We observed one heterozygous change in SOX2: c.*22 G > A (exon 1 + 22 bp) in two patients, includi...",143,49,Am_J_Med_Genet_A_2010_Nov_11_152A(11)_2736-2742.txt
22+2C>T,...ient VU1202 with biallelic mutations in DDX11 (IVS22+2C>T and c.2689_2691delAAG) and his mother (VU1...,20,460,Anemia_2010_Jul_18_2010_565268.txt
22+2C>T,"...and c.2689_2691delAAG) and his mother (VU1203, IVS22+2C>T) [19]. The FA-J patient EUFA1333 and FA-B ...",20,518,Anemia_2010_Jul_18_2010_565268.txt
22+2C>T,Con-3	VU1203	DDX11	 IVS22+2C>T	Mother of VU1202	[19],73,24,Anemia_2010_Jul_18_2010_565268.txt
109G>T,...etal hemoglobin results from a novel mutation (g.-109G>T) in the HBG2 gene promoter Chassanidis Chri...,3,240,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,"...1a). Also, 31 heterozygotes for the silent HBB:g.-101C>T β-thalassemia mutation have been included (...",19,264,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...llenic type of nd-HPFH, bearing the novel HBG2:g.-109G>T promoter mutation (depicted in black) and t...",20,139,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
158C>T,...oter mutation (depicted in black) and the HBG2:g.-158C>T polymorphism (depicted in light gray) or th...,20,200,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...g the compound heterozygous for the novel HBG2:g.-109G>T mutation and the silent HBB:g.-101C>T β-tha...,22,126,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,...vel HBG2:g.-109G>T mutation and the silent HBB:g.-101C>T β-thalassemia mutation (I-3; see also Fig. ...,22,164,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,Hematological indices	HBB:g.-101C>T,24,30,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,HBG2:g.-109G>T (I-3)	Wild-type	Wild-type,25,9,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...the gene’s transcription initiation site (HBG2:g.-109G>T; Fig. 2b). DNA sequencing did not reveal an...,48,521,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...3) was also compound heterozygous for the HBG2:g.-109G>T promoter mutation and the silent HBB:g.-101...,53,628,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,...g.-109G>T promoter mutation and the silent HBB:g.-101C>T β-thalassemia mutation. The HBG2:g.-109G>T ...,53,675,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
117G>A,"..., the dominant nd-HPFH is the Greek type (HBG1:g.-117G>A [6]), accounting for almost 90% of the HPFH...",61,213,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
201C>T,"...econd most frequent type, followed by the HBG1:g.-201C>T and the HBG2:g.-196C>T mutations [19]. No d...",61,379,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
201C>T,"...econd most frequent type, followed by the HBG1:g.-201C>T and the HBG2:g.-196C>T mutations [19]. No d...",61,379,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
101C>T,"...o, compound heterozygosity with the silent HBB:g.-101C>T β-thalassemia mutation resulted in substant...",63,568,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,"...contrary, compound heterozygosity for the HBG2:g.-109G>T mutation and the HBG2:g.-158C>T polymorphis...",63,958,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...m itself exerts a silencing effect on the HBG2:g.-109G>T mutation or (b) another yet unidentified ci...,63,1205,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
109G>T,...ur EMSA analysis data indicating that the HBG2:g.-109G>T transversion results in abolishing protein ...,65,652,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
117G>A,"...uction [25]. This is unexpected since the HBG1:g.-117G>A nd-HPFH mutation, residing at the 5′ end of...",67,819,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
117G>A,"...uction [25]. This is unexpected since the HBG1:g.-117G>A nd-HPFH mutation, residing at the 5′ end of...",67,819,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
-158 C>T,... A>G) is linked with the XmnI polymorphism (Ggamma-158 C>T) Hemoglobin 1995 19 419 423 10.3109/03630...,84,164,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
-158 C>T,...hereditary persistence of fetal hemoglobin [Agamma-158 C>T] results from two independent gene conver...,85,435,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
-196 C->T,"...aitis G Loutradi-Anagnostou A Karababa P  (G)gamma-196 C->T, (A)gamma-201 C->T: two novel mutations ...",95,96,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
-196 C->T,"... Loutradi-Anagnostou A, Karababa P (2008) (G)gamma-196 C->T, (A)gamma-201 C->T: two novel mutations ...",95,443,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
-158 C>T,... Sabine confirms the functional role of the Agamma-158 C>T mutation in gamma-globin gene transcripti...,99,297,Ann_Hematol_2009_Jun_3_88(6)_549-555.txt
835 T > A,...ALDH gene revealed a homozygous novel mutation c. 835 T > A (p.Y279N) in exon 6,37,118,Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_425-427.txt
835 T > A,... in one patient. We detected a novel mutation (c. 835 T > A) in exon 6 in our patient,48,714,Ann_Indian_Acad_Neurol_2013_Jul-Sep_16(3)_425-427.txt
163T>C,"...1, compared to A101 alleles (1142C>T in intron 4, 163T>C and 179C>T in intron 6, 467C>T and 803G>C i...",9,507,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
803G>C,"...tron 4, 163T>C and 179C>T in intron 6, 467C>T and 803G>C in exon 7. The cis-AB01 allele has the only...",15,245,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
803G>C,... allele has the only one nucleotide difference of 803G>C compared with the A105 allele,15,325,Ann_Lab_Med_2015_Mar_12_35(2)_279-280.txt
-838C>A,...ucleotide polymorphism in the human p27kip1 gene (-838C>A) affects basal promoter activity and the r...,3,169,BMC_Biol_2004_Apr_2_2_5.txt
-838C>A,...ucleotide polymorphism in the human p27kip1 gene (-838C>A) affects basal promoter activity and the r...,3,169,BMC_Biol_2004_Apr_2_2_5.txt
-838C>A,...ucleotide polymorphism in the human p27kip1 gene (-838C>A) affects basal promoter activity and the r...,3,169,BMC_Biol_2004_Apr_2_2_5.txt
326T>G,"...ymorphisms (SNPs) within the human p27kip1 gene: +326T>G (V109G), -79C>T, and -838C>A (nucleotide po...",21,486,BMC_Biol_2004_Apr_2_2_5.txt
-838C>A,"... human p27kip1 gene: +326T>G (V109G), -79C>T, and -838C>A (nucleotide positions numbered relative to...",21,514,BMC_Biol_2004_Apr_2_2_5.txt
-838C>A,"... human p27kip1 gene: +326T>G (V109G), -79C>T, and -838C>A (nucleotide positions numbered relative to...",21,514,BMC_Biol_2004_Apr_2_2_5.txt
-838C>A,"...cribed (rs2066827 and rs34330, respectively), and -838C>A is a novel polymorphism. +326T>G (V109G) i...",21,742,BMC_Biol_2004_Apr_2_2_5.txt
-838C>A,"...cribed (rs2066827 and rs34330, respectively), and -838C>A is a novel polymorphism. +326T>G (V109G) i...",21,742,BMC_Biol_2004_Apr_2_2_5.txt
326T>G,"...pectively), and -838C>A is a novel polymorphism. +326T>G (V109G) is a missense polymorphism in exon ...",21,776,BMC_Biol_2004_Apr_2_2_5.txt
326T>G,"...pectively), and -838C>A is a novel polymorphism. +326T>G (V109G) is a missense polymorphism in exon ...",21,776,BMC_Biol_2004_Apr_2_2_5.txt
-838C>A,"... of MI. Among the three SNPs described here, only -838C>A showed differences in allele frequency bet...",31,901,BMC_Biol_2004_Apr_2_2_5.txt
-838C>A,... analysis of the promoter sequence containing the -838C>A SNP using the MatInspector v2.2 and TRANSF...,33,602,BMC_Biol_2004_Apr_2_2_5.txt
-838C>A,"Three polymorphisms of the human p27kip1 gene (-838C>A, -79C>T, and V109G) were analysed as candi...",38,48,BMC_Biol_2004_Apr_2_2_5.txt
-838C>A,"Three polymorphisms of the human p27kip1 gene (-838C>A, -79C>T, and V109G) were analysed as candi...",38,48,BMC_Biol_2004_Apr_2_2_5.txt
-838C>A,...gure 1 Single-strand conformation analysis of the -838C>A polymorphism within the human p27kip1 gene...,67,53,BMC_Biol_2004_Apr_2_2_5.txt
-838C>A,...gure 1 Single-strand conformation analysis of the -838C>A polymorphism within the human p27kip1 gene...,67,53,BMC_Biol_2004_Apr_2_2_5.txt
-838C>A,...gure 1 Single-strand conformation analysis of the -838C>A polymorphism within the human p27kip1 gene...,67,53,BMC_Biol_2004_Apr_2_2_5.txt
-838C>A,-838C>A	F: TCCAGGTCCCGGCTTCCCGGt**,93,1,BMC_Biol_2004_Apr_2_2_5.txt
-79C>T,-79C>T	F: TGATCAGCGGAGACTCGGCG,95,1,BMC_Biol_2004_Apr_2_2_5.txt
326T>G,+326T>G (V109G)	F: TGCGAGTGTCTAACGGGAGC,97,2,BMC_Biol_2004_Apr_2_2_5.txt
-79C>T,"Table 3 Genotype frequencies for the -838C>A, -79C>T, and V109G p27kip1 single-nucleotide polymo...",101,47,BMC_Biol_2004_Apr_2_2_5.txt
-79C>T,"Table 3 Genotype frequencies for the -838C>A, -79C>T, and V109G p27kip1 single-nucleotide polymo...",101,47,BMC_Biol_2004_Apr_2_2_5.txt
-79C>T,-79C>T,108,2,BMC_Biol_2004_Apr_2_2_5.txt
35829419 C>A,... NLRP2 (F359L) rs17699678 C>T and NLRP3 (Q705K) rs35829419 C>A. The genotyping reactions were perfor...,47,295,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
1769967 C>T,Table 3 Association analysis of rs1769967 C>T polymorphism in NLRP2 with pancreatic ...,90,35,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
35829419 C>A,"...ee Tables 4, 5).Table 4 Association analysis of rs35829419 C>A Q705K polymorphism in NLRP3 with peri...",123,516,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
35829419 C>A,"...ee Tables 4, 5).Table 4 Association analysis of rs35829419 C>A Q705K polymorphism in NLRP3 with peri...",123,516,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
35829419 C>A,...trated a clear and distinct correlation between rs35829419 C>A in NLRP3 and rs17699678 C>T in NLRP2 ...,202,250,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
17699678 C>T,...correlation between rs35829419 C>A in NLRP3 and rs17699678 C>T in NLRP2 polymorphism and periodontit...,202,278,Arch_Immunol_Ther_Exp_(Warsz)_2015_Aug_8_63(6)_485-494.txt
575A > G,... a glutamine-to-arginine substitution at position 575A > G (PON1 Q192R) and a leucine to-methionine ...,24,127,Arch_Med_Sci_2015_Jun_19_11(3)_513-520.txt
521T > C,"...linkage disequilibrium with a non-synonymous SNP, 521T > C (rs4149056). The 521T/C transition (SLCO1...",49,758,Arch_Med_Sci_2016_Jun_1_12(3)_645-658.txt
421C>A,"...,3]) or biliary secretion of teriflunomide (ABCG2 421C>A, rs2231142) [4,5]). Polymorphisms that had ...",20,644,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
19C>A,"...A2*1F, (CYP1A2 163C>A, rs762551) and DHODH (DHODH 19C>A, rs3213422) [3,6,7]) were also studied. DHOD...",20,785,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
421C>A,...ted that while 0 of 14 who had the AC genotype at 421C>A ABCG2 ceased leflunomide as a result of dia...,121,791,Arthritis_Res_Ther_2012_Jul_12_14(4)_R163.txt
119846C>T,"...ted two novel mutations (NC_010450.3:g. 99514A>G, 119846C>T) by DNA sequencing and polymerase chain ...",7,759,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,...ignificant relevance in Hanjiang (p = 0.017); the 119846C>T mutation suggested significant associati...,7,1300,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,...ignificant relevance in Hanjiang (p = 0.017); the 119846C>T mutation suggested significant associati...,7,1300,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1351T>C,"In previous studies, a 1351T>C transition and 1666A>C transversion in the...",18,24,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1666A>C,"In previous studies, a 1351T>C transition and 1666A>C transversion in the 3′ end of LEF-1 mRNA a...",18,47,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
1666A>C,"In previous studies, a 1351T>C transition and 1666A>C transversion in the 3′ end of LEF-1 mRNA a...",18,47,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,"...s. Two novel mutations (NC_010450.3: g. 99514A>G, 119846C>T) were firstly detected by DNA pool seque...",52,233,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"...h the Hardy-Weinberg equilibrium (p>0.05). In the 99514A>G mutation, low level PIC was observed in H...",55,379,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"The frequencies of widespread allele “A” in 99514A>G mutation ranged from 0.5536 to 0.9118, an...",58,45,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,"...mutation ranged from 0.5536 to 0.9118, and “T” in 119846C>T mutation ranged from 0.4833 to 08824 in ...",58,104,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,The 99514A>G mutation revealed an extremely significan...,63,5,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"...el single nucleotide polymorphism (NC_010450.3:g. 99514A>G, 119846C>T) located in exon 4 (P4) and in...",81,644,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,"...(p = 0.017), but no significance in BM, while the 119846C>T mutation displayed significant associati...",81,980,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"...ciated with higher teat numbers. In addition, the 99514A>G mutation itself demonstrated a synonymous...",81,1378,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,"... BM, and LW. The data strongly suggested that the 99514A>G mutation showed extremely significant sta...",85,676,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,Table 2 Genetic indexes of the 99514A>G and 119846C>T mutation within porcine LEF...,140,32,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,99514A>G	GZ	0.3787	0.6212	2.6406	0.3537,143,1,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
119846C>T,...Genotypic and allelic frequencies of 99514A>G and 119846C>T mutation within porcine LEF-1 gen,153,59,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
99514A>G,99514A>G	AA	12.36±1.16	13.52±0.87	13.35±1.16	11.81...,185,1,Asian-Australas_J_Anim_Sci_2014_Sep_27(9)_1254-1262.txt
108C>G,"g.15,108C>G (rs34604640)	74,168,493	P39R	0.000	-",25,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
288G>A,"g.15,288G>A	74,168,313	R99H	0.000	-",39,6,Behav_Brain_Funct_2011_Sep_7_7_39.txt
190T>C,"... frequencies and measures of association for g.15,190T>C (rs2270676 encoding  F66F) and g.15,240G>A ...",44,75,Behav_Brain_Funct_2011_Sep_7_7_39.txt
240G>A,"...r g.15,190T>C (rs2270676 encoding  F66F) and g.15,240G>A (rs17215437 encoding R83H), based on data f...",44,118,Behav_Brain_Funct_2011_Sep_7_7_39.txt
240G>A,"...r g.15,190T>C (rs2270676 encoding  F66F) and g.15,240G>A (rs17215437 encoding R83H), based on data f...",44,118,Behav_Brain_Funct_2011_Sep_7_7_39.txt
190T>C,"frequency in controls	g.15,190T>C (F66F",47,28,Behav_Brain_Funct_2011_Sep_7_7_39.txt
190T>C,"frequency in controls	g.15,190T>C (F66F",47,28,Behav_Brain_Funct_2011_Sep_7_7_39.txt
3773364 A>G,...ittal B.   Association of intronic polymorphism rs3773364 A>G in synapsin-2 gene with idiopathic epi...,158,100,Behav_Brain_Res_2013_Aug_15_251_65-74.txt
47086497C>T,"...en identified in an unrelated clinical case [chrX:47086497C>T, Q00536-2 (isoform 2): p.Arg488Ter] (h...",91,889,Biochem_J_2015_Aug_1_469(Pt_3)_409-420.txt
47086497C>T,"...en identified in an unrelated clinical case [chrX:47086497C>T, Q00536-2 (isoform 2): p.Arg488Ter] (h...",91,889,Biochem_J_2015_Aug_1_469(Pt_3)_409-420.txt
825C>T,...al A  Frossard PM   G-protein beta 3 subunit gene 825C>T dimorphism is associated with left ventricu...,240,78,Biomark_Insights_2016_May_17_11_69-75.txt
9435 T > A,MAs	2	M	c.5946delT	9435 T > A	Cerebellum	Ashkenazi Jewish Sibling of ...,33,20,Biomark_Res_2015_Jun_6_3_13.txt
8447 T > A,MB	2.3	M	c.658_659delGT	8447 T > A	Hemispheric	Sibling of the following	[1...,38,25,Biomark_Res_2015_Jun_6_3_13.txt
8447 T > A,MB	2.3	M	c.658_659delGT	8447 T > A	Hemispheric	Sibling of the following	[1...,38,25,Biomark_Res_2015_Jun_6_3_13.txt
-1195G>A,"...ns/del, NFKBIA -826C/T, COX-1 (50C>T), and COX-2 (-1195G>A) polymorphisms on prostate cancer risk. T...",7,575,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,COX-1 (50C>T) Polymorphis,36,8,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,...amplification of the region containing the COX-2 (1195G>A) polymorphism were 5′-CCC TGA GCA CTA CCC ...,41,76,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
1195G>A,...amplification of the region containing the COX-2 (1195G>A) polymorphism were 5′-CCC TGA GCA CTA CCC ...,41,76,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
-1195G>A,"...rols in the genotypic distribution was the COX-2 (-1195G>A) polymorphism. Among the cases, 71, 269, ...",54,147,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"... 14 in controls (χ2 = 0.51, P = 0.77). For COX-1 (50C>T) polymorphism, the CC, CT, and TT genotypes ...",56,335,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"... 14 in controls (χ2 = 0.51, P = 0.77). For COX-1 (50C>T) polymorphism, the CC, CT, and TT genotypes ...",56,335,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,...f significant association was observed for COX-1 (50C>T) polymorphism and PPARG Pro12Ala polymorphis...,68,68,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
-1195G>A,"...uced [26]. On the other hand, the promoter COX-2 (-1195G>A) polymorphism can alter the transcription...",84,554,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,"...f prostate cancer risk association for the COX-1 (50C>T) polymorphism. This indicates that, despite ...",84,715,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
-1195G>A,...were available for the association between COX-2 (-1195G>A) polymorphism and prostate cancer risk. O...,84,1743,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
-1195G>A,...ed the absence of risk association between COX-2 (-1195G>A) polymorphism and prostate cancer risk,84,2016,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
-1195G>A,...ed the absence of risk association between COX-2 (-1195G>A) polymorphism and prostate cancer risk,84,2016,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
-1195G>A,...ed the absence of risk association between COX-2 (-1195G>A) polymorphism and prostate cancer risk,84,2016,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
-1195G>A,COX-2 (-1195G>A)	 	 	18.34	<0.01,124,8,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
50C>T,COX-1 (50C>T)	 	 	4.05	0.13,129,8,Biomed_Res_Int_2015_Dec_14_2015_674039.txt
308G>A,"... potential for a biological significance of TNFA −308G>A polymorphism on the risk of obesity, M. Bar...",19,413,Biomed_Res_Int_2015_Jan_14_2015_135931.txt
12769316G>A,...nal SNPs (NFκB1: rs28362491del>ins ATTG; NFκB2: rs12769316G>A; IκBα: rs2233406C>T and rs696G>A) were...,31,787,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
12769316G>A,...nal SNPs (NFκB1: rs28362491del>ins ATTG; NFκB2: rs12769316G>A; IκBα: rs2233406C>T and rs696G>A) were...,31,787,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
2233406C>T,...362491del>ins ATTG; NFκB2: rs12769316G>A; IκBα: rs2233406C>T and rs696G>A) were analyzed to evaluate...,31,808,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
12769316G>A,...nctional SNPs (rs28362491del>ins ATTG in NFκB1; rs12769316G>A in NFκB2; rs2233406C>T and rs696 G>A i...,41,128,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696 G>A,...NFκB1; rs12769316G>A in NFκB2; rs2233406C>T and rs696 G>A in IκBα) and NPC risk in 906 NPC patients ...,41,169,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
12769316 G>A,"...rphisms [i.e., rs28362491del>ins ATTG of NFκB1; rs12769316 G>A of NFκB2; rs2233406C>T and rs696G>A o...",48,158,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,...FκB1; rs12769316 G>A of NFκB2; rs2233406C>T and rs696G>A of IκBα] were putatively functional and rep...,48,200,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,... gene-gene interaction of rs28362491del/ins and rs696G>A polymorphism on the risk of NPC was also in...,74,205,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,"...s for gastric cancer and CRC risk. Furthermore, rs696G>A polymorphism in the 3′-UTR of IκBα showed a...",86,665,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,...As previous biological mechanism indicated that rs696G>A SNP in IκBα could depress its expression; i...,88,385,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,"...NFκB1, rs12769316G>A in NFκB2, rs2233406C>T and rs696G>A in IκBα detected by the TaqMan allelic disc...",96,175,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,"...NFκB1, rs12769316G>A in NFκB2, rs2233406C>T and rs696G>A in IκBα detected by the TaqMan allelic disc...",96,175,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696G>A,Figure 1 Effects of the rs696G>A polymorphism and treatment with microRNAs o...,107,27,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
2233406 C>T, rs2233406 C>T	 	 	 	 	 	 	 	 	 ,167,4,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
696 G>A,IκBα: rs696 G>A,334,9,Biomed_Res_Int_2015_Jun_16_2015_362542.txt
6566A>G,WD40 repeat (WD40)	6566A>G	Y2189C	14	8	Middle-age to late onset of di...,105,20,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
6566A>G,WD40 repeat (WD40)	6566A>G	Y2189C	14	8	Middle-age to late onset of di...,105,20,Biomed_Res_Int_2015_Mar_2_2015_678701.txt
599839 A>G,rs599839 A>G	AA	107 (48.4)	48 (56.5)	59 (43.4)	3.668...,194,3,Biomed_Res_Int_2015_Mar_8_2015_678924.txt
646776 T>C,rs646776 T>C	TT	170 (76.9)	73 (80.2)	97 (72.9)	1.568...,204,3,Biomed_Res_Int_2015_Mar_8_2015_678924.txt
646776 T>C,rs646776 T>C	TT	170 (76.9)	73 (80.2)	97 (72.9)	1.568...,204,3,Biomed_Res_Int_2015_Mar_8_2015_678924.txt
1G>A,"A2	M	47	AADC, GAD, TPH	HP, D, V	c.879+1G>A/c.879+1G>A",22,50,Blood_2008_Oct_1_112(7)_2657-2666.txt
2A>A,36	3	+ (52%)	−	Intron 6/IVS7−2A>A,72,30,Blood_Cancer_J_2011_Feb_25_1(2)_e5.txt
1273 C>T,"... gene revealed that she had heterozygous mutation 1273 C>T in exon 12, that affects codon 425 result...",20,714,Blood_Res_2016_Sep_23_51(3)_210-213.txt
617V>F,...i V Fabris F  Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera...,106,150,BMC_Bioinformatics_2009_Jan_30_10(Suppl_1)_S53.txt
239G>A,"... kinase domain of EPHB2. The fourth change, R80H (239G>A) in exon 3, was initially observed in a Fin...",37,2003,BMC_Cancer_2006_Jun_1_6_145.txt
2581G>A,"PAP211	14	2581G>A	D861N	HPP*, 58 years, UK	mother, CRC, 36 y...",91,11,BMC_Cancer_2006_Jun_1_6_145.txt
5-36 G>A,"TP53	EX5-36 G>A, R175H	EX8+35 C>T, R273C	EX8+35 C>T, R273...",167,8,BMC_Cancer_2008_May_28_8_152.txt
8+35 C>T,"TP53	EX5-36 G>A, R175H	EX8+35 C>T, R273C	EX8+35 C>T, R273C	EX4+62 G>A, W53X...",167,26,BMC_Cancer_2008_May_28_8_152.txt
8+35 C>T,"TP53	EX5-36 G>A, R175H	EX8+35 C>T, R273C	EX8+35 C>T, R273C	EX4+62 G>A, W53X...",167,26,BMC_Cancer_2008_May_28_8_152.txt
4+62 G>A,"... G>A, R175H	EX8+35 C>T, R273C	EX8+35 C>T, R273C	EX4+62 G>A, W53X",167,62,BMC_Cancer_2008_May_28_8_152.txt
-271 G>A,...erapy. We investigated the characteristics of the -271 G>A polymorphism of the KDR gene to gain info...,4,194,BMC_Cancer_2009_May_12_9_144.txt
-271 G>A,The sequences of the -271 G>A polymorphism of the KDR gene were assayed...,31,22,BMC_Cancer_2009_May_12_9_144.txt
-271 G>A,The sequences of the -271 G>A polymorphism of the KDR gene were assayed...,31,22,BMC_Cancer_2009_May_12_9_144.txt
-271 G>A,"...lymorphisms in the investigated region except the -271 G>A polymorphism in the 5' UTR. Consequently,...",46,334,BMC_Cancer_2009_May_12_9_144.txt
-271 G>A,"...requencies of the AA, AG, and GG genotypes of the -271 G>A polymorphism in the NSCLC patients were 2...",50,56,BMC_Cancer_2009_May_12_9_144.txt
-271 G>A,The correlations between the -271 G>A polymorphism genotype and the patients' c...,54,30,BMC_Cancer_2009_May_12_9_144.txt
-271 G>A,The -271 G>A polymorphism was not related to the KDR p...,91,5,BMC_Cancer_2009_May_12_9_144.txt
-271 G>A,The -271 G>A polymorphism was not related to the KDR p...,91,5,BMC_Cancer_2009_May_12_9_144.txt
-271 G>A,...irst study to assess the relationship between the -271 G>A polymorphism of KDR and KDR mRNA and prot...,113,235,BMC_Cancer_2009_May_12_9_144.txt
-271 G>A,...n in NSCLC patients. Our results suggest that the -271 G>A polymorphism of the KDR gene may be a fun...,113,348,BMC_Cancer_2009_May_12_9_144.txt
1806C>T,BR386	40	1806C>T	Q563X	3	- (0)	- (0)	1+/2+	0.311	0.048	0.35...,47,10,BMC_Cancer_2009_Oct_10_9_360.txt
300T>G,BR587	38+60 CBC	300T>G	C61G	3	- (0)	- (0)	1+	0.922	0.063	0.984	2 (...,55,17,BMC_Cancer_2009_Oct_10_9_360.txt
4274A>G,BR427	48	4274A>G	L1385L	2	+ (7)	+ (7)	1+	0.000	0.010	0.011	...,89,11,BMC_Cancer_2009_Oct_10_9_360.txt
4274A>G,BR427	48	4274A>G	L1385L	2	+ (7)	+ (7)	1+	0.000	0.010	0.011	...,89,11,BMC_Cancer_2009_Oct_10_9_360.txt
5221T>C,BR570	47	5221T>C	L1701P	3	- (0)	+ (3)	3+	0.094	0.169	0.264	...,95,11,BMC_Cancer_2009_Oct_10_9_360.txt
1767A>G,1767A>G	N550H,105,4,BMC_Cancer_2009_Oct_10_9_360.txt
2-7T>A,"BR376	55	IVS2-7T>A		2	+ (6)	+ (3)	1+	0.000	0.008	0.008	2 (45, ...",109,14,BMC_Cancer_2009_Oct_10_9_360.txt
6328C>T,BR390	51 OC+54 BBC	6328C>T	R2034C	2	+ (5)	+ (8)	-	0.130	0.648	0.777	3...,111,21,BMC_Cancer_2009_Oct_10_9_360.txt
6328C>T,BR390	51 OC+54 BBC	6328C>T	R2034C	2	+ (5)	+ (8)	-	0.130	0.648	0.777	3...,111,21,BMC_Cancer_2009_Oct_10_9_360.txt
9329A>G,BR486	56	2457T>C/ 9329A>G	H743H/R3034Q	3	+ (5)	+ (8)	-	0.000	0.000	0...,115,20,BMC_Cancer_2009_Oct_10_9_360.txt
6751C>G,BR505	67	6751C>G	Q2175E	1	+ (7)	+ (7)	-	0.018	0.426	0.444	4...,117,11,BMC_Cancer_2009_Oct_10_9_360.txt
6751C>G,BR505	67	6751C>G	Q2175E	1	+ (7)	+ (7)	-	0.018	0.426	0.444	4...,117,11,BMC_Cancer_2009_Oct_10_9_360.txt
4236G>A,BR538	62	4236G>A	L1356L	2	+ (7)	+ (7)	-	0.001	0.025	0.026	2...,119,11,BMC_Cancer_2009_Oct_10_9_360.txt
4158A>G,BR552	70	4158A>G	R1347G	3	+ (5)	+ (3)	3+	0.000	0.012	0.012	...,130,11,BMC_Cancer_2009_Oct_10_9_360.txt
4158A>G,BR552	70	4158A>G	R1347G	3	+ (5)	+ (3)	3+	0.000	0.012	0.012	...,130,11,BMC_Cancer_2009_Oct_10_9_360.txt
6328C>T,6328C>T	R2034C,132,4,BMC_Cancer_2009_Oct_10_9_360.txt
4+67A>C,BR567	50	IVS4+67A>C		3	+ (6)	+ (7)	-	0.009	0.215	0.225	3 (37 B...,134,14,BMC_Cancer_2009_Oct_10_9_360.txt
2457T>C,2457T>C	H743H,136,4,BMC_Cancer_2009_Oct_10_9_360.txt
9-34T>C,"BR571	31	IVS9-34T>C		2	+ (3)	+ (6)	3+	0.001	0.037	0.038	3 (50,...",138,14,BMC_Cancer_2009_Oct_10_9_360.txt
5972C>T,5972C>T	T1951M,140,4,BMC_Cancer_2009_Oct_10_9_360.txt
3238G>A,BR580	43	3238G>A	S1040N	3	+ (7)	+ (5)	1+	0.001	0.030	0.031	...,142,11,BMC_Cancer_2009_Oct_10_9_360.txt
-1082 G > A,...A Singh AN Dalela D Srivastava AN Mittal RD IL-10 -1082 G > A: a risk for prostate cancer but may be...,180,83,BMC_Cancer_2010_Aug_24_10_456.txt
20+1G > A,B149	R273H	0	1	1	0	0	0	NA	c.IVS20+1G > A	31,47,32,BMC_Cancer_2010_Nov_30_10_654.txt
2-9C > G,B171	R306X	1	0	0	0	0	1	NA	c.IVS2-9C > G	33,58,32,BMC_Cancer_2010_Nov_30_10_654.txt
2-9C > G,B171	R306X	1	0	0	0	0	1	NA	c.IVS2-9C > G	33,58,32,BMC_Cancer_2010_Nov_30_10_654.txt
817C > T,"...wo mutations in codon 273 are visible (nucleotide 817C > T as originally described, and surprisingly...",74,142,BMC_Cancer_2011_Jun_13_11_243.txt
817C > T,"...wo mutations in codon 273 are visible (nucleotide 817C > T as originally described, and surprisingly...",74,142,BMC_Cancer_2011_Jun_13_11_243.txt
817C > T,"...wo mutations in codon 273 are visible (nucleotide 817C > T as originally described, and surprisingly...",74,142,BMC_Cancer_2011_Jun_13_11_243.txt
7-1A>G,"...gous variant genotype (GG) of XRCC4 rs1805377 (IVS7-1A>G, splice-site) was associated with a signifi...",10,325,BMC_Cancer_2013_May_10_13_234.txt
1799796 A>T,XRCC3: rs1799796 A>T	nsSNP/ A17893G	0.289	0.406,83,10,BMC_Cancer_2013_May_10_13_234.txt
1799796 A>T,XRCC3: rs1799796 A>T	nsSNP/ A17893G	0.289	0.406,83,10,BMC_Cancer_2013_May_10_13_234.txt
1799796 A>T,XRCC3: rs1799796 A>T	nsSNP/ A17893G	0.289	0.406,83,10,BMC_Cancer_2013_May_10_13_234.txt
1799796 A>T,XRCC3: rs1799796 A>T	nsSNP/ A17893G	0.289	0.406,83,10,BMC_Cancer_2013_May_10_13_234.txt
1799943 G>A,BRCA2: rs1799943 G>A	Promoter	0.279	0.722,84,10,BMC_Cancer_2013_May_10_13_234.txt
2227973 G>A,RAG1: rs2227973 G>A	nsSNP/ R820K	0.465	0.586,86,9,BMC_Cancer_2013_May_10_13_234.txt
4541G>A,XRCC3: rs1799794 (−4541G>A),105,20,BMC_Cancer_2013_May_10_13_234.txt
26G>A,BRCA2: rs1799943 (−26G>A),113,20,BMC_Cancer_2013_May_10_13_234.txt
7-1A>G,"...e the first evidence that the XRCC4 rs1805377 (IVS7-1A>G, splice-site) and LIG4 rs1805388 (Ex2 +54C>...",220,139,BMC_Cancer_2013_May_10_13_234.txt
5723G>A,c.117–5723G>A		rs17216473,53,8,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
113G>C,"...that some APOE polymorphisms, i.e., APOE –219G>T, 113G>C, 334T>C (APOE*4), and 472C>T (APOE*2) eithe...",279,835,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
113G>C,"...that some APOE polymorphisms, i.e., APOE –219G>T, 113G>C, 334T>C (APOE*4), and 472C>T (APOE*2) eithe...",279,835,BMC_Cardiovasc_Disord_2015_Oct_24_15_135.txt
46C>T,...uency of the 'risk' variant T in the polymorphism 46C>T (rs1801020) ranges from 0.081 to 0.357 in th...,58,312,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,"...ase of the F7 gene,[12] the FST value for the F12 46C>T 'risk' variant decreased when the Bolivian s...",61,162,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,"...Coast, second, were removed from the dataset. The 46C>T FST value was not significantly different fr...",61,291,BMC_Evol_Biol_2010_Mar_27_10_84.txt
46C>T,"...f the three datasets considered (All Populations: 46C>T FST = 0.104, neutral FST 95% CI [-0.012, 0.1...",61,425,BMC_Evol_Biol_2010_Mar_27_10_84.txt
869T>C,"...TGFB1 SNPs [-509C>T (rs1800469) in the promoter, +869T>C (rs1800470) and +915G>C (rs1800471) in the ...",29,70,BMC_Gastroenterol_2009_Oct_16_9_77.txt
915G>C,"...800469) in the promoter, +869T>C (rs1800470) and +915G>C (rs1800471) in the exon 1] and three promot...",29,94,BMC_Gastroenterol_2009_Oct_16_9_77.txt
-634G>C,"...bed [24]. Assays on the VEGF -1498T>C (rs833061), -634G>C (rs2010963), and +936C>T (rs3025039) SNPs ...",29,623,BMC_Gastroenterol_2009_Oct_16_9_77.txt
-509C>T,"...librium in the control subjects, except for TGFB1 -509C>T and VEGF -634G>C, indicating some possible...",69,289,BMC_Gastroenterol_2009_Oct_16_9_77.txt
-634G>C,"...ntrol subjects, except for TGFB1 -509C>T and VEGF -634G>C, indicating some possible selection bias i...",69,306,BMC_Gastroenterol_2009_Oct_16_9_77.txt
-634G > C,VEGF -634G > C (rs2010963)			0.006,101,6,BMC_Gastroenterol_2009_Oct_16_9_77.txt
-634 G>C,...s of gastric cancer risk associated with the VEGF -634 G>C genotype frequencie,123,81,BMC_Gastroenterol_2009_Oct_16_9_77.txt
-509C>T,"The roles of -509C>T, +869T>C and +915G>C SNPs in TGFB1 have be...",184,14,BMC_Gastroenterol_2009_Oct_16_9_77.txt
869T>C,"The roles of -509C>T, +869T>C and +915G>C SNPs in TGFB1 have been implica...",184,24,BMC_Gastroenterol_2009_Oct_16_9_77.txt
-634G>C,"... potentially functional SNPs (-2578C>A, -1498T>C, -634G>C, and +936C>T) of the VEGF gene or their ha...",186,511,BMC_Gastroenterol_2009_Oct_16_9_77.txt
936C>T,"...unctional SNPs (-2578C>A, -1498T>C, -634G>C, and +936C>T) of the VEGF gene or their haplotypes achie...",186,525,BMC_Gastroenterol_2009_Oct_16_9_77.txt
-634C>G,"...orts the notion that variant genotypes of the VEGF-634C>G polymorphism, but not other tested SNPs, m...",191,137,BMC_Gastroenterol_2009_Oct_16_9_77.txt
4+6A>G,Intron 4	IVS4+6A>G	NA	none	benign	AA 17/39; AG 18/39; GG 4/39 ...,33,13,BMC_Gastroenterol_2012_Oct_15_12_141.txt
17-12 C>A,Intron 17	IVS17-12 C>A	NA	none	benign	1/39 (het: Pt-9) (0.013)	...,40,14,BMC_Gastroenterol_2012_Oct_15_12_141.txt
11+1G>A,"...,26-28]. Genotypes of those cases were 851del4/IVS11+1G>A [9,27], 1638ins23/S225X [26], and genotype...",108,310,BMC_Gastroenterol_2012_Oct_15_12_141.txt
6+5G>A,"...er common mutations were 1638ins23, S255X, and IVS6+5G>A [20]. There is no doubt about the pathogeni...",110,336,BMC_Gastroenterol_2012_Oct_15_12_141.txt
467C>T,...B expression. Sequencing of this A allele (having 467C>T and 1061delC associated with the common A2 ...,7,661,BMC_Genet_2003_Nov_17_4_17.txt
220C>T,"...02] allele: 106C>T (Val36Phe), 188G>A (Arg63His), 220C>T (Pro74Ser) in exons 3, 4 and 5, respectivel...",7,836,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,"...4 and 5, respectively. The additional presence of 46G>A (Ala16Thr) was noted, whilst 189C>T that nor...",7,916,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,"...al presence of 46G>A (Ala16Thr) was noted, whilst 189C>T that normally accompanies 188G>A in O1v was...",7,951,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,"...as noted, whilst 189C>T that normally accompanies 188G>A in O1v was missing, as were all O1v-related...",7,984,BMC_Genet_2003_Nov_17_4_17.txt
646T>A,"...ated mutations in exons 6 and 7 (261delG, 297A>G, 646T>A, 681G>A, 771C>T and 829G>A). On screening o...",7,1080,BMC_Genet_2003_Nov_17_4_17.txt
681G>A,"...ations in exons 6 and 7 (261delG, 297A>G, 646T>A, 681G>A, 771C>T and 829G>A). On screening other sam...",7,1088,BMC_Genet_2003_Nov_17_4_17.txt
681G>A,"...ations in exons 6 and 7 (261delG, 297A>G, 646T>A, 681G>A, 771C>T and 829G>A). On screening other sam...",7,1088,BMC_Genet_2003_Nov_17_4_17.txt
829G>A,"...nd 7 (261delG, 297A>G, 646T>A, 681G>A, 771C>T and 829G>A). On screening other samples, 46G>A was abs...",7,1107,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,"...d an African O1v allele having 188G>A but lacking 189C>T. Sequencing of introns 2, 3, 4 and 5 in com...",7,1263,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,"... allele. Surprisingly, the O1v-specific mutation, 189C>T, was absent, whereas a hitherto undescribed...",43,223,BMC_Genet_2003_Nov_17_4_17.txt
46G>A,"... as several weak A alleles) had the new mutation, 46G>A (Ala16Thr). Amongst all these samples one O1...",49,230,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,...dividual was found to have the O1v-characteristic 188G>A (Arg63His) mutation. One O1v allele from an...,49,357,BMC_Genet_2003_Nov_17_4_17.txt
189C>T,... African individual lacked the O1v-characteristic 189C>T (silent) mutation,49,457,BMC_Genet_2003_Nov_17_4_17.txt
399G>A,"...e consensus from O1v-specific, whereas 354G>A and 399G>A were mutations not previously encountered i...",114,232,BMC_Genet_2003_Nov_17_4_17.txt
277A>G,"...allele when compared to the A consensus sequence (277A>G, 286C>T, 911G>T and 952A>G). However, intro...",117,173,BMC_Genet_2003_Nov_17_4_17.txt
277A>G,"...allele when compared to the A consensus sequence (277A>G, 286C>T, 911G>T and 952A>G). However, intro...",117,173,BMC_Genet_2003_Nov_17_4_17.txt
952A>G,"... A consensus sequence (277A>G, 286C>T, 911G>T and 952A>G). However, intron 6 in three normal A2 alle...",117,200,BMC_Genet_2003_Nov_17_4_17.txt
106C>T,"...veral respects. The O1v-characteristic mutations, 106C>T, 188G>A and 220C>T in exons 3, 4 and 5, res...",122,97,BMC_Genet_2003_Nov_17_4_17.txt
220C>T,"... O1v-characteristic mutations, 106C>T, 188G>A and 220C>T in exons 3, 4 and 5, respectively, in combi...",122,116,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,Few mutations have been found in exon 4. Both 188G>A and 189C>T have hitherto been exclusive cha...,128,47,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,... one otherwise normal O1v allele (African) having 188G>A but lacking 189C>T and one otherwise normal...,128,451,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,... one otherwise normal O1v allele (African) having 188G>A but lacking 189C>T and one otherwise normal...,128,451,BMC_Genet_2003_Nov_17_4_17.txt
188G>A,"...one otherwise normal O1 allele (Jordanian) having 188G>A. Although infrequent, additional genetic di...",128,531,BMC_Genet_2003_Nov_17_4_17.txt
106G>T,"...utations in exon 2 at 46G>A (Ala16Thr), exon 3 at 106G>T (Val36Phe), exon 4 at 188G>A (Arg63His) and...",130,857,BMC_Genet_2003_Nov_17_4_17.txt
205C>T,"... (the consensus 205C rather than the O1v-specific 205C>T, as well as the unique 354G>A and 399G>A) a...",134,117,BMC_Genet_2003_Nov_17_4_17.txt
1024G > T, COL1A1	c.101+1024G >,69,15,BMC_Genet_2010_Oct_21_11_95.txt
64G>A,"...rozen. Genotypes of the individuals for the SILV c64G>A mutation, presumably responsible for dilutio...",159,1058,BMC_Genomics_2007_Sep_24_8_335.txt
964A>G,"rs153109, corresponding to position c.-964A>G of the IL-27 locus, was amplified from geno...",7,40,BMC_Infect_Dis_2014_Sep_5_14(Suppl_5)_S5.txt
-964A>G,"...cular, we analyzed the genotype of this SNP on c. -964A>G. Our data show a different distribution of...",92,214,BMC_Infect_Dis_2014_Sep_5_14(Suppl_5)_S5.txt
1+27G>C,...e 1) and in his non-affected mother (genotyped IVS1+27G>C/+). The IVS1+27G>C variation was not previ...,47,982,BMC_Med_Genet_2005_Mar_24_6_12.txt
765C>T,"...ts non-pathogenic consequences [27]. Finally, the 765C>T polymorphism (referred to as SNP1 [9]) loca...",47,1150,BMC_Med_Genet_2005_Mar_24_6_12.txt
1+27G>C,IVS1+27G>C / [V27I; E114G]	1	Altaian,107,4,BMC_Med_Genet_2005_Mar_24_6_12.txt
1+27G>C,IVS1+27G>C / [V27I; E114G]	1	Altaian,107,4,BMC_Med_Genet_2005_Mar_24_6_12.txt
1+27G>C,IVS1+27G>C / [V27I; E114G]	1	Altaian,107,4,BMC_Med_Genet_2005_Mar_24_6_12.txt
1+27G>C,IVS1+27G>C,151,5,BMC_Med_Genet_2005_Mar_24_6_12.txt
1+27G>C,IVS1+27G>C,151,5,BMC_Med_Genet_2005_Mar_24_6_12.txt
79G>A,V27I	79G>A	1,156,6,BMC_Med_Genet_2005_Mar_24_6_12.txt
79G>A,V27I	79G>A	1,156,6,BMC_Med_Genet_2005_Mar_24_6_12.txt
79G>A,V27I	79G>A	1,156,6,BMC_Med_Genet_2005_Mar_24_6_12.txt
-207G>C,...The OCTN2-promoter (rs2631367) is a transversion (-207G>C) disrupting a heat shock element in the pr...,24,855,BMC_Med_Genet_2006_Jun_23_7_54.txt
-207G>C,"...1173605_1, respectively. For the SLC22A5 promoter -207G>C (rs2631367), a TaqMan Assay by Design was ...",31,365,BMC_Med_Genet_2006_Jun_23_7_54.txt
-207G>C,"...1173605_1, respectively. For the SLC22A5 promoter -207G>C (rs2631367), a TaqMan Assay by Design was ...",31,365,BMC_Med_Genet_2006_Jun_23_7_54.txt
1672G>C,"Regarding the L503F (1672G>C) polymorphism, it was described by Pelteko...",67,22,BMC_Med_Genet_2006_Jun_23_7_54.txt
2233546C>T,"... CAPN5 gene variants(rs948976A>G, rs4945140G>A, rs2233546C>T and rs2233549G>A) with several cardiova...",6,719,BMC_Med_Genet_2007_Jan_16_8_1.txt
2233546C>T,"... CAPN5 gene variants(rs948976A>G, rs4945140G>A, rs2233546C>T and rs2233549G>A) with several cardiova...",6,719,BMC_Med_Genet_2007_Jan_16_8_1.txt
2233546C>T,"... CAPN5 gene variants(rs948976A>G, rs4945140G>A, rs2233546C>T and rs2233549G>A) with several cardiova...",6,719,BMC_Med_Genet_2007_Jan_16_8_1.txt
948976 A>G,We have analysed two polymorphisms in intron 1 (rs948976 A>G and rs4945140 G>A) and two polymorphism...,69,51,BMC_Med_Genet_2007_Jan_16_8_1.txt
223546 C>T,"...rphisms located in the, intron 3 of CAPN5 gene (rs223546 C>T and rs223549 G>A) (Figure 1). These las...",69,145,BMC_Med_Genet_2007_Jan_16_8_1.txt
223549 G>A,"...n the, intron 3 of CAPN5 gene (rs223546 C>T and rs223549 G>A) (Figure 1). These last two SNPs are lo...",69,162,BMC_Med_Genet_2007_Jan_16_8_1.txt
223546 C>T,"...G allele in rs4945140 G>A, 0.94 for C allele in rs223546 C>T and 0.80 for G allele in rs223549G>A. T...",84,234,BMC_Med_Genet_2007_Jan_16_8_1.txt
223546 C>T,"...G allele in rs4945140 G>A, 0.94 for C allele in rs223546 C>T and 0.80 for G allele in rs223549G>A. T...",84,234,BMC_Med_Genet_2007_Jan_16_8_1.txt
223546 C>T,"...G allele in rs4945140 G>A, 0.94 for C allele in rs223546 C>T and 0.80 for G allele in rs223549G>A. T...",84,234,BMC_Med_Genet_2007_Jan_16_8_1.txt
223546 C>T,rs223546 C>T	0.94	1.0	CC	CT	TT,95,3,BMC_Med_Genet_2007_Jan_16_8_1.txt
223546 C>T,rs223546 C>T	0.94	1.0	CC	CT	TT,95,3,BMC_Med_Genet_2007_Jan_16_8_1.txt
4945140 G>A,"...A, 27.8 ± 4.2 kg/m2; p = 0.041, r2 = 2.0%). The rs4945140 G>A marker is also associated with DBP val...",102,547,BMC_Med_Genet_2007_Jan_16_8_1.txt
223549G>A,"...ron 1 (D' = -1, r2 = 0.26) and rs223546 C>T and rs223549G>A in intron 3 (D' = -1, r2 = 0.02), separa...",114,142,BMC_Med_Genet_2007_Jan_16_8_1.txt
1G>C,III	P	F	35	9.2	21.6	4032	7.80	485	+/+	c.808-1G>C/r.spl?,52,45,BMC_Med_Genet_2008_Jun_20_9_54.txt
1G>C,C	F	28	1.1	0.8	97	1.70	127	-/-	c.808-1G>C/r.spl?,53,39,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,VII	P	F	28	2.0	1.9	948	8.00	428	-/+	c. 995 G>C/pG332A,59,40,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,F	M	60	1.6	2.0	30	1.12 (619)	78	-/-	c. 995 G>C/pG332A,60,41,BMC_Med_Genet_2008_Jun_20_9_54.txt
808-1 G>C,...lice acceptor site between intron 7 and exon 8 (c 808-1 G>C) and is expected to affect normal splici...,181,919,BMC_Med_Genet_2008_Jun_20_9_54.txt
1G>C,III	P	13.15	39.55	c.808-1G>C/r.spl?,193,25,BMC_Med_Genet_2008_Jun_20_9_54.txt
1G>C,C	16.85	50.67	c.808-1G>C/r.spl?,195,22,BMC_Med_Genet_2008_Jun_20_9_54.txt
995 G>C,C	19.21	57.77	c. 995 G>C/pG332A,200,19,BMC_Med_Genet_2008_Jun_20_9_54.txt
481C>T,"...983, rs59855457), 341T>C (rs1801280, rs56935242), 481C>T (rs1799929, rs60310310), 590G>A (rs1799930,...",27,227,BMC_Med_Genet_2009_Dec_31_10_148.txt
590G>A,"...280, rs56935242), 481C>T (rs1799929, rs60310310), 590G>A (rs1799930, rs60190029), 803A>G (rs1208, rs...",27,259,BMC_Med_Genet_2009_Dec_31_10_148.txt
803A>G,"...929, rs60310310), 590G>A (rs1799930, rs60190029), 803A>G (rs1208, rs56599719, rs58999469), and 857G>...",27,291,BMC_Med_Genet_2009_Dec_31_10_148.txt
191G>A,...mples that were genotyped for all SNPs except SNP 191G>A as this is rare in non-African populations....,27,522,BMC_Med_Genet_2009_Dec_31_10_148.txt
191G>A,"...ier implemented in NAT2PRED of the functional SNP 191G>A which, although monomorphic in most worldwi...",34,661,BMC_Med_Genet_2009_Dec_31_10_148.txt
179A>G,"...hree nucleotide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to th...",12,52,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,"...hree nucleotide substitutions were identified: c.-179A>G, c.-27A>C, and c.-22T>C. With respect to th...",12,52,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...G, c.-27A>C, and c.-22T>C. With respect to the c.-22T>C mutation, GALK1 activity in 13 subjects with...",12,107,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"The c.-22T>C mutation, which was observed frequently in i...",15,8,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,... CAC CAT AG-3') primer was used to confirm the c.-179A>G and c.-27A>C mutations. We screened 101 hea...,36,437,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,... CAC CAT AG-3') primer was used to confirm the c.-179A>G and c.-27A>C mutations. We screened 101 hea...,36,437,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,"...confirmed by performing PCR-RFLP (Fig. 1). For c.-179A>G, 56 subjects with A/A genotype, 5 with A/G ...",49,557,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...C, are benign sequence variations. In terms of c.-22T>C, 50 individuals with T/T, 12 with T/C, and 1...",49,967,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,"...hism. Genotype distributions of the c.-179A>G, c.-27A>C and c.-22T>C variations did not deviate from...",49,1273,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,"...e distributions of the c.-179A>G, c.-27A>C and c.-22T>C variations did not deviate from those expect...",49,1286,BMC_Med_Genet_2009_Mar_24_10_29.txt
179A>G,c.-179A>G	A/A	56	117.2 ± 41.7	0.012	1.39 ± 2.06	0.001...,56,4,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,...uencing revealed the presence of a mutation of c.-22T>C (A). Gel electrophoresis patterns of PCR amp...,69,131,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,"...f GALK1 (Table 1), which further suggests that c.-27A>C is a nonfunctional polymorphism",71,983,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,"...d increase (Fig. 3). In terms of c.-179A>G and c.-27A>C, the relative luciferase activity was not si...",80,488,BMC_Med_Genet_2009_Mar_24_10_29.txt
27A>C,"...d increase (Fig. 3). In terms of c.-179A>G and c.-27A>C, the relative luciferase activity was not si...",80,488,BMC_Med_Genet_2009_Mar_24_10_29.txt
22T>C,Figure 3 c.-22T>C mutation resulted in increased reporter acti...,82,13,BMC_Med_Genet_2009_Mar_24_10_29.txt
-786T > C,"...te R Gensini GF Endothelial nitric oxide synthase -786T > C, but not 894G > T and 4a4b, polymorphism...",212,128,BMC_Med_Genet_2010_Sep_20_11_133.txt
3754032	T > A,1	111784127	rs3754032	T > A	26.0	WDR77	0.02	0.505	0.07	0.032	0.0...,90,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
10496276	T > G,2	82913481	rs10496276	T > G	19.2		0.02	0.638	0.01	0.696	0.00	0....,92,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
10496734	G > A,2	135824309	rs10496734	G > A	14.9	ZRANB3	-0.04	0.363	-0.03	0.447...,94,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
2251471	T > C,2	158955976	rs2251471	T > C	6.7	CCDC148	0.09	0.123	0.12	0.027	0....,95,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
10513577	T > C,3	163243925	rs10513577	T > C	31.0		0.00	0.991	0.01	0.773	0.02	0....,98,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
10513577	T > C,3	163243925	rs10513577	T > C	31.0		0.00	0.991	0.01	0.773	0.02	0....,98,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
1033059	A > G,3	163273126	rs1033059	A > G	31.0		0.00	0.943	0.01	0.815	0.02	0.5...,99,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
2099082	T > C,5	54231548	rs2099082	T > C	23.6	ESM1	0.00	0.903	-0.01	0.767	0.0...,105,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
6925466	C > T,6	96483564	rs6925466	C > T	38.9	FUT9	0.00	0.870	0.00	0.888	-0.0...,108,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
7786503	A > C,7	14495103	rs7786503	A > C	8.0	DGKB	0.02	0.643	0.02	0.759	0.02	...,109,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
10499444	C > G,7	14497256	rs10499444	C > G	7.7	DGKB	0.01	0.869	-0.01	0.898	0.0...,110,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
6462230	G > C,7	30896348	rs6462230	G > C	10.7	FLJ22374	0.04	0.396	0.06	0.221	...,111,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
6462230	G > C,7	30896348	rs6462230	G > C	10.7	FLJ22374	0.04	0.396	0.06	0.221	...,111,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
6462230	G > C,7	30896348	rs6462230	G > C	10.7	FLJ22374	0.04	0.396	0.06	0.221	...,111,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
6462230	G > C,7	30896348	rs6462230	G > C	10.7	FLJ22374	0.04	0.396	0.06	0.221	...,111,14,BMC_Med_Genet_2011_Jan_28_12_19.txt
2214681	G > A,7	147333625	rs2214681	G > A	42.5	CNTNAP2	0.00	0.950	-0.01	0.723	...,112,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
238358	G > A,13	41736674	rs238358	G > A	9.5	AKAP11	0.03	0.536	0.03	0.516	-0.0...,116,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
10492621	G > A,13	92478066	rs10492621	G > A	24.2	GPC5	-0.06	0.068	-0.07	0.042	-...,117,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
10513893	C > T,14	86696500	rs10513893	C > T	7.2		0.01	0.830	-0.01	0.821	0.04	0....,118,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
8049649	A > T,16	26362052	rs8049649	A > T	17.6	HS3ST4	0.06	0.080	0.05	0.197	0....,119,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
10485640	A > G,20	23097739	rs10485640	A > G	9.7	CD93	-0.05	0.274	-0.05	0.334	-0...,120,15,BMC_Med_Genet_2011_Jan_28_12_19.txt
1G>A,"...ote at this gene. One of these alterations, c.574+1G>A, is located at the splice donor site of intro...",7,756,BMC_Med_Genet_2011_Jun_27_12_86.txt
2 A>G,"...intron 5. We also found a second mutation, c.2206-2 A>G, not previously reported in the literature, ...",7,851,BMC_Med_Genet_2011_Jun_27_12_86.txt
2 A>G,"...intron 5. We also found a second mutation, c.2206-2 A>G, not previously reported in the literature, ...",7,851,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>A,...ing analysis. It has been proposed that the c.574+1G>A mutation would cause exon 5 skipping during N...,7,1091,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>A,...ing analysis. It has been proposed that the c.574+1G>A mutation would cause exon 5 skipping during N...,7,1091,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,"...tantly, we provide evidence that the novel c.2206-2A>G mutation also disrupts normal NTRK1 splicing,...",7,1259,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,"... patient were shown to be carriers for the c.2206-2A>G mutation, whereas her mother was shown to be ...",38,406,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>A,...ge affecting the first nucleotide of IVS 5 (c.574+1G>A) has been reported in an earlier study [12],38,700,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>C,"To assess the consequences of the c.574+1G>C and c.2206-2A>G mutations on NTRK1 splicing, ...",40,41,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,"...n of the first 21 bp of exon 17. Thus, the c.2206-2A>G mutation leads to the production of two diffe...",42,1023,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,"...r of the proband, who are carriers for the c.2206-2A>G mutation",42,1898,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,"...r of the proband, who are carriers for the c.2206-2A>G mutation",42,1898,BMC_Med_Genet_2011_Jun_27_12_86.txt
1G>C,"...6,14]. The skipping of exon 5 caused by the c.574+1G>C mutation introduces a frame shift that is pre...",44,1318,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,...-functional NTRK1 protein (Figure 2B). The c.2206-2A>G mutation is of greater interest in the contex...,44,1463,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,...-functional NTRK1 protein (Figure 2B). The c.2206-2A>G mutation is of greater interest in the contex...,44,1463,BMC_Med_Genet_2011_Jun_27_12_86.txt
2A>G,...-functional NTRK1 protein (Figure 2B). The c.2206-2A>G mutation is of greater interest in the contex...,44,1463,BMC_Med_Genet_2011_Jun_27_12_86.txt
-786T>C,"...helial nitric oxide synthase Glu298Asp, 4b/a, and -786T>C gene variants with diabetic nephropathy J ...",403,80,BMC_Med_Genet_2014_Jan_16_15_9.txt
-634 G-->C,...potential implication of the VEGF -1154 G-->A and -634 G-->C polymorphisms in the development of nep...,67,1985,BMC_Musculoskelet_Disord_2007_Jan_4_8_1.txt
-634 G-->C,...potential implication of the VEGF -1154 G-->A and -634 G-->C polymorphisms in the development of nep...,67,1985,BMC_Musculoskelet_Disord_2007_Jan_4_8_1.txt
1408C>T,8	1408C>T	Gln470X	Exon 11	-	[1],61,3,BMC_Neurol_2011_Oct_1_11_119.txt
1576 G>A,11	1576 G>A	Glu526Lys	Exon 12	-	[1],67,4,BMC_Neurol_2011_Oct_1_11_119.txt
3232 G>A,14	3232 G>A	Ala1078Thr	Exon 27	Pakistani	[2],73,4,BMC_Neurol_2011_Oct_1_11_119.txt
458C>G,c. 458C>G	c. 1204C>T,119,4,BMC_Neurosci_2016_Feb_1_17_6.txt
985A > G,...le have an increased frequency of the common MCAD 985A > G mutation J Inherit Metab Dis 2005 28 551 ...,148,142,BMC_Pediatr_2010_Nov_17_10_82.txt
677C-->T,"... P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR 677C-->T polymorphism and risk of coronary heart d...",210,70,BMJ_2009_Nov_5_339_b4265.txt
677C-->T,"... P, Clarke R, Blom HJ, Kok FJ, Schouten EG. MTHFR 677C-->T polymorphism and risk of coronary heart d...",210,70,BMJ_2009_Nov_5_339_b4265.txt
4+919G>A,... of the later-onset GLA mutation c.936+919G>A (IVS4+919G>A) . Hum Mutat,491,121,BMJ_Open_2016_Apr_8_6(4)_e010422.txt
-27 G>A,...stigated the Kruppel-like factor 6 rs37508611 IVSI-27 G>A polymorphism on two cohorts of 306 UK and ...,275,271,BMJ_Open_Gastroenterol_2015_Feb_17_2(1)_e000019.txt
144 T -> G,"amino acid change, 144 T -> G and 192 C -* T. One alteration",344,20,Br_J_Cancer_1997_76(12)_1550-1553.txt
765G>C,... a statistically significant effect of the COX-2 −765G>C gene polymorphism on colon cancer risk amon...,122,99,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
765G>C,"...ase activity in reporter expression studies. The −765G>C mutation lies within this region, and is al...",130,635,Br_J_Cancer_2004_May_4_90(9)_1760-1764.txt
464 T>C,c.1-464 T>C	Promotera	44	30 (68%)	6 (14%)	8 (18%)	38	1...,103,5,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
644 A>G,c.1-644 A>G	5′ UTRd	44	29 (66%)	8 (18%)	7 (16%)	48	12 ...,109,5,Br_J_Cancer_2004_Sep_13_91(6)_1119-1130.txt
1306C>T,...-nucleotide polymorphism (SNP) analysis for MMP-2−1306C>T and MMP-9−1562C>T was performed by tetra-p...,20,132,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1306C>T,"...did not show an association with either SNP MMP-2−1306C>T or MMP-9−1562C>T, and the latter was also ...",26,450,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1562C>T,"...ssociation with either SNP MMP-2−1306C>T or MMP-9−1562C>T, and the latter was also not associated wi...",26,467,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1562C>T,"...ssociation with either SNP MMP-2−1306C>T or MMP-9−1562C>T, and the latter was also not associated wi...",26,467,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1562C>T,"...ssociation with either SNP MMP-2−1306C>T or MMP-9−1562C>T, and the latter was also not associated wi...",26,467,Br_J_Cancer_2008_Jun_3_98(11)_1820-1823.txt
1306C>T,"... (Miller et al, 1988). The SNP analysis for MMP-2−1306C>T and MMP-9−1562C>T was performed by restric...",30,121,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
-2-1306C>T,"...(Meijer et al, 2006). Genotype frequencies for MMP-2-1306C>T were CC: n=108: CT: n=79 and TT: n=11, ...",30,438,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
-9-1562C>T,"...were CC: n=108: CT: n=79 and TT: n=11, and for MMP-9-1562C>T CC: n=139; CT: n=50 and TT: n=9",30,499,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
-2-1306C>T,The genotypes of the MMP-2-1306C>T and MMP-9-1562C>T polymorphism were dis...,38,25,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
-9-1562C>T,The genotypes of the MMP-2-1306C>T and MMP-9-1562C>T polymorphism were distributed according...,38,43,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
-9-1562C>T,The genotypes of the MMP-2-1306C>T and MMP-9-1562C>T polymorphism were distributed according...,38,43,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
-9-1562C>T,The genotypes of the MMP-2-1306C>T and MMP-9-1562C>T polymorphism were distributed according...,38,43,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
-9-1562C>T,The genotypes of the MMP-2-1306C>T and MMP-9-1562C>T polymorphism were distributed according...,38,43,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
1306C>T,...ld be more likely. T allele carriers of the MMP-2−1306C>T polymorphism have lower promoter activity ...,45,483,Br_J_Cancer_2012_Apr_24_106(9)_1495-1498.txt
2T>C,...tation giving a similar truncated protein to the c2T>C mutation,66,765,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"...ted with pMEP4-ATM wt (pTAM2), pMEP4-ATM 8672G>A (8672G>A) or pMEP4 vector alone (pMEP4) all with N-...",114,1142,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"...ted with pMEP4-ATM wt (pTAM2), pMEP4-ATM 8672G>A (8672G>A) or pMEP4 vector alone (pMEP4) all with N-...",114,1142,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"...targets Smc1, KAP-1 and Nbs1 by the p.Gly2891Asp (8672G>A) protein were substantially lower than tho...",114,1564,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
8672G>A,"...targets Smc1, KAP-1 and Nbs1 by the p.Gly2891Asp (8672G>A) protein were substantially lower than tho...",114,1564,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
10-6T>G,...nnon P Haile RW  2003 ATM variants 7271T>G and IVS10-6T>G among women with unilateral and bilateral ...,130,199,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
6T>G,...iated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Re...,131,311,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
6T>G,...iated with ATM gene variants c.7271T>G and c.1066-6T>G (IVS10-6T>G) from the Breast Cancer Family Re...,131,311,Br_J_Cancer_2012_Jan_17_106(2)_262-268.txt
387T>G,"...T1A6 (19T>G, 315A>G, 541A>G, and 552A>C), UGT1A7 (387T>G, 391C>A, 392G>A, and 622T>C), CYP2A6*4 (who...",36,522,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
387T>G,"...T1A6 (19T>G, 315A>G, 541A>G, and 552A>C), UGT1A7 (387T>G, 391C>A, 392G>A, and 622T>C), CYP2A6*4 (who...",36,522,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
391C>A,"...T>G, 315A>G, 541A>G, and 552A>C), UGT1A7 (387T>G, 391C>A, 392G>A, and 622T>C), CYP2A6*4 (whole delet...",36,530,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
541A>G,"...ucleotide polymorphisms in UGT1A6 (19T>G, 315A>G, 541A>G and 552A>C) and UGT1A7 (387T>G, 391C>A, 392...",70,128,Br_J_Cancer_2013_Sep_17_109(6)_1420-1427.txt
86G>T,RP-773	38	20	0.05	0.05	RP	c.33N86G>T(23)	p.Arg1129Leu	ND	ND	NP,104,32,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
6-32 T>C,IVS6-32 T>C		915,116,5,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
6-32 T>C,IVS6-32 T>C		915,116,5,Br_J_Ophthalmol_2009_May_21_93(5)_614-621.txt
16445774 G>A,"....Pro149Leu, which is located in exon 2 and g.chr7:16445774 G>A, c.643 C>T, p.Gln215* in exon 3. Exom...",116,422,Brain_2013_Jan_3_136(1)_269-281.txt
16445843 C>T,"... heterozygous missense mutation in exon 2: g.chr7:16445843 C>T, which is c.377G>A, leading to p.Arg1...",116,837,Brain_2013_Jan_3_136(1)_269-281.txt
284G>A,(i)	1	4 y	c.[284G>A] (M) + c.[148G> A];c.[364-1G>A]a (P)	p.R95H...,47,14,Brain_2014_May_18_137(5)_1350-1360.txt
98A>T,2	5 y 2 m	c.[98A>T] + c.[98A>T]	p.D33V + p.D33V	6 h	Hoffmann et...,48,15,Brain_2014_May_18_137(5)_1350-1360.txt
98A>T,"2	5 y 2 m	c.[98A>T] + c.[98A>T]	p.D33V + p.D33V	6 h	Hoffmann et al., 2007",48,27,Brain_2014_May_18_137(5)_1350-1360.txt
637C>T,4*	4 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	None*	Novel...,50,12,Brain_2014_May_18_137(5)_1350-1360.txt
637C>T,4*	4 m	c.[637C>T] + c.[637C>T]	p.P213S + p.P213S	None*	Novel,50,25,Brain_2014_May_18_137(5)_1350-1360.txt
283C>T,5	1 y	c.[283C>T] (M) + c.[283C>T] (P)	p.R95C (M) + p.R95C (P)	2 h	Khayat et ...,51,28,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,(ii)	7	6 y 5 m	c.[347G>A] (M) + c.[347G>A] (P)	p.R116Q (M) + p.R116Q...,53,19,Brain_2014_May_18_137(5)_1350-1360.txt
347G>A,(iii)	8	9 y	c.[347G>A] + c.[347G>A]	p.R116Q + p.R116Q	3 h	Novel,54,16,Brain_2014_May_18_137(5)_1350-1360.txt
998A>T,"9	2 y	c.[98A>T] + c.[998A>T]	p.D33V + p.D33V	3 w	Hoffmann et al., 2007",55,23,Brain_2014_May_18_137(5)_1350-1360.txt
98A>T,12	41 y	c.[98A>T] + c.[347G>A] + c. [673C>T]	p.D33V + p.R116Q...,58,13,Brain_2014_May_18_137(5)_1350-1360.txt
673C>T,12	41 y	c.[98A>T] + c.[347G>A] + c. [673C>T]	p.D33V + p.R116Q + p.R225Cb	14 d	Hoffmann ...,58,39,Brain_2014_May_18_137(5)_1350-1360.txt
673C>T,12	41 y	c.[98A>T] + c.[347G>A] + c. [673C>T]	p.D33V + p.R116Q + p.R225Cb	14 d	Hoffmann ...,58,39,Brain_2014_May_18_137(5)_1350-1360.txt
347G >A,14	3 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R2...,60,36,Brain_2014_May_18_137(5)_1350-1360.txt
674G>A,14	3 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H + p.R116Q;p.R225H c	30 min...,60,48,Brain_2014_May_18_137(5)_1350-1360.txt
674G>A,15	9 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H +...,61,23,Brain_2014_May_18_137(5)_1350-1360.txt
674G>A,15	9 y	c.[347G>A];c.[674G>A] + c.[347G >A];c.[674G>A]	p.R116Q;p.R225H +...,61,23,Brain_2014_May_18_137(5)_1350-1360.txt
148G>A,"ac.[148G>A] and c.[364-1G>A] were inherited in cis, th...",74,5,Brain_2014_May_18_137(5)_1350-1360.txt
1G>A,...ent 1) in cis with the splice site mutation c.364-1G>A (IVS3-1g>a). Previous expression studies conc...,153,951,Brain_2014_May_18_137(5)_1350-1360.txt
364-1G>A,"ac.[148G>A] and c.[364-1G>A] were inherited in cis, this was confrime...",201,20,Brain_2014_May_18_137(5)_1350-1360.txt
364-1G>A,"R95H, R95C and E50K with c.[364-1G>A]: alleles associated with infertility, mi...",222,29,Brain_2014_May_18_137(5)_1350-1360.txt
364-1G>A,"R95H, R95C and E50K with c.[364-1G>A]: alleles associated with infertility, mi...",222,29,Brain_2014_May_18_137(5)_1350-1360.txt
-432C>T,... genotype and allelic distributions of the PIK3C3 -432C>T (rs3813065) between BD patients and contro...,52,271,Brain_Behav_2011_Nov_1(2)_119-124.txt
677C -> T,... Calhoun VD  Wassink TH  Weiss AP  Ho BC    MTHFR 677C -> T genotype disrupts prefrontal function in...,378,73,Brain_Imaging_Behav_2014_Jan_8_8(2)_153-182.txt
1260C>A,... was used to assess functional expression of the –1260C>A CYP27B1 variants. The association between ...,3,2099,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
1260C>A,...ream of the transcription start site of CYP27B1 (–1260C>A) and was strongly associated with either t...,24,104,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
2838T>C,CYP27B1 +2838T>C,95,10,Calcif_Tissue_Int_2011_Feb_25_88(2)_109-116.txt
61A >G,"...R ligands. Variants in the ligand EGF, namely EGF 61A >G seemed to be associated with an improved OS...",66,162,Cancer_Manag_Res_2009_Jul_23_1_79-88.txt
-712C>T,"...ms and their haplotypes, -1263A>G (rs4645978) and -712C>T (rs4645981), have been reported to both af...",23,354,Cancer_Res_Treat_2012_Mar_31_44(1)_32-36.txt
13006529A>T,...risk [12]. The V410I (rs13010627G>A) and I522L (rs13006529A>T) polymorphisms of the CASP10 gene have...,23,501,Cancer_Res_Treat_2012_Mar_31_44(1)_32-36.txt
13006529A>T,...risk [12]. The V410I (rs13010627G>A) and I522L (rs13006529A>T) polymorphisms of the CASP10 gene have...,23,501,Cancer_Res_Treat_2012_Mar_31_44(1)_32-36.txt
13006529A>T,...risk [12]. The V410I (rs13010627G>A) and I522L (rs13006529A>T) polymorphisms of the CASP10 gene have...,23,501,Cancer_Res_Treat_2012_Mar_31_44(1)_32-36.txt
-420C > G,"...sis through AMPK activation [58]. Furthermore, SNP-420C > G of the resistin gene was associated with...",318,919,Cardiovasc_Diabetol_2011_Jan_21_10_8.txt
5067G>A,"c5067G>A, p.Trp1689X",71,2,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
5067G>A,"c5067G>A, p.Trp1689X",71,2,Case_Rep_Neurol_Med_2014_Sep_18_2014_141953.txt
1432A>G,"...itivity. Therefore, the association of homozygous 1432A>G with sensitivity to ionizing radiation was...",15,612,Cell_Death_Dis_2014_Mar_20_5(3)_e1130.txt
1432A>G,"...redicted to be deleterious by Polyphen.38, 39 The 1432A>G MTPAP mutation, and lack of ATM mutations,...",21,1401,Cell_Death_Dis_2014_Mar_20_5(3)_e1130.txt
1 G > T,"...sion at the exon-intron junction of exon 6 (c.748+1 G > T), which segregated with the disease in the...",23,787,Cell_Rep_2014_Aug_7_8(3)_647-655.txt
2995G>A,"... in 1998 found SNPs in exons 21 (2677G>T) and 24 (2995G>A) in the MDR1 gene. Subsequently, over 50 d...",47,769,Chin_J_Cancer_2012_Feb_31(2)_51-57.txt
34G>A,"...nt polymorphisms of BCRP among over 50 others are 34G>A and 421C>A[66],[67]. The 421C>A SNP has been...",47,1619,Chin_J_Cancer_2012_Feb_31(2)_51-57.txt
421C>A,"...phisms of BCRP among over 50 others are 34G>A and 421C>A[66],[67]. The 421C>A SNP has been associate...",47,1629,Chin_J_Cancer_2012_Feb_31(2)_51-57.txt
2043556	A>G,Has-miR-605	10q21.1	rs2043556	A>G	99.77	0.753	0.281,82,23,Chin_J_Cancer_2016_Aug_11_35_77.txt
4919510	G>C,Has-miR-608	10q25.1	rs4919510	G>C	99.85	0.835	0.425	0.245	0.408,87,23,Chin_J_Cancer_2016_Aug_11_35_77.txt
318C>T,...hn J  Capasso M  Lanciotti M    The polymorphism −318C>T in the promoter and 49A>G in exon 1 of CTLA...,146,57,Clin_Dev_Immunol_2012_Aug_26_2012_123789.txt
49A>G,...M    The polymorphism −318C>T in the promoter and 49A>G in exon 1 of CTLA4 and the risk of aplastic ...,146,84,Clin_Dev_Immunol_2012_Aug_26_2012_123789.txt
1082G > A,"...lationship of three SNPs in IL-10 gene promoter (−1082G > A, −824C > T, and −597C > A) with SLE susc...",65,456,Clin_Dev_Immunol_2012_Sep_20_2012_963730.txt
824C > T,"...f three SNPs in IL-10 gene promoter (−1082G > A, −824C > T, and −597C > A) with SLE susceptibility i...",65,468,Clin_Dev_Immunol_2012_Sep_20_2012_963730.txt
14+1G>A,"...San Juan Capistrano, CA), was negative for the IVS14+1G>A mutation in the DPD gene, which accounts f...",32,472,Cureus_8(9)_e798.txt
1679 T>G,"...detected. The commonly found DPYD gene mutations (1679 T>G, 1905+1 G>A, 2846 A>T) were not detected ...",32,1129,Cureus_8(9)_e798.txt
2846 A>T,"... found DPYD gene mutations (1679 T>G, 1905+1 G>A, 2846 A>T) were not detected either",32,1151,Cureus_8(9)_e798.txt
1905+1 G>A,"...herapy [8]. Interestingly, DPYD*2A (also known as 1905+1 G>A) was not significantly associated with ...",37,686,Cureus_8(9)_e798.txt
3435C-->T,...e risk of hyperbilirubinemia are predicted by the 3435C-->T polymorphism at the multidrug resistance...,225,131,Clin_Pharmacol_2013_Sep_27_5_153-159.txt
-786T>C,...uded in the analysis. They were genotyped for eNOS-786T>C SNP (rs2070744) with the Taqman® allelic d...,85,287,Clin_Pharmacol_Ther_2014_Jul_17_96(1)_27-35.txt
-786T>C,...ura M  Sakamoto T  Abe K  Yamamuro M  Shono M    A-786T>C polymorphism in the endothelial nitric oxi...,224,72,Clin_Pharmacol_Ther_2014_Jul_17_96(1)_27-35.txt
1-126G > T,"... investigation (25). For instance, the variant IVS1-126G > T in a large family with the G533C mutati...",26,2178,Clinics_(Sao_Paulo)_2012_Apr_67(Suppl_1)_91-97.txt
949C>T,"... NFKB1 c.-798_-795delATTG (rs28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10...",9,80,Croat_Med_J_2014_Dec_55(6)_638-646.txt
949C>T,"... NFKB1 c.-798_-795delATTG (rs28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10...",9,80,Croat_Med_J_2014_Dec_55(6)_638-646.txt
352A>T,"...s28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF ...",9,108,Croat_Med_J_2014_Dec_55(6)_638-646.txt
352A>T,"...s28362491), NFKBIA c.-949C>T (rs2233406), IL-8 c.-352A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF ...",22,650,Croat_Med_J_2014_Dec_55(6)_638-646.txt
418G>A,"...A>T (rs4073), IL-10 c.-854T>C (rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629) p...",22,703,Croat_Med_J_2014_Dec_55(6)_638-646.txt
488G>A,"...(rs1800871), TNF c.-418G>A (rs361525), and TNF c.-488G>A (rs1800629) polymorphisms with breast cance...",22,733,Croat_Med_J_2014_Dec_55(6)_638-646.txt
418G>A,"For TNF c.-418G>A (rs361525) polymorphism, the primers used w...",37,12,Croat_Med_J_2014_Dec_55(6)_638-646.txt
488G>A,"...c.-418G>A polymorphism, and GA genotype of TNF c.-488G>A polymorphism significantly reduced breast c...",320,288,Croat_Med_J_2014_Dec_55(6)_638-646.txt
1555A>G,"...ne, in which the hearing loss associated with the 1555A>G mitochondrial mutation is more severe in p...",66,940,Curr_Genomics_2010_Jun_11(4)_269-278.txt
1331T>C,...traceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump ...,254,225,Curr_Med_Chem_2009_Aug_16(23)_3041-3053.txt
1331T>C,...traceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump ...,254,225,Curr_Med_Chem_2009_Aug_16(23)_3041-3053.txt
-262C>T,...between functional polymorphism of catalase gene (-262C>T) and recurrent depressive disorder. Neuro....,214,126,Curr_Neuropharmacol_2014_Mar_12(2)_108-119.txt
1165G>C,"... receptor polymorphisms: analysis of c145A>G and c1165G>C . Hum. Mutat ., 14 , 271. 10477438",252,127,Database_(Oxford)_2016_Sep_1_2016_baw124.txt
-629C>A,"...diconis X, Chew SK, Loh LM, Tan CE: The TaqIB and -629C>A polymorphisms at the cholesteryl ester tra...",74,111,Diabetes_2008_Oct_57(10)_2851-2857.txt
1648707 A>C,"... A>G; SNP3 = rs266729 C>G; in MONICA/KORA S123, rs1648707 A>C has served as proxy for SNP3 with link...",24,1304,Diabetes_2009_Apr_15_58(4)_984-991.txt
1648707 A>C,"... A>G; SNP3 = rs266729 C>G; in MONICA/KORA S123, rs1648707 A>C has served as proxy for SNP3 with link...",24,1304,Diabetes_2009_Apr_15_58(4)_984-991.txt
4 C > T,"...ified as −550 G > C (H/l), − 221G > C (Y/X), and +4 C > T (P/Q), respectively, were also identified ...",38,477,Diabetes_2010_Aug_3_59(8)_2080-2085.txt
-948C > A,...20). They found a significant association between -948C > A and T2DM (p = 0.021). In a non-diabetic ...,91,163,Diabetol_Metab_Syndr_2010_Mar_26_2_21.txt
-1535C > T,"...recently, Yan et al. [42] suggested that Visfatin -1535C > T polymorphism might be associated with r...",97,56,Diabetol_Metab_Syndr_2010_Mar_26_2_21.txt
-1535C > T,"...recently, Yan et al. [42] suggested that Visfatin -1535C > T polymorphism might be associated with r...",97,56,Diabetol_Metab_Syndr_2010_Mar_26_2_21.txt
4478 T > G,"Robitaille, 2004 [36]	n: 217	N/D	29.6 ± 4.3	N/D	4478 T > G, 4437–4438insA and 10733G > C	No associ...",302,49,Diabetol_Metab_Syndr_2015_Apr_28_7_38.txt
4478 T > G,"Robitaille, 2004 [36]	n: 217	N/D	29.6 ± 4.3	N/D	4478 T > G, 4437–4438insA and 10733G > C	No associ...",302,49,Diabetol_Metab_Syndr_2015_Apr_28_7_38.txt
-11A>G,IVS2 -11A>G	Exon skipping	Protein truncation	CGL2	[33],121,6,Diagn_Pathol_2013_May_9_8_78.txt
1G>A,IVS4 +1G>A	Exon skipping	Protein truncation	CGL2	[5],122,7,Diagn_Pathol_2013_May_9_8_78.txt
1G>A,IVS4 +1G>A	Exon skipping	Protein truncation	CGL2	[5],122,7,Diagn_Pathol_2013_May_9_8_78.txt
-2A>G,IVS5 -2A>G	Exon skipping	Protein truncation	CGL2	[27],123,6,Diagn_Pathol_2013_May_9_8_78.txt
2A>C,IVS5- 2A>C	Exon skipping	Protein truncation	CGL2	[34],124,7,Diagn_Pathol_2013_May_9_8_78.txt
2A>C,IVS5- 2A>C	Exon skipping	Protein truncation	CGL2	[34],124,7,Diagn_Pathol_2013_May_9_8_78.txt
2A>C,IVS5- 2A>C	Exon skipping	Protein truncation	CGL2	[34],124,7,Diagn_Pathol_2013_May_9_8_78.txt
5G>A,IVS6 +5G>A	Exon skipping	Protein truncation	CGL2	[5],125,7,Diagn_Pathol_2013_May_9_8_78.txt
5G>A,IVS6 +5G>A	Exon skipping	Protein truncation	CGL2	[5],125,7,Diagn_Pathol_2013_May_9_8_78.txt
-181A>G,"MMP1 -519A>G, -1607 1G>2G, MMP7 -181A>G gene polymorphisms in blad",303,33,Dis_Markers_2010_Sep_8_29(1)_37-46.txt
1555A>G,Heteroplasmy for the 1555A>G mutation in the mitochondria,502,22,Dis_Markers_2011_Jul_1_30(6)_283-289.txt
1555A>G,Heteroplasmy for the 1555A>G mutation in the mitochondria,502,22,Dis_Markers_2011_Jul_1_30(6)_283-289.txt
1555A>G,Heteroplasmy for the 1555A>G mutation in the mitochondria,502,22,Dis_Markers_2011_Jul_1_30(6)_283-289.txt
7510T>C,Spanish family with the 7510T>C mutation in the mitochon,579,25,Dis_Markers_2011_Jul_1_30(6)_283-289.txt
7510T>C,supports a pathogenic role for the 7510T>C mutation of mi,583,36,Dis_Markers_2011_Jul_1_30(6)_283-289.txt
2548G>A,"...ntel MMG   LEPR p.Q223R, β 3-AR p.W64R and LEP c.-2548G>A gene variants in obese Brazilian subjects ...",142,112,Dis_Markers_2013_Nov_6_35(6)_673-677.txt
1513A>C,"...cal region as control group. The SNP detection of 1513A>C and -762T>C was performed using PCR-RFLP, ...",8,364,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"...s control group. The SNP detection of 1513A>C and -762T>C was performed using PCR-RFLP, and the leve...",8,376,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"...s control group. The SNP detection of 1513A>C and -762T>C was performed using PCR-RFLP, and the leve...",8,376,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...l subjects were determined. Results. AC and CC of 1513A>C and TC and CC of -762T>C had higher freque...,8,514,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"... TT. Additionally, patients carrying TC and CC of -762T>C had more MTB in sputum than those carrying...",8,767,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,"...um than those carrying TT. Conclusion. P2X7 SNPs, 1513A>C and -762T>C, may be associated with the su...",8,845,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"...e carrying TT. Conclusion. P2X7 SNPs, 1513A>C and -762T>C, may be associated with the susceptibility...",8,857,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"...ated with the susceptibility to tuberculosis, and -762T>C SNP may contribute to the development of M...",8,929,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,...to the development of MTB. The mutant genotype of -762T>C (TC and CC) may lower human capability of ...,8,1006,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"..., while there was no significant association with -762T>C polymorphism [15, 16]. However, some previ...",13,994,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...th polymorphism (PCR-RFLP) was used for analyzing 1513A>C and PCR for -762T>C SNPs. PCR primers were...,26,182,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,"..., and 50 ng genome DNA. The PCR amplification for 1513A>C included initial denaturation at 95°C for ...",26,808,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...NPs between case and control groups. AC and CC of 1513A>C and TC and CC of -762T>C in case group had...,38,415,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,...NPs between case and control groups. AC and CC of 1513A>C and TC and CC of -762T>C in case group had...,38,415,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"...I = 1.466~3.511). Additionally, both TC and CC of -762T>C were risk factors of TB, and C was risk al...",38,744,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,The data in Table 2 suggested that 1513A>C and -762T>C SNPs may correlate to the susc...,41,36,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,The data in Table 2 suggested that 1513A>C and -762T>C SNPs may correlate to the susc...,41,36,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,...own in Table 3. TB patients carrying TC and CC of -762T>C had higher positive rate of IgG responses ...,41,258,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"As shown in Table 3, -762T>C SNP in P2X7 gene was associated with the l...",44,22,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,...ent and progression of TB. The mutant genotype of -762T>C (TC and CC) may lower human capability of ...,47,350,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,...ent and progression of TB. The mutant genotype of -762T>C (TC and CC) may lower human capability of ...,47,350,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"...requency of AC and CC of 1513A>C and TC and CC of -762T>C was observed in TB patients, suggesting th...",49,97,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"...or function or expression, especially 1513A>C and -762T>C SNPs [13]. A previous study published by G...",51,186,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,... study was that TB patients carrying TC and CC of -762T>C had higher positive rate of IgG responses ...,53,83,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,...tive rate of IgG responses to MTB was detected in -762T>C SNP. Hur et al. also demonstrated that sig...,53,867,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"...nclusion, our study demonstrated that 1513A>C and -762T>C SNPs in P2X7 gene may be associated with t...",55,56,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,"...nclusion, our study demonstrated that 1513A>C and -762T>C SNPs in P2X7 gene may be associated with t...",55,56,Dis_Markers_2015_Dec_20_2015_671272.txt
1513A>C,Figure 1 The electropherograms of 1513A>C and 762T>C SNPs in P2X7 gene after enzyme ...,66,35,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,-762T>C	 	 	 	 	 ,131,1,Dis_Markers_2015_Dec_20_2015_671272.txt
-762T>C,-762T>C	 	 	 	 	 ,131,1,Dis_Markers_2015_Dec_20_2015_671272.txt
-308G>A,"...  Zhang F.  Wang Y.   Tumor necrosis factor alpha -308G>A, -863C>A, -857C>T gene polymorphisms and t...",159,86,Dis_Markers_2015_Dec_20_2015_671272.txt
1 G>A,"... was homozygous for a novel splice variant, c.636+1 G>A. This substitution was predicted to be patho...",45,155,Doc_Ophthalmol_2014_May_24_129(1)_57-63.txt
1 G>A,"... was homozygous for a novel splice variant, c.636+1 G>A. This substitution was predicted to be patho...",45,155,Doc_Ophthalmol_2014_May_24_129(1)_57-63.txt
1 G>A,"... was homozygous for a novel splice variant, c.636+1 G>A. This substitution was predicted to be patho...",45,155,Doc_Ophthalmol_2014_May_24_129(1)_57-63.txt
1 G>A,"... was homozygous for a novel splice variant, c.636+1 G>A. This substitution was predicted to be patho...",45,155,Doc_Ophthalmol_2014_May_24_129(1)_57-63.txt
1 G>A,"...on, we report a novel BEST1 splice variant, c.636+1 G>A, identified homozygously in a proband clinic...",68,62,Doc_Ophthalmol_2014_May_24_129(1)_57-63.txt
1 G>A,"...on, we report a novel BEST1 splice variant, c.636+1 G>A, identified homozygously in a proband clinic...",68,62,Doc_Ophthalmol_2014_May_24_129(1)_57-63.txt
617V>F,...ielmelli P    Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera...,178,85,Drug_Des_Devel_Ther_2015_May_18_9_2687-2694.txt
617V>F,...ielmelli P    Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera...,178,85,Drug_Des_Devel_Ther_2015_May_18_9_2687-2694.txt
617V>F,...ielmelli P    Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera...,178,85,Drug_Des_Devel_Ther_2015_May_18_9_2687-2694.txt
238 G>A,...C  Schmut O  Wedrich A    TNF-alpha –308 G>A and –238 G>A polymorphisms are not major risk factors i...,89,102,Electron_Physician_2016_Feb_25_8(2)_1978-1983.txt
3A>T,"...hy	6: L13RfsX3, R291K, I9V, R245Q, Q12R, c.1586 + 3A>T	Cassandrini et al (2013), Edvardson et al (20...",29,107,EMBO_Mol_Med_2013_Mar_21_5(3)_332-343.txt
2+299G>A,...ymorphism in ALAD at an Msp1 site in intron 2 (IVS2+299G>A,137,84,Environ_Health_Perspect_2003_Aug_111(10)_1335-1339.txt
2+299G>A,sizes for ALAD IVS2+299G>A were 160 b,347,19,Environ_Health_Perspect_2003_Aug_111(10)_1335-1339.txt
2+299G>A,phism by ALAD IVS2+299G>A and its alle,356,18,Environ_Health_Perspect_2003_Aug_111(10)_1335-1339.txt
-1639G>A,"...rtant polymorphic variants of the VKORC1 gene are -1639G>A (rs9923231) in the promoter region, 1173C...",60,66,EPMA_J_2012_Sep_27_3(1)_10.txt
-1639G>A,...tion is shown to be 0.391 for polymorphic variant -1639G>A. The coefficient of determination (R2) ca...,94,343,EPMA_J_2012_Sep_27_3(1)_10.txt
2069910 C>T,"...F = 0.441) in the 5′-regulatory region of PROC, rs2069910 C>T (MAF = 0.387) in intron 2, and rs20699...",154,255,EPMA_J_2012_Sep_27_3(1)_10.txt
-1639G>A,"...el in experiments in China showed that the VKORC1 -1639G>A, alleles CYP2C9 and EPHX1 691A>G, as well...",208,78,EPMA_J_2012_Sep_27_3(1)_10.txt
-1639G>A,"...el in experiments in China showed that the VKORC1 -1639G>A, alleles CYP2C9 and EPHX1 691A>G, as well...",208,78,EPMA_J_2012_Sep_27_3(1)_10.txt
1-1639G>A,"...hen L Zhong QJ Wang XF Hao J Chen BC Chen JJ VKORC1-1639G>A, CYP2C9, EPHX1691A>G genotype, body weig...",320,83,EPMA_J_2012_Sep_27_3(1)_10.txt
1691A>G,"...Hao J Chen BC Chen JJ VKORC1-1639G>A, CYP2C9, EPHX1691A>G genotype, body weight, and age are importa...",320,106,EPMA_J_2012_Sep_27_3(1)_10.txt
1691A>G,"...Hao J Chen BC Chen JJ VKORC1-1639G>A, CYP2C9, EPHX1691A>G genotype, body weight, and age are importa...",320,106,EPMA_J_2012_Sep_27_3(1)_10.txt
1691A>G,"...Hao J Chen BC Chen JJ VKORC1-1639G>A, CYP2C9, EPHX1691A>G genotype, body weight, and age are importa...",320,106,EPMA_J_2012_Sep_27_3(1)_10.txt
3243A>G,"mutations (e.g. 3243A>G, m.4300A>G) in specific clinical scenarios...",446,17,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
3243A>G,3243A>G BMC Cardiovasc Disord 2002 2 12 doi:10.118...,678,1,Eur_Heart_J_2012_Dec_30_33(24)_3023-3033.txt
88068052C > A,...lymorphisms (SNPs) within intron 2 at position g. 88068052C > A [Figure 3a] and intron 5 at position...,40,879,Eur_J_Dent_2014_Jan-Mar_8(1)_79-84.txt
88033661T > C,...8052C > A [Figure 3a] and intron 5 at position g. 88033661T > C [Figure 3b] in homozygous condition,40,933,Eur_J_Dent_2014_Jan-Mar_8(1)_79-84.txt
88033661T > C,...thin intron 2 (g. 88068052C > A) and intron 5 (g. 88033661T > C). According to the SNP database of N...,53,194,Eur_J_Dent_2014_Jan-Mar_8(1)_79-84.txt
521 T>C,...*1a-HEK293T (P < 0.05). Gene mutation of OATP1B1 (521 T>C) may decrease its transport capacity. Howe...,160,806,Eur_J_Drug_Metab_Pharmacokinet_2014_Apr_16_39(3)_221-230.txt
1G>T,"...n=84), subjects who had a LOF SNP at either c.151+1G>T, c.G946A, c.1096C>G, c.1513A>C or c.1729T>A (...",47,141,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1G>T,"...evision.46 In our study, heterozygosity for c.151+1G>T that leads to one null allele37 had no impact...",52,1995,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
1G>T,rs35933842	c.151+1G>T	0.01	0.97 (0.01)	0.93 (0.03)	*	0.3	−0.041,105,18,Eur_J_Hum_Genet_2012_May_11_20(5)_559-564.txt
5109G>C,"...in vitro,17 a consequence of the presence of a g.−5109G>C SNP variant. Although none of the four hap...",21,2063,Eur_J_Hum_Genet_2015_Sep_22_23(9)_doi_10_1038_ejhg_2014_226.txt
1717-1G>A,"...location of variants. For example, the well-known 1717-1G>A and 3120+1G>A variants (legacy names) ar...",20,1136,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
621+1G>T, 621+1G>T	c.489+1G>T	 ,166,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>T, 711+1G>T	c.579+1G>T	 ,171,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1898+1G>A, 1898+1G>A	c.1766+1G>A	 ,178,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
2789+5G>A, 2789+5G>A	c.2657+5G>A	 ,180,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3120+1G>A, 3120+1G>A	c.2988+1G>A	 ,181,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 3120+1G>A	c.2988+1G>A	 ,181,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 3120+1G>A	c.2988+1G>A	 ,181,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
406-1G>A, 406-1G>A	c.274-1G>A	 ,190,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1G>A, 406-1G>A	c.274-1G>A	 ,190,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
5G>A, 711+5G>A	c.579+5G>A	 ,203,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
5G>A, 711+5G>A	c.579+5G>A	 ,203,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
712-1G>T, 712-1G>T	c.580-1G>T	 ,204,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1248+1G>A, 1248+1G>A	c.1116+1G>A	 ,219,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1717-1G>A, 1717-1G>A	c.1585-1G>A	 ,232,2,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
8G>A, 1717-8G>A	c.1585-8G>A	 ,233,19,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3743G>A, W1204X(3743G>A)	c.3611G>A	p.Trp1204*,280,9,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
1075C>A, Q359K/T360K	c.[1075C>A;1079C>A]	p.[Gln359Lys;Thr360Lys],298,17,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
3808G>A,[R74W;D1270N]c.[220C>T;3808G>A,337,24,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
621+1G>T,...ound heterozygote (two alleles in trans)a	F508del/621+1G>T	c.[1521_1523delCTT][489+1G>T],352,55,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
621+1G>T,...ound heterozygote (two alleles in trans)a	F508del/621+1G>T	c.[1521_1523delCTT][489+1G>T],352,55,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
5G>A,"...; LS, large spectrum variant (p.Leu206Trp, c.2657+5G>A …); M, mild variant with variable disease pen...",396,120,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
5G>A,"...; LS, large spectrum variant (p.Leu206Trp, c.2657+5G>A …); M, mild variant with variable disease pen...",396,120,Eur_J_Hum_Genet_2016_Apr_27_24(4)_469-478.txt
504 C>T,... from all cases. We identified five cases with C. 504 C>T heterozygous mutations of exon 6 of the MD...,3,1898,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,"...e revealed a single nucleotide substitution, a C. 504 C>T homozygous mutation in 14/41 premature inf...",39,102,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,"...e revealed a single nucleotide substitution, a C. 504 C>T homozygous mutation in 14/41 premature inf...",39,102,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,... in the experimental group. It also revealed a C. 504 C>T homozygous mutation in 7/56 premature infa...,39,271,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,... in the experimental group. It also revealed a C. 504 C>T homozygous mutation in 7/56 premature infa...,39,271,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,"...d logistics regression analysis, SPSS 17.0) of C. 504 C>T was significantly different between the ex...",39,585,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...lirubin between the premature infants with the C. 504 C>T mutation and the premature infants without...,44,186,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,...). The results revealed that the patients with C. 504 C>T in the experimental group had raised serum...,44,575,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485 T>A,...Table V shows that the preterm infant with the C. 485 T>A mutation had raised r-GGT,44,694,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485 T>A,... in the experimental group was detected with a C. 485 T>A missense mutation and raised r-GGT. Our re...,55,381,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485T>A,"...on position, GAAAAAGGA; nucleic acid position, C. 485T>A; protein position, P. Ile 162 Lys, missense...",63,152,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
504 C>T,With C. 504 C>T mutation	19	127±20.1	128.8±20.7	70.2±10.8	...,93,9,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
485 T>A,Table V Laboratory results of infant with C. 485 T>A mutation,99,46,Exp_Ther_Med_2014_Nov_19_8(5)_1655-1659.txt
1G>A,20	c.5277 + 1G>A	4	11	c.4314delC	1,74,13,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
1G>A,20	c.5277 + 1G>A	4	11	c.4314delC	1,74,13,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
3C>G,17	c.4987-3C>G	1	21	c.8723T>G	1,86,11,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
25A>C,19(I)	c.5194-25A>C	1,87,14,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
3C>G,"...mutation probabilities below 20%. The UVs: c.4987-3C>G (putative splice variant), and c.5216A>G in B...",152,137,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
25A>C,20	c.5194-25A>C	NA	1	14.0	17.4	–	–	0	ND	ND,160,11,Fam_Cancer_2010_Jun_1_9(2)_193-201.txt
1G>A,IVS17 − 1G>A	n.i.	Bil	No	RT	Sarcoma	Rhab (8),119,9,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
1G>C,IVS20 − 1G>C	n.i.	Bil	Yes	RT	Epithelial	Bl (62),121,9,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
1G>C,IVS20 − 1G>C	n.i.	Bil	No	RT	Sarcoma	His (31),123,9,Fam_Cancer_2012_Jun_29_11(2)_225-233.txt
32-13T>G,"...utation among Caucasian children and adults is c.-32-13T>G (IVS1), a splicing defect which allows fo...",23,68,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
32-13T>G,"...utation among Caucasian children and adults is c.-32-13T>G (IVS1), a splicing defect which allows fo...",23,68,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
32-13T>G,"...utation among Caucasian children and adults is c.-32-13T>G (IVS1), a splicing defect which allows fo...",23,68,Front_Aging_Neurosci_2014_Jul_23_6_177.txt
-455T>C,"... lipase S447X, apolipoprotein E exon 4, and apoC3 -455T>C polymorphisms on the susceptibility to dia...",322,77,Front_Endocrinol_(Lausanne)_2015_May_28_6_88.txt
677 C>T,...dence of ASD in mothers and children with a MTHFR 677 C>T variant genotype that leads to inefficient...,106,363,Front_Genet_2014_Aug_26_5_289.txt
1236C>T,...Smith P. Dandara C.   (2012a ). ABCB1 4036A>G and 1236C>T polymorphisms affect plasma efavirenz leve...,320,67,Front_Genet_2014_Jun_4_5_167.txt
-251A >T,Association between -251A >T polymorphism in the interleukin-8 gene an...,210,21,Front_Immunol_2015_May_5_6_214.txt
2-2A > C,...transferase gene (chat) on chromosome 13	tf247	IVS2-2A > C	Attenuated transmission at neuromuscular ...,120,69,Front_Mol_Neurosci_2016_Jun_29_9_50.txt
341C>T,...Li J.   (2013 ). The glutathione S-transferase P1 341C>T polymorphism and cancer risk: a meta-analys...,237,95,Front_Pharmacol_2014_Aug_28_5_200.txt
341C>T,...Li J.   (2013 ). The glutathione S-transferase P1 341C>T polymorphism and cancer risk: a meta-analys...,237,95,Front_Pharmacol_2014_Aug_28_5_200.txt
9532494 C > T,gl187.9	Fertile	CHr1:9532494 C > T	P25 > S,73,22,Front_Plant_Sci_2015_Mar_12_6_147.txt
9532503 G > A,gl23	Sterile	CHr1:9532503 G > A	G28 > R,74,19,Front_Plant_Sci_2015_Mar_12_6_147.txt
9532608 G > A,s3pl5	Sterile	CHr1:9532608 G > A	D33 > N,75,20,Front_Plant_Sci_2015_Mar_12_6_147.txt
9532887 G > A,gl865.6	Sterile	CHr1:9532887 G > A	G70 > D,77,22,Front_Plant_Sci_2015_Mar_12_6_147.txt
9532899 G > A,s6pl30	Sterile	CHr1:9532899 G > A	G74 > D,78,21,Front_Plant_Sci_2015_Mar_12_6_147.txt
9533483 G > A,gl172.10	Sterile	CHr1:9533483 G > A	G135 > D,80,23,Front_Plant_Sci_2015_Mar_12_6_147.txt
9533486 G > A,s2pl6	Fertile	CHr1:9533486 G > A	G136 > E,82,20,Front_Plant_Sci_2015_Mar_12_6_147.txt
9533599 G > A,gl392.8	Sterile	CHr1:9533599 G > A	splicing site of the 4th intron,83,22,Front_Plant_Sci_2015_Mar_12_6_147.txt
9533621 G > A,s1pl41	Sterile	CHr1:9533621 G > A	C155 > Y,84,21,Front_Plant_Sci_2015_Mar_12_6_147.txt
9533751 G > A,s10pl47	Sterile	CHr1:9533751 G > A	splicing site of the 5th intron,85,22,Front_Plant_Sci_2015_Mar_12_6_147.txt
61A > G,...g H-G  Choi JE  Lee WK  Kam S  Cha SI  Kim CH    +61A > G polymorphism in the EGF gene does not incr...,130,57,Gastroenterol_Hepatol_Bed_Bench_2013_Summer_6(3)_129-135.txt
61A > G,...g H-G  Choi JE  Lee WK  Kam S  Cha SI  Kim CH    +61A > G polymorphism in the EGF gene does not incr...,130,57,Gastroenterol_Hepatol_Bed_Bench_2013_Summer_6(3)_129-135.txt
786T>C,...stigate the association of ET-1 5665G>T and eNOS −786T>C polymorphisms with soluble adhesion molecul...,5,500,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,The ET-1 5665G>T (rs5370) and eNOS −786T>C (rs2070744) gene...,27,10,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,The ET-1 5665G>T (rs5370) and eNOS −786T>C (rs2070744) gene polymorphisms were investi...,27,37,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,The ET-1 5665G>T polymorphism was analyzed in 101 SCA patie...,40,10,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,"...rium. In the control group, the frequency of ET-1 5665G>T gene polymorphism was 60.2% (65/108) for w...",40,730,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,... variant allele (Table 1). The frequency of eNOS −786T>C was 54.3% (44/81) for wild-type genotype an...,40,917,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,... variant allele (Table 1). The frequency of eNOS −786T>C was 54.3% (44/81) for wild-type genotype an...,40,917,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,...resting result regarding the association of eNOS −786T>C gene polymorphism and sVCAM-1 levels. SCA p...,55,78,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,"...ediators’ balance because of the presence of ET-1 5665G>T minor allele, once this gene polymorphism ...",59,998,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,Figure 1 Presence of ET-1 5665G>T alleles and occurrence of acute chest synd...,87,27,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,ET-1 5665G>T	GG	60.2 (65/108)	66.3 (67/101),96,6,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,eNOS −786T>C	TT	54.3 (44/81)	567 (34/60),99,7,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
5665G>T,ET-1 5665G>T	0.358	0.126	2.843	0.009,155,6,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,"...e multivariable model of the association of eNOS −786T>C gene polymorphism, white blood cell (WBC) c...",160,61,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
786T>C,eNOS −786T>C	0.420	0.187	2.249	0.037,164,7,Gene_Regul_Syst_Bio_2016_Jul_28_10_67-72.txt
2945A>G,LR00-144	CE11A	g.-2945A>G	A/G	A/A	A/G	n/a	0/330 (0%),146,19,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,LP98-052	PPR	g.-1453C>G	C/G	C/G	C/C	n/a	1/528 (0.2%),156,17,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,"...00-204 both harboured identical variants (i.e. g.-1453C>G). Thus, a total of 15 novel variants were ...",162,87,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,...tients LR00-204 and LP98-052 both harbored the g.-1453C>G substitution,174,244,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,...tients LR00-204 and LP98-052 both harbored the g.-1453C>G substitution,174,244,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
2945A>G,"...ozygote for NR2E1 mutations. Importantly, both g.-2945A>G and g.-1767G>T reside within the proximal ...",178,990,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,...entify a single control subject bearing either g.-1453C>G / g.11559C>T or g.21762C>A / g.21796G>A al...,180,416,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,...entify a single control subject bearing either g.-1453C>G / g.11559C>T or g.21762C>A / g.21796G>A al...,180,416,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1453C>G,"...4). Of the four functional polymorphisms, one (g.-1453C>G) was predicted to create binding of two ne...",183,598,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
2945A>G,"...t harboring candidate mutations is as follows: g.-2945A>G (518 chromosomes), g.-1767G>T (706 chromos...",221,630,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1767G>T,"...s is as follows: g.-2945A>G (518 chromosomes), g.-1767G>T (706 chromosomes), g.-1726C>A (716 chromos...",221,660,Genes_Brain_Behav_2007_Aug_6(6)_503-516.txt
1068T>C,"...8; OR= 2.06; 95% CI: 1.14–3.75) at SNP rs1718119 (1068T>C; Thr-348-Ala), and a second synonymous var...",8,724,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
208293	G>A,rs208293	G>A	Intron 4	-	G (+)a	0.650	0.557	0.150,116,3,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
1405A>G,rs2230912	1405A>G	Exon 13	Gln-460-Arg	A (+)a	0.783	1	0.983,124,11,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
1513T>G,rs3751143	1513T>G	Exon 13	Glu-496-Ala	T (+)a	0.864	0.761	0.9...,126,11,Genes_Immun_2010_Jul_10_11(5)_374-383.txt
1965708 G>T,"...SNPs for DC-SIGN (at rs11465396 G>A), SP-A2 (at rs1965708 G>T) and SP-D (at rs721917 G>A) in lung ti...",113,99,Genes_Immun_2013_Mar_17_14(2)_99-106.txt
3435C>T,"...ug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability Pharmacogenet Genom...",207,111,Genes_Immun_2013_Mar_17_14(2)_99-106.txt
876 G > A,"... novel polymorphism in exon 5 at position 876 (c.+876 G > A, GenBank accession No. NM_214379) of the...",40,575,Genet_Mol_Biol_2011_Mar_1_Jan-Mar_34(1)_56-61.txt
421A > G,421A > G	S141G	Heterozygous	Yes	Neutral (75%)	0.45...,147,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
421A > G,421A > G	S141G	Heterozygous	Yes	Neutral (75%)	0.45...,147,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
421A > G,421A > G	S141G	Heterozygous	Yes	Neutral (75%)	0.45...,147,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
454A > G,454A > G	K152E	Heterozygous	Yes	Neutral (83%)	0.52...,148,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
455A > G,455A > G	K152R	Heterozygous	Yes	Neutral (83%)	0.50...,149,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
455A > G,455A > G	K152R	Heterozygous	Yes	Neutral (83%)	0.50...,149,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1045G > A,1045G > A	V349M	Unknown	No	Neutral (60%)	0.47 ± 0....,153,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1120G > A,1120G > A	A374T	Unknown	No	Neutral (83%)	0.71 ± 0....,154,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1502T > C,1502T > C	M501T	Unknown	No	Neutral (83%)	0.61 ± 0....,156,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1835C > T,1835C > T	S612L	Heterozygous	No	Neutral (74%)	0.49...,157,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
97A > G,hSSRP1	97A > G	K33E	Heterozygous	Yes	Deleterious (87%)	1....,162,8,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1108C > T,1108C > T	R370C	Heterozygous	No	Deleterious (65%)	...,167,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1441T > C,1441T > C	S481P	Unknown	No	Deleterious (61%)	Non-f...,169,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1950G > T,1950G > T	K650N	Unknown	No	Neutral (83%)	1.07 ± 0....,173,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
1950G > T,1950G > T	K650N	Unknown	No	Neutral (83%)	1.07 ± 0....,173,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
348G > T,hPPP1CC	348G > T	E116D	Unknown	Yes	Neutral (75%)	0.57 ± 0....,176,9,Genetics_2015_Nov_9_201(3)_1263-1274.txt
559C > T,559C > T	R187W	Unknown	Yes	Deleterious (87%)	0.05 ...,177,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
601C > T,601C > T	L201F	Heterozygous	Yes	Deleterious (51%)	...,178,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
601C > T,601C > T	L201F	Heterozygous	Yes	Deleterious (51%)	...,178,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
610C > A,610C > A	L204I	Unknown	Yes	Neutral (63%)	0.97 ± 0....,179,2,Genetics_2015_Nov_9_201(3)_1263-1274.txt
4148981C>T,...ion were linked to reduced SLCO1A2 mRNA levels (rs4148981C>T) and methotrextate clearance (rs1104598...,23,268,Genome_Med_2012_May_25_4(5)_45.txt
11045981 T>G,...els (rs4148981C>T) and methotrextate clearance (rs11045981 T>G)	[3],23,311,Genome_Med_2012_May_25_4(5)_45.txt
829C>T,... miR-24 binding site in the 3' UTR of human DHFR (829C>T) interfered with miR-24 function and result...,27,105,Genome_Med_2012_May_25_4(5)_45.txt
-1639G>A,...r allele frequency 0.467) in its promoter region (-1639G>A) results in the formation of a novel E-bo...,86,549,Genome_Med_2012_May_25_4(5)_45.txt
1045385 A>C,"...l lines harboring a TFAP2A 3' UTR polymorphism, rs1045385 A>C, miR-200b/200c/429 cannot bind its mRN...",88,795,Genome_Med_2012_May_25_4(5)_45.txt
-1639G>A,...in [137]. The clinical implications of the VKORC1 -1639G>A regulatory variant and a coding variant o...,135,1056,Genome_Med_2012_May_25_4(5)_45.txt
124 C>T,"...>C [46]. However, when these mutations (−57 A>C, −124 C>T, −146 C>T) are introduced into tumor cells...",49,348,Genome_Med_2016_Jun_20_8_69.txt
146 C>T,"...owever, when these mutations (−57 A>C, −124 C>T, −146 C>T) are introduced into tumor cells (A375 mel...",49,358,Genome_Med_2016_Jun_20_8_69.txt
57 A>C,"...ntroduced three common hTERT promoter mutations (−57 A>C, −124 C>T, −146 C>T) into isogenic human em...",51,530,Genome_Med_2016_Jun_20_8_69.txt
124 C>T,"... three common hTERT promoter mutations (−57 A>C, −124 C>T, −146 C>T) into isogenic human embryonic s...",51,539,Genome_Med_2016_Jun_20_8_69.txt
4883G>A,"...gene, at least one G allele (GG; AG) at the CD44 +4883G>A gene locus (rs187116) associated with clin...",53,638,Gut_Liver_2011_Dec_21_5(4)_397-405.txt
2743T>C,"...er, two linked nucleotide substitutions (2642A>T, 2743T>C, Acc. U37574) in BRCA1 intron 1 were detec...",3,1679,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2642A>T,...eletion 2223delAAAAA and two linked substitutions 2642A>T and 2743T>C do not significantly alter BRC...,3,2501,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2743T>C,...delAAAAA and two linked substitutions 2642A>T and 2743T>C do not significantly alter BRCA1 expressio...,3,2513,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2642A>T,"...de sequence alterations within the BRCA1 intron 1 2642A>T, 2743T>C (Acc. U37574) were also detected ...",35,206,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2642A>T,"...ragment with two linked nucleotide substitutions: 2642A>T, 2743T>",45,64,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2743T>C,"...ith two linked nucleotide substitutions: 2642A>T, 2743T>",45,73,Hered_Cancer_Clin_Pract_2006_Jan_15_4(1)_20-24.txt
2A>G,c.342-2A>,611,7,Hum_Genome_Var_2014_Nov_6_1_14020.txt
5G>A,c.128+5G>,713,7,Hum_Genome_Var_2014_Nov_6_1_14020.txt
11+1G>T,"... flicker amplitude. Patient no. 22, who had an IVS11+1G>T mutation, exhibited nearly negative ERG in...",23,1441,Hum_Genome_Var_2016_Feb_11_3_15052.txt
5+2T>G,"...X), c.109_110insG (p.Ala2GlyfsX19), IVS5+1G>T, IVS5+2T>G, c.551_552insG (p.Glu9ArgfsX15), c.802G>T (...",26,762,Hum_Genome_Var_2016_Feb_11_3_15052.txt
5+2T>G,"...X), c.109_110insG (p.Ala2GlyfsX19), IVS5+1G>T, IVS5+2T>G, c.551_552insG (p.Glu9ArgfsX15), c.802G>T (...",26,762,Hum_Genome_Var_2016_Feb_11_3_15052.txt
5+1G>T,7	2	Familial	Intron5	IVS5+1G>T	Splice error	NA	PD	Yes	36	F	Total/total	−/−...,58,25,Hum_Genome_Var_2016_Feb_11_3_15052.txt
5+1G>T,8	2	 	Intron5	IVS5+1G>T	Splice error	NA	PD	Yes	1	M	Total/total	+/+	...,59,18,Hum_Genome_Var_2016_Feb_11_3_15052.txt
5+2T>G,10	3	 	Intron5	IVS5+2T>G	Splice error	NA	PD	Yes	38	M	Total/total	−/−...,61,19,Hum_Genome_Var_2016_Feb_11_3_15052.txt
5+2T>G,10	3	 	Intron5	IVS5+2T>G	Splice error	NA	PD	Yes	38	M	Total/total	−/−...,61,19,Hum_Genome_Var_2016_Feb_11_3_15052.txt
521 T > C,"...re prospectively enrolled on the basis of SLCO1B1 521 T > C genotype. Additionally, subjects were ge...",3,1275,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
388 A > G,"...typed for SLCO1B1  11187 G > A, - 10499 A > C and 388 A > G polymorphisms, and the CYP2C8*3 polymorp...",3,1377,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,...lled and stratified in the study based on SLCO1B1 521 T > C genotype. The clinical study was approve...,19,370,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
388 A > G,"...1B1 polymorphisms: -11187 G > A, -10499 A > C and 388 A > G (Asn130Asp). In terms of CYP2C8, subject...",25,895,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
11187 G > A,SLCO1B1 - 11187 G > A	PCR-forward: TGCTGCAACCATATCAACAA,30,11,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
11187 G > A,SLCO1B1 - 11187 G > A	PCR-forward: TGCTGCAACCATATCAACAA,30,11,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
-10499 A > C,SLCO1B1 -10499 A > C	PCR-forward: Biotin-GTAAAAGCCATTCCCAA...,33,9,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
388 A > G,SLCO1B1 388 A > G	PCR-forward: CATTTCACTTTTACCCAT,36,9,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,"... (range 45.7 to 93.3 kg). In terms of the SLCO1B1 521 T > C screening genotype, 13 subjects were T/T...",116,215,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,"... (range 45.7 to 93.3 kg). In terms of the SLCO1B1 521 T > C screening genotype, 13 subjects were T/T...",116,215,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
521 T > C,...t al. which showed no association between SLCO1B1 521 T > C genotype and rosiglitazone or pioglitazo...,129,1309,Hum_Genomics_2008_Sep_1_3(1)_7-16.txt
-786T >C,...he endothelial nitric oxide synthase (eNOS) gene (-786T >C and 894G >T) enhance endo-thelial dysfunc...,3,926,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...l nitric oxide synthase (eNOS) gene (-786T >C and 894G >T) enhance endo-thelial dysfunction and have...,3,939,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...rotocol was designed for the analysis of the eNOS 894G >T polymorphism. Genomic DNA was amplified us...,36,69,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...rotocol was designed for the analysis of the eNOS 894G >T polymorphism. Genomic DNA was amplified us...,36,69,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
-786T >C,Distribution of eNOS -786T >C and 894G >T polymorphism,80,22,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,Distribution of eNOS -786T >C and 894G >T polymorphism,80,35,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,Distribution of eNOS -786T >C and 894G >T polymorphism,80,35,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
-786T >C,"... were in Hardy-Weinberg equilibrium. For the eNOS -786T >C polymorphism, the frequencies of the geno...",81,248,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,"... p = 0.46, respectively). Similarly, for the eNOS 894G >T polymorphism, the frequencies of genotypes...",81,429,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,"... p = 0.46, respectively). Similarly, for the eNOS 894G >T polymorphism, the frequencies of genotypes...",81,429,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,Table 2 Frequencies of eNOS -786T > C and 894G > T genotypes and alleles in CABG patients an...,83,43,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
-786T >C,"...hypertension, diabetes mel-litus and smoking, the -786T >C polymorphism did not differ among the var...",129,118,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,"... the various categories (data not shown). For the 894G >T polymorphism, the frequencies of the 894TT...",129,210,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,"... the various categories (data not shown). For the 894G >T polymorphism, the frequencies of the 894TT...",129,210,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,...pe 2 diabetes) among genotypes or alleles for the 894G >T polymorphism (data not shown). The same an...,129,1440,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,Table 3 Frequencies of the eNOS 894G > T genotypes and alleles in CABG patients ac...,131,33,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,eNOS 894G > T genotypes	n (%)	95% CI	n (%)	95% CI,136,6,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G >T,"..., we investigated the association of -786T >C and 894G >T polymorphisms of the eNOS gene with CAD. O...",192,418,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
894G > T,"...ide synthase gene polymorphisms (-786T > C. 4a4b, 894G > T) in Korean patients with coronary artery ...",215,114,Hum_Genomics_2010_Aug_1_4(6)_375-383.txt
61A > G,ABCB1	rs9282564	G	61A > G; N21D	0.0	0.0	0.0	NA	NA	0.1	0.0	0.07	0.0,301,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
61A > G,ABCB1	rs9282564	G	61A > G; N21D	0.0	0.0	0.0	NA	NA	0.1	0.0	0.07	0.0,301,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1236C > T,ABCB1	rs1128503	T	1236C > T	0.13	0.23	0.12	0.11	0.14	0.39	0.68	0.54	...,307,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1236C > T,ABCB1	rs1128503	T	1236C > T	0.13	0.23	0.12	0.11	0.14	0.39	0.68	0.54	...,307,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
-24C > T,ABCC2	rs717620	T	-24C > T	0.03	0.04	0.04	0.02	0.04	0.18	0.22	0.23	0...,312,19,Hum_Genomics_2011_May_1_5(4)_265-282.txt
-24C > T,ABCC2	rs717620	T	-24C > T	0.03	0.04	0.04	0.02	0.04	0.18	0.22	0.23	0...,312,19,Hum_Genomics_2011_May_1_5(4)_265-282.txt
593T > C,"CYP2B6	rs36079186	C	593T > C; M198T, *27	0.0	0.0	NA	NA	NA	NA	NA	NA	NA",315,22,Hum_Genomics_2011_May_1_5(4)_265-282.txt
15237414G > A,CYP2C18	rs10509675	A	15237414G > A	0.15	0.09	0.27	0.18	0.17	0.21	0.02	N...,318,23,Hum_Genomics_2011_May_1_5(4)_265-282.txt
-806C > T,"CYP2C19	rs12248560	T	-806C > T, *17	0.15	0.09	0.27	NA	NA	0.21	0.02	NA	0...",320,23,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1846G > A,"CYP2D6	rs3892097	A	1846G > A, *4	0.0	0.01	NA	NA	NA	0.5	NA	NA	NA",322,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
1846G > A,"CYP2D6	rs3892097	A	1846G > A, *4	0.0	0.01	NA	NA	NA	0.5	NA	NA	NA",322,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
566T > C,"CYP3A4	rs4987161	C	566T > C; F189S, *17	0.0	0.0	0.0	NA	NA	0.0	0.0	NA	...",327,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
566T > C,"CYP3A4	rs4987161	C	566T > C; F189S, *17	0.0	0.0	0.0	NA	NA	0.0	0.0	NA	...",327,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
-1630 T > C,CYP3A5	rs4646450	T	-1630 T > C	0.97	0.83	1.0	0.98	0.85	0.13	0.34	NA	N...,329,21,Hum_Genomics_2011_May_1_5(4)_265-282.txt
601324 C > T,UGT1A1	rs887829	T	601324 C > T	0.35	0.36	0.55	NA	NA	0.28	0.08	0.35	0...,333,20,Hum_Genomics_2011_May_1_5(4)_265-282.txt
28A>G,...pathogenicity of previously reported variants (c.-28A>G and c.-7C>T) within the MLH1 5′untranslated ...,8,777,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...ter. Sequencing revealed that the c.-28A>G and c.-7C>T variants were the only potentially pathogenic...,8,1205,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
64G>T,"...drome, namely, c.-411_-413del, c.-432_-435del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-...",15,148,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>T,"...35del, c.-64G>T, c.-53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green et a...",15,188,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
11C>T,"...53G>T, c.-42C>T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green et al., 2003; Hitchins e...",15,208,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...T, c.-28A>G, c.-28A>T, c.-27C>A, c.-11C>T, and c.-7C>T [Green et al., 2003; Hitchins et al., 2011; W...",15,222,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
42C>T,"... MLH1. In support of this, the c.-411_-413del, c.-42C>T, c.-27C>A, and c.-11C>T variants also signif...",15,1114,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
42C>T,"... MLH1. In support of this, the c.-411_-413del, c.-42C>T, c.-27C>A, and c.-11C>T variants also signif...",15,1114,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
42C>T,"... MLH1. In support of this, the c.-411_-413del, c.-42C>T, c.-27C>A, and c.-11C>T variants also signif...",15,1114,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
27C>A,"...support of this, the c.-411_-413del, c.-42C>T, c.-27C>A, and c.-11C>T variants also significantly re...",15,1124,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...we aimed to determine the pathogenicity of the c.-28A>G and c.-7C>T variants within the MLH1 5′ untr...,17,66,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...we aimed to determine the pathogenicity of the c.-28A>G and c.-7C>T variants within the MLH1 5′ untr...,17,66,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...etermine the pathogenicity of the c.-28A>G and c.-7C>T variants within the MLH1 5′ untranslated regi...,17,79,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...2 and Proband N; Fig. 1) with the c.-28A>G and c.-7C>T variants (all nucleotide numbering used throu...,21,74,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...2 and Proband N; Fig. 1) with the c.-28A>G and c.-7C>T variants (all nucleotide numbering used throu...,21,74,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...ected in the MLH1 or PMS2 genes except for the c.-28A>G and c.-7C>T heterozygous variants in the MLH...,21,1205,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...ion of two probands with the MLH1 c.-28A>G and c.-7C>T variants from two unrelated cancer-affected f...,23,71,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...y cancer. Family N showed cosegregation of the c.-28A>G and c.-7C>T variants across two generations....,23,384,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...y cancer. Family N showed cosegregation of the c.-28A>G and c.-7C>T variants across two generations....,23,384,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"To confirm the presence of the c.-28A>G and c.-7C>T variants, we performed sequencin...",48,35,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"To confirm the presence of the c.-28A>G and c.-7C>T variants, we performed sequencin...",48,35,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...gous variants, namely, c.-93G>A, c.-28A>G, and c.-7C>T (Supp. Fig. S1A). No further sequence variant...",48,295,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,"...ants were identified in this region. While the c.-93G>A is a common and benign variant, the c.-28A>G...",48,392,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...thin the MLH1 gene other than the c.-28A>G and c.-7C>T variants. A: The locations of the 15 genes wi...,53,147,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...e S2 cosegregated with the c.-93G>A, c.-28A>G, c.-7C>T, and VILL c.1164del variants in the first-deg...",57,1577,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...ithin or flanking the MLH1 gene other than the c.-28A>G and c.-7C>T variants prompted us to investig...,60,111,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...n the MS-MLPA assay) that was abolished by the c.-7C>T variant (Fig. 4A). Bisulfite sequencing of in...,65,555,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...n the MS-MLPA assay) that was abolished by the c.-7C>T variant (Fig. 4A). Bisulfite sequencing of in...,65,555,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,...ng of individual promoter molecules across the c.-93G>A variant confirmed the lack of methylation on...,65,647,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...tical bars), and the sequence encompassing the c.-7C>T site. The presence of the c.-7C>T variant abo...",67,312,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...mpassing the c.-7C>T site. The presence of the c.-7C>T variant abolishes a HhaI restriction site. B:...,67,346,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...ding to allele of origin, as determined by the c.-7C>T variant (yellow diamond). Black arrows indica...",67,1297,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"... were located in the immediate vicinity of the c.-28A>G and c.-7C>T variants. However, comparison of...",69,1019,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...drome families. Specifically, the c.-28A>G and c.-7C>T variants were associated with ∼50% reduction ...",72,189,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...sion from the variant allele, we show that the c.-28A>G and c.-7C>T variants are not associated with...",72,788,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,...ective transcription. Our observation that the c.-28A>G and c.-7C>T variants are associated with par...,74,1094,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...e transcriptional activity associated with the c.-28A>G and c.-7C>T variants in other tissues, inclu...",74,1760,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...onal activity associated with the c.-28A>G and c.-7C>T variants in other tissues, including colorect...",74,1773,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...n whether the grandfather had the c.-28A>G and c.-7C>T variants. This variable penetrance may be exp...,76,454,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
42C>T,"...H1 expression, as described previously for the c.-42C>T variant, which was associated with drastical...",76,593,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
42C>T,"...H1 expression, as described previously for the c.-42C>T variant, which was associated with drastical...",76,593,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
42C>T,...lyses of the tumor from an individual with the c.-42C>T variant revealed deletion of the MLH1 allele...,76,882,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,Further evidence that the c.-28A>G and c.-7C>T variants are the most likely cause of cancer ...,78,43,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...thin or flanking the MLH1 gene, other than the c.-28A>G and c.-7C>T variants. This approach identifi...",78,516,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...thin or flanking the MLH1 gene, other than the c.-28A>G and c.-7C>T variants. This approach identifi...",78,516,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...ILL gene. The cosegregation of the c.1164del1, c.-28A>G, and c.-7C>T variants in a first-degree rela...",78,664,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...ic history of this haplotype. For example, the c.-28A>G and c.-7C>T variants have an identical MAF o...",78,921,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...ants cosegregated. Therefore, the c.-28A>G and c.-7C>T variants are the most likely cause of predisp...",78,1964,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"... BRAF wild-type. Separate from the c.-7C>T and c.-28A>G variants, no constitutional mutations in MLH...",80,395,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"... BRAF wild-type. Separate from the c.-7C>T and c.-28A>G variants, no constitutional mutations in MLH...",80,395,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"...tion is provided. Therefore, the rarity of the c.-28A>G and c.-7C>T haplotype at the population leve...",80,687,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...ded. Therefore, the rarity of the c.-28A>G and c.-7C>T haplotype at the population level, but its pr...",80,700,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...ded. Therefore, the rarity of the c.-28A>G and c.-7C>T haplotype at the population level, but its pr...",80,700,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...n whether both or only one are pathogenic. The c.-7C>T variant was found in a member of a hereditary...,82,121,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>T,...-28A nucleotide may be pathogenic. Whether the c.-28A>T variant in this family was associated with r...,82,525,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
93G>A,"The presence of the c.-93G>A, c.-28A>G, c.-7C>T, and c.655A>G variants in...",84,24,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"The presence of the c.-93G>A, c.-28A>G, c.-7C>T, and c.655A>G variants in both probands allow...",84,44,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,"...hypermethylation was an artifact caused by the c.-7C>T variant, which lies within a recognition site...",84,553,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
7C>T,...ynch syndrome associated with the c.-28A>G and c.-7C>T variants. Our analysis shows that these varia...,86,111,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
28A>G,"Figure S4. Co-segregation of the c.-93G>A, c.-28A>G, c.-7C>T and VILL c.1164del1 variants in a f...",99,47,Hum_Mutat_2015_Jun_17_36(6)_622-630.txt
-308 G>A,... Liu L  Gao T   TNF-a Gene Promoter – 238 G>A and -308 G>A Polymorphisms Alter Risk of Psoriasis Vul...,138,74,Indian_J_Dermatol_2015_Jul-Aug_60(4)_345-350.txt
72 G>C,TP53 (p53) codon 72 G>C Arg/Pro rs1042522,89,18,Infect_Agent_Cancer_2013_May_4_8_15.txt
399 G>A,XRCC1 codon 399 G>A Arg/Gln rs25487,113,13,Infect_Agent_Cancer_2013_May_4_8_15.txt
72 G>C,TP53 (p53) codon 72 G>C Arg/Pro (rs1042522),143,18,Infect_Agent_Cancer_2013_May_4_8_15.txt
9330A>C,"...isms include five SNPs (AAFC02034082.1:g.9224G>A, 9330A>C, 9367G>C, 9419A>C and 9435T>G) and one ins...",43,382,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9330A>C,"...isms include five SNPs (AAFC02034082.1:g.9224G>A, 9330A>C, 9367G>C, 9419A>C and 9435T>G) and one ins...",43,382,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9330A>C,"...isms include five SNPs (AAFC02034082.1:g.9224G>A, 9330A>C, 9367G>C, 9419A>C and 9435T>G) and one ins...",43,382,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9419A>C,"...SNPs (AAFC02034082.1:g.9224G>A, 9330A>C, 9367G>C, 9419A>C and 9435T>G) and one insertion/deletion (A...",43,400,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9419A>C,"...SNPs (AAFC02034082.1:g.9224G>A, 9330A>C, 9367G>C, 9419A>C and 9435T>G) and one insertion/deletion (A...",43,400,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9419A>C,"...n these two markers (AAFC02034082.1:g.9367G>C and 9419A>C), which were significantly associated with...",48,100,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
9419A>C,"...n these two markers (AAFC02034082.1:g.9367G>C and 9419A>C), which were significantly associated with...",48,100,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
83897 T>A,"...sociation of obesity with the SNP +61450 C>A and +83897 T>A haplotype (χ2 = 7.637, p = 0.02). Howeve...",53,972,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
83897 T>A,"...sociation of obesity with the SNP +61450 C>A and +83897 T>A haplotype (χ2 = 7.637, p = 0.02). Howeve...",53,972,Int_J_Biol_Sci_2006_May_18_2(4)_171-178.txt
3435C>T,"...ug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability Pharmacogenet Genom...",218,110,Int_J_Biol_Sci_2013_Apr_22_9(4)_350-360.txt
653G>A,c.-653G>A (rs2333227)	Non-coding,273,4,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
822C>A,c.− 822C>A (rs2243827)	Non-coding,298,5,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
653G>A,c.− 653G>A (rs2333227)	Non-coding,306,5,Int_J_Cardiol_2014_Jun_1_174(1)_96-105.txt
234 T>G,"...t 13 families exhibited a BRCA1 exon 3 nucleotide 234 T>G mutation (pCys39Gly), which is not previou...",123,96,Int_J_Circumpolar_Health_2012_Aug_16_71_10_3402_ijch_v71i0_19155.txt
12A>G,"...ly). In addition, other documented polymorphisms (12A>G, c.769G>T, c.1193G>C, c.2145C>T, c.2173A>C, ...",42,282,Int_J_Endocrinol_2013_Apr_29_2013_987186.txt
763C>G,...ticleGeneticsGynecology and Female InfertilityThe 763C>G Polymorphism of The Secretory PLA2II,3,220,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,"...rabi M, Dabaghi T, Alizadeh SA, Najafipour R. The 763C>G polymorphism o",33,122,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,"...rabi M, Dabaghi T, Alizadeh SA, Najafipour R. The 763C>G polymorphism o",33,122,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,"...rabi M, Dabaghi T, Alizadeh SA, Najafipour R. The 763C>G polymorphism o",33,122,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
763C>G,...this study was to determine the prevalence of the 763C>G polymorphism of PLA2G2A in women with endom...,60,393,Int_J_Fertil_Steril_2015_Feb_7_Jan-Mar_8(4)_437-444.txt
617V> F,...ielmelli P    Clinical profile of homozygous JAK2 617V> F mutation in patients with polycythemia ver...,227,85,Int_J_Hematol_Oncol_Stem_Cell_Res_2016_Apr_1_10(2)_70-78.txt
351A>G,...striction site polymorphism involves a rs9340799 (351A>G),18,1220,Int_J_Med_Sci_2013_Mar_2_10(4)_457-466.txt
126 G > T,"..., two other variants of RET were identified (IVS1–126 G > T; rs2565206) and (IVS8+82 A > G; rs302675...",79,59,Int_J_Mol_Sci_2011_Dec_27_13(1)_221-239.txt
126 G > T,"..., two other variants of RET were identified (IVS1–126 G > T; rs2565206) and (IVS8+82 A > G; rs302675...",79,59,Int_J_Mol_Sci_2011_Dec_27_13(1)_221-239.txt
8+82 A > G,"... diagnosis of MTC. On the other hand, variant (IVS8+82 A > G; InsC 85–86) was associated with the pr...",79,354,Int_J_Mol_Sci_2011_Dec_27_13(1)_221-239.txt
584C > T,"... (LIPC) −250G > A, endothelial lipase gene (LIPG) 584C > T, methylenetetrahydrofolate reductase (MTH...",3,2319,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,"... (LIPC) −250G > A, endothelial lipase gene (LIPG) 584C > T, methylenetetrahydrofolate reductase (MTH...",3,2319,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,"...G > A (rs2070895), endothelial lipase gene (LIPG) 584C > T (rs2000813), methylenetetrahydrofolate re...",19,301,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,"...G > A (rs2070895), endothelial lipase gene (LIPG) 584C > T (rs2000813), methylenetetrahydrofolate re...",19,301,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
294T > C,...me proliferator-activated receptor delta (PPARD) +294T > C (rs2016520) and Scavenger receptor class ...,19,637,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,LIPG 584C > T (rs2000813)	CC	454 (46.4)	308 (41.0),141,6,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A (rs2070895)	GG	117.1 ± 16.9	74.2 ± 9.3	42...,211,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,DBP	LIPG 584C > T genotype	1.396	0.403	0.077	3.460	0.001,271,10,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A allele	4.415	1.267	0.117	3.484	0.001,288,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A allele	1.938	0.782	0.085	2.478	0.013,293,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A allele	1.938	0.782	0.085	2.478	0.013,293,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
584C > T,LIPG 584C > T allele	2.783	0.764	0.126	3.644	0.000,295,7,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
250G > A,LIPC −250G > A allele	2.414	0.882	0.093	2.736	0.006,302,8,Int_J_Mol_Sci_2012_Sep_24_13(9)_12062-12081.txt
1051730 G>A,c CHRNA5-A3-B4 genotype represented by tag SNP rs1051730 G>A with the highest risk genotype for smo...,93,50,Int_J_Mol_Sci_2013_Apr_16_14(4)_8381-8392.txt
66A>G,...van der Linde I.J.  Daniels O.  Blom H.J.   MTRR  66A>G polymorphism in relation to congenital heart...,224,113,Int_J_Mol_Sci_2013_Jan_28_14(2)_2739-2752.txt
235Met >Thr,"... births [54]. However, the mechanism by which the 235Met >Thr mutation affects maternal-placental an...",115,693,Int_J_Pediatr_Endocrinol_2012_May_15_2012(1)_12.txt
-1347C > T,...eta1 expression due to the common SNP -509C-T (c. -1347C > T). Hum Genet. 2006 120 4 461 9 10.1007/s...,188,146,Iran_J_Cancer_Prev_2016_Feb_24_9(1)_e5266.txt
-420 C>G,"...eale et al showed no association between resistin -420 C>G polymorphism with PCOS, they found an ass...",306,449,Iran_J_Reprod_Med_2013_Mar_11(3)_185-194.txt
531G>A,"...RB1 transcript revealed a heterozygous variation, 531G>A, which leads to the amino acid substitution...",17,481,Ital_J_Pediatr_2013_Feb_14_39_12.txt
531G>A,"...riation found in this child as 467G>A in stead of 531G>A [5]. We have analyzed R156H, as well as sev...",19,429,Ital_J_Pediatr_2013_Feb_14_39_12.txt
531G>A,"...riation found in this child as 467G>A in stead of 531G>A [5]. We have analyzed R156H, as well as sev...",19,429,Ital_J_Pediatr_2013_Feb_14_39_12.txt
2T>C,"....97) canonical donor splice site of exon 4 (c.754+2T>C), which is absent from variant databases (Var...",58,695,J_Am_Coll_Cardiol_2015_Apr_7_65(13)_1324-1336.txt
681G>A,Cytochrome P450 2C19 681G>A polymorphism and high on‐clopidogrel platel...,115,22,J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.txt
681G>A,Cytochrome P450 2C19 681G>A polymorphism and high on‐clopidogrel platel...,115,22,J_Am_Heart_Assoc_2013_Apr_24_2(2)_e000131.txt
300T >G,"...82insC found in 29 out of 16,849 samples (0.17%). 300T >G and 3819del5 mutations were found in respe...",3,1954,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...82insC found in 29 out of 16,849 samples (0.17%). 300T >G and 3819del5 mutations were found in respe...",30,155,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...quencies for combined Polish founder 5382insC and 300T >G mutations without the division into provin...,30,421,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...quencies for combined Polish founder 5382insC and 300T >G mutations without the division into provin...,30,421,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...l distribution and frequencies of BRCA1 5382insC, 300T >G, 185delAG, and 3819del5 mutations. * - onl...",33,123,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...or this mutation at OR = 17 (95%CI 6.6–43.4). For 300T >G missense mutation (2 out of 4352 control s...,37,449,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...BRCA1 mutations, truncating 5382insC and missense 300T >G comprise 70–90% of all BRCA1 pathogenic al...",40,763,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...BRCA1 mutations, truncating 5382insC and missense 300T >G comprise 70–90% of all BRCA1 pathogenic al...",40,763,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...NA change was detected in 0.05% control subjects. 300T >G mutation is regarded as the founder change...,46,210,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,"...es, show high frequencies of founder 5382insC and 300T >G BRCA1 mutations in Polish general populati...",55,95,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...evalence for combined Polish founder 5382insC and 300T >G mutations was 0.25% (1/400). Carriage of o...,55,216,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
300T >G,...evalence for combined Polish founder 5382insC and 300T >G mutations was 0.25% (1/400). Carriage of o...,55,216,J_Appl_Genet_2011_Aug_19_52(3)_325-330.txt
1G > A,"...onor sequence of intron 6, c.357 + 1G > A (IVS6 + 1G > A) (Fig. 2).Fig. 2 Forward sequence analysis ...",73,946,J_Appl_Genet_2013_Aug_13_54(3)_345-351.txt
1G > A,...G/A transition in intron 6 at position +1 c.357 + 1G >,73,1156,J_Appl_Genet_2013_Aug_13_54(3)_345-351.txt
2518 A>G,...nificant difference in the distribution of MCP-1 −2518 A>G polymorphic variants in patients with SLE...,7,198,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,3.2. Association of MCP-1 –2518 A>G Genotypes with Clinical Symptoms of SL,34,28,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,3.2. Association of MCP-1 –2518 A>G Genotypes with Clinical Symptoms of SL,34,28,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,Reports on the contribution of the MCP-1 –2518 A>G polymorphism to SLE incidence and clinica...,42,43,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,Reports on the contribution of the MCP-1 –2518 A>G polymorphism to SLE incidence and clinica...,42,43,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,...rve differences in the distribution of the MCP-1 –2518 A>G polymorphic variant between patients with...,42,214,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,...rve differences in the distribution of the MCP-1 –2518 A>G polymorphic variant between patients with...,42,214,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,...rve differences in the distribution of the MCP-1 –2518 A>G polymorphic variant between patients with...,42,214,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,Table 1 Association of the MCP-1 –2518 A>G polymorphism with clinical manifestation ...,63,35,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
2518 A>G,Table 1 Association of the MCP-1 –2518 A>G polymorphism with clinical manifestation ...,63,35,J_Biomed_Biotechnol_2010_Apr_21_2010_130265.txt
9909601 G>A,"...NA binding. Eventually, we found that two SNPs (rs9909601 G>A and rs1838149 C>T) might affect miRNA ...",26,373,J_Biomed_Res_2013_May_25_27(3)_215-219.txt
724G>A,724G>A	4	Ala242Thr	49	F	+7.1	+10.7	N	Y	Y	N	S	Proba...,107,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
724G>A,724G>A	4	Ala242Thr	41	F	+3.1	+3.1	N	Y	Y	N	F	Probab...,128,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
266A>G,266A>G	2	Gln89Arg	6,140,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
530C>A,530C>,167,2,J_Bone_Miner_Res_2016_Mar_6_31(3)_640-649.txt
1G>A,"...% of the alleles, followed by c.769C>T, and c.879+1G>A (Figure 3 and Supplemental Table 2). We then ...",133,292,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
1C>G,...PS1 cohorts. Of particular interest was the c.879+1C>G splice mutation found in three homozygous pat...,158,150,J_Clin_Endocrinol_Metab_2016_Aug_2_101(8)_2975-2983.txt
636G>A,"...tion of the CYP2C19*2 (681G>A, rs4244285) and *3 (636G>A, rs4986893) alleles was performed by polyme...",37,272,J_Clin_Pharmacol_2016_Apr_8_56(4)_408-413.txt
934C>T,"3	51/F	Insulin-dependent DM	DM, pigmentation	934C>T/934C>T in HJV, no mutation in ATP7B	HJV-HH",51,46,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
934C>T,"...51/F	Insulin-dependent DM	DM, pigmentation	934C>T/934C>T in HJV, no mutation in ATP7B	HJV-HH",51,53,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
934C>T,"...51/F	Insulin-dependent DM	DM, pigmentation	934C>T/934C>T in HJV, no mutation in ATP7B	HJV-HH",51,53,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
745G>C,"4	48/M	Insulin-dependent DM	DM, pigmentation	745G>C/745G>C in HJV	HJV-HH",52,46,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
1206C>A,"...endent DM, history of alcoholism	DM, pigmentation	1206C>A/wt in TFR2	FPN-like iron overload",57,69,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
714C>G,...e	Glucose-intolerance	187C>G (H63D)/wt in HFE and 714C>G/wt in TFR2	Intravenousiron load,58,82,J_Clin_Transl_Hepatol_2015_Jun_28_3(2)_85-92.txt
45T>G,... showed that the associations between rs2241766 (+45T>G) and rs1501299 (+276G>T) in the ADIPOQ gene ...,27,575,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
276G>T,...ations between rs2241766 (+45T>G) and rs1501299 (+276G>T) in the ADIPOQ gene and cardiovascular dise...,27,598,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
11391G>A,"... in Caucasian patients23. Studies on rs17300539 (−11391G>A) and rs182052 (−10069G>A) are scarce, par...",27,931,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
11391G>A,"... in Caucasian patients23. Studies on rs17300539 (−11391G>A) and rs182052 (−10069G>A) are scarce, par...",27,931,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
10069G>A,"... Studies on rs17300539 (−11391G>A) and rs182052 (−10069G>A) are scarce, particularly in type 2 diabe...",27,956,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
45T>G,"... study to examine the associations of rs2241766 (+45T>G), rs1501299 (+276G>T), rs17300539 (−11391G>A...",29,260,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
45T>G,"Four SNPs were genotyped rs2241766 (+45T>G), rs1501299 (+276G>T), rs17300539 (−11391G>A...",43,38,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
10069G>A,"... (+276G>T), rs17300539 (−11391G>A) and rs182052 (−10069G>A) of the ADIPOQ gene",43,105,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
10069G>A,"... (+276G>T), rs17300539 (−11391G>A) and rs182052 (−10069G>A) of the ADIPOQ gene",43,105,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
45T>G,...ferent arguments from the literature: rs2241766 (+45T>G) and rs1501299 (+276G>T) are the most cited ...,45,97,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
276G>T,...he literature: rs2241766 (+45T>G) and rs1501299 (+276G>T) are the most cited regarding the cardiovas...,45,120,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
182052 G>A,rs182052 G>A (n = 189)	Genotypes	Dominant model,128,3,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
2241766 T>G,rs2241766 T>G	CAD	HTGW	Triglycerides,149,3,J_Diabetes_Investig_2014_Mar_23_5(2)_192-198.txt
5557G > A,"...is to evaluate the association between ATM exon39 5557G > A (D1853N, rs1801516) polymorphism and bre...",4,330,J_Exp_Clin_Cancer_Res_2010_Aug_27_29(1)_117.txt
5557G > A,"... common single nucleotide polymorphism ATM exon39 5557G > A (D1853N, rs1801516) may be considered as...",20,93,J_Exp_Clin_Cancer_Res_2010_Aug_27_29(1)_117.txt
936C>T,"... in this study: SLC2A1 -2841A>T (rs710218), VEGFA+936C>T (rs3025039) [NM_001025366.1:c.*237C>T], APE...",31,248,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
-2841A>T,SLC2A1	-2841A>,52,8,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
-2841A>T,"...uencies of the AA, AT, and TT genotypes of SLC2A1 -2841A>T were 51.7%, 37.7%, and 10.6%, respectivel...",91,117,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,VEGFA +936C>T	CC	102	(67.1%)	C:T	0.819:0.181	0.2579,100,8,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,VEGFA +936C>T	CC	102	(67.1%)	C:T	0.819:0.181	0.2579,100,8,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
-2841A>T,SLC2A1 -2841A>T	AA (n = 41)	9.40 ± 2.63	0.155	AA	9.40 ± 2...,118,8,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
-2841A>T,SLC2A1 -2841A>T	AA (n = 41)	9.40 ± 2.63	0.155	AA	9.40 ± 2...,118,8,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
-2841A>T,TG	SLC2A1 -2841A>T	AA (n = 20)	9.72 ± 3.00	0.984	AA	9.72 ± 3...,142,11,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
936C>T,...h NSCLC. Wolf et al. [11] reported that the VEGFA+936C>T polymorphism is associated with FDG-uptake ...,169,490,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
-2841A>T,...ients with early stage NSCLC. Although the SLC2A1 -2841A>T polymorphism in combination with the APEX...,171,197,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
-2841A>T,...ients with early stage NSCLC. Although the SLC2A1 -2841A>T polymorphism in combination with the APEX...,171,197,J_Exp_Clin_Cancer_Res_2010_Jun_12_29(1)_69.txt
105 C>T,...lse-negative. Normalisation was performed to the G105 C>T allele,79,965,J_Exp_Clin_Cancer_Res_2014_May_21_33(1)_44.txt
105 C>T,...lse-negative. Normalisation was performed to the G105 C>T allele,79,965,J_Exp_Clin_Cancer_Res_2014_May_21_33(1)_44.txt
2T>A,"...nsertion (p.D293X), a splice-site mutation (c.319+2T>A), and a missense mutation (p.I364T) located i...",61,509,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1G>A,"...groups of controls (Table 2). Of these, the c.444+1G>A splice site mutation has been previously repo...",61,763,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
2T>A,c.319+2T>A	-	Novel	1/171	ND	Swedish	0	0	-	-,66,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
2T>A,c.319+2T>A	-	Novel	1/171	ND	Swedish	0	0	-	-,66,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1G>A,c.444+1G>A	-	Reported	1/171	Germline	Swedish	0	0	-	-,72,7,J_Exp_Med_2013_Aug_26_210(9)_1729-1742.txt
1791+2T>G,"...ith complete IL-12Rβ1 deficiency (P1, c.1791+2T>G/1791+2T>G; P2, c.1791+2T>G/p.R486X; P3, c.C1207T/C...",96,247,J_Exp_Med_2016_Apr_4_213(4)_569-583.txt
1294C>G,Genotyping for the polymorphism c. 1294C>G (p. Leu432Val) in gene CYP1B1 was done usi...,41,36,J_Gynecol_Oncol_2011_Jun_30_22(2)_110-119.txt
47T>C,"...MT, c. 313A>G (p. Ile105Val) in gene GSTP1 and c. 47T>C (p. Val16Ala) in gene MnSOD was performed on...",41,513,J_Gynecol_Oncol_2011_Jun_30_22(2)_110-119.txt
515W>L,... F Characteristics and clinical correlates of MPL 515W>L/K mutation in essential thrombocythemia Blo...,137,160,J_Hematol_Oncol_2013_Jan_25_6_11.txt
616G>C,"...ommon polymorphisms (−1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T and 12-bp repeat...",3,1745,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521T>C,"...ymorphisms (−1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T and 12-bp repeat) and a k...",3,1754,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,...m region. A single nucleotide polymorphism (SNP) −809G>A in the promoter region was found to be sign...,3,1916,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
873G>A,"...otal of eleven SNPs: −1106T>C, −930C>G, −906T>C, −873G>A, −809G>A, −616G>C, −603G>T, −595G>del, −521...",41,123,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
873G>A,"...otal of eleven SNPs: −1106T>C, −930C>G, −906T>C, −873G>A, −809G>A, −616G>C, −603G>T, −595G>del, −521...",41,123,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
376C>T,"..., −809G>A, −616G>C, −603G>T, −595G>del, −521T>C, −376C>T, and −291C>T, and a 12-bp repeat polymorphi...",41,179,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
291C>T,"...16G>C, −603G>T, −595G>del, −521T>C, −376C>T, and −291C>T, and a 12-bp repeat polymorphism (Fig. 1). ...",41,192,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
930C>G,"...repeat polymorphism (Fig. 1). One novel variant, −930C>G (deposited into GenBank as ss61570833), was...",41,262,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
1106T>C,"The eight markers, −1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C...",43,21,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521T>C,"...ht markers, −1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T, and the 12-bp repeat pol...",43,58,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521T>C,"...ht markers, −1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T, and the 12-bp repeat pol...",43,58,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521T>C,"...ht markers, −1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T, and the 12-bp repeat pol...",43,58,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
376C>T,"...s, −1106T>C, −906T>C, −809G>A, −616G>C, −521T>C, −376C>T, −291C>T, and the 12-bp repeat polymorphism...",43,67,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
906T>C,...1 in the distal [(120-bp repeat) − (−1106T>C) − (−906T>C)] and proximal [(−376C>T) − (−291C>T) − (−1...,82,91,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
376C>T,...repeat) − (−1106T>C) − (−906T>C)] and proximal [(−376C>T) − (−291C>T) − (−12-bp)] segments of the up...,82,116,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
291C>T,...1106T>C) − (−906T>C)] and proximal [(−376C>T) − (−291C>T) − (−12-bp)] segments of the upstream regio...,82,128,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
291C>T,...1106T>C) − (−906T>C)] and proximal [(−376C>T) − (−291C>T) − (−12-bp)] segments of the upstream regio...,82,128,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
906T>C,...discrete distal [(120-bp repeat) − (−1106T>C) − (−906T>C)] and proximal [(−376C>T) − (−291C>T) − (12...,83,508,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,"Both upstream region variants, the single marker −809G>A and a multi-marker combination, displayed a...",99,51,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
521T>C,"...iation with schizophrenia in this study. The SNP −521T>C, which was previously reported to show asso...",99,155,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
809G>A,...s testing failed to replicate the association of −809G>A in a sample set of 80 complete schizophreni...,99,1529,J_Hum_Genet_2007_Jan_7_52(1)_86-91.txt
1G>A,"...G). Seven splice site mutations were found (c.416-1G>A, c.600+1G>T, c.601-1G>A, c.919-2A>G, c.1001+1...",32,471,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
5G>A,"..., c.919-2A>G, c.1001+1G>A, c.1002-9A>G and c.1707+5G>A)",32,549,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
5G>A,"..., c.919-2A>G, c.1001+1G>A, c.1002-9A>G and c.1707+5G>A)",32,549,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,"...hat accounted for 36.0%, and the second was c.919-2A>G found in 7.0%, followed by c.1707+5G>A (4.0%)...",38,91,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
5G>A,"... was c.919-2A>G found in 7.0%, followed by c.1707+5G>A (4.0%). Frequency of the other 36 mutations w...",38,130,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
5G>A,"... was c.919-2A>G found in 7.0%, followed by c.1707+5G>A (4.0%). Frequency of the other 36 mutations w...",38,130,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2A>G,"...e Japanese and Korean populations,8 whereas c.919-2A>G is most common in the Chinese.",56,411,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
367C>T,"c. 367C>T	p. P123S	4	 	1	 	0.50	Tsukamoto et al.2, 4",84,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
367C>T,"c. 367C>T	p. P123S	4	 	1	 	0.50	Tsukamoto et al.2, 4",84,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
600+1G>T,c. 600+1G>T	 	Intron 5	 	1	 	0.50	This study,87,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1105A>G,"c. 1105A>G	p. K369E	9	 	1	 	0.50	Usami et al.2, 3",94,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1105A>G,"c. 1105A>G	p. K369E	9	 	1	 	0.50	Usami et al.2, 3",94,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1115C>T,"c. 1115C>T	p. A372V	9	 	1	 	0.50	Usami et al.2, 3",95,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1115C>T,"c. 1115C>T	p. A372V	9	 	1	 	0.50	Usami et al.2, 3",95,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1174A>T,"c. 1174A>T	p. N392Y	10	 	3	 	1.50	Park et al.14, 16",96,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1187G>A,c. 1187G>A	p. G396E	10	 	1	 	0.50	This study,97,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1187G>A,c. 1187G>A	p. G396E	10	 	1	 	0.50	This study,97,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1300G>A,c. 1300G>A	p. A434T	11	 	 	1	0.50	This study,100,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1343C>T,"c. 1343C>T	p. S448L	11	 	1	 	0.50	Wang et al.7, 8",102,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1579A>G,"c. 1579A>G	p. T527P	14	 	2	 	1.00	Suzuki et al.5, 6",103,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1586T>G,"c. 1586T>G	p. I529S	14	 	1	 	0.50	Wang et al.7, 8",104,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1586T>G,"c. 1586T>G	p. I529S	14	 	1	 	0.50	Wang et al.7, 8",104,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1595G>T,"c. 1595G>T	p. S532I	14	 	2	 	1.00	Usami et al.3, 17",105,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,"c. 1707+5G>A	 	Intron 15	1	6	 	4.00	Park et al.8, 9",108,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1970G>A,"c. 1970G>A	p. S657N	17	 	1	 	0.50	Tsukamoto et al.2, ...",111,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1970G>A,"c. 1970G>A	p. S657N	17	 	1	 	0.50	Tsukamoto et al.2, ...",111,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1975G>C,"c. 1975G>C	p. V659L	17	 	3	 	1.50	Wang et al.7, 8",112,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2168A>G,"c. 2168A>G	p. H723R	19	11	40	10	36.00	Usami et al.2, ...",116,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2168A>G,"c. 2168A>G	p. H723R	19	11	40	10	36.00	Usami et al.2, ...",116,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2168A>G,"c. 2168A>G	p. H723R	19	11	40	10	36.00	Usami et al.2, ...",116,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
2180T>A,c. 2180T>A	p. L727X	19	 	1	 	0.50	This study,118,4,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1001+1G>A,2498	0	p. [919-2A>G][1001+1G>A]	0	+	+	NA	−	−	86.25	86.25	83.8,143,22,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,2804	2	p. [1707+5G>A][H723R]	0	+	+	−	−	−	78.75	78.75	82.5,149,12,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1002-9A>G,4097	3	p. [N392Y][1002-9A>G]	0	−	−	−	−	−	106.25	85	93.1,161,19,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
919-2A>G,4098	26	p. [N392Y][919-2A>G]	2	−	+	+	+	−	110	37.5	71.3,162,20,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4434	8	p. [T410M][1707+5G>A]	1	+	+	−	+	−	92.5	100	91.3,174,19,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4486	20	p. [1707+5G>A][1707+5G>A]	4	+	+	+	+	+	72.5	95	78.1,177,13,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4486	20	p. [1707+5G>A][1707+5G>A]	4	+	+	+	+	+	72.5	95	78.1,177,13,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4486	20	p. [1707+5G>A][1707+5G>A]	4	+	+	+	+	+	72.5	95	78.1,177,13,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4486	20	p. [1707+5G>A][1707+5G>A]	4	+	+	+	+	+	72.5	95	78.1,177,13,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4486	20	p. [1707+5G>A][1707+5G>A]	4	+	+	+	+	+	72.5	95	78.1,177,13,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4486	20	p. [1707+5G>A][1707+5G>A]	4	+	+	+	+	+	72.5	95	78.1,177,24,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4486	20	p. [1707+5G>A][1707+5G>A]	4	+	+	+	+	+	72.5	95	78.1,177,24,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
919-2A>G,4518	26	p. [H723R][919-2A>G]	0	+	+	+	+	−	105	97.5	98.1,180,20,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4545	12	p. [1707+5G>A][H723R]	4	+	+	+	+	+	86.25	28.75	53.1,182,13,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4545	12	p. [1707+5G>A][H723R]	4	+	+	+	+	+	86.25	28.75	53.1,182,13,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
1707+5G>A,4545	12	p. [1707+5G>A][H723R]	4	+	+	+	+	+	86.25	28.75	53.1,182,13,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
600+1G>T,4671	2	p. [H723R][600+1G>T]	0	+	−	−	+	−	NA	NA	NA,213,19,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
919-2A>G,3309	5	p. [919-2A>G][P76S]	0	+	+	+	+	−	106.25	106.25	101.3,217,12,J_Hum_Genet_2014_May_6_59(5)_262-268.txt
53C>T,... in the exon 9-flanking region in intron 8 (c.832-53C>T),33,403,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
1G>T,11	int2	c.94-1G>T	 	Splice donor variant,95,14,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
2A>G,20	int54	c.8218-2A>G	 	Splice donor variant,104,17,J_Hum_Genet_2016_Jun_25_61(6)_483-489.txt
290A>G,"...sion analysis, in addition to the age, only RANKL 290A>G remained as an independent risk factor for ...",149,591,J_Immunol_Res_2015_Dec_21_2015_745647.txt
-550G>C,"...ys polymorphism [rs5030737] and DrdI for the MBL2 -550G>C [rs11003125]), so that if a polymorphism i...",42,540,J_Immunol_Res_2015_Mar_24_2015_478412.txt
310 T>C,I.23	29	M	486	53	59	No	Yes	IBD	Yes	Yes	Yes	 	c.[310 T>C];[=,200,50,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,I.23	29	M	486	53	59	No	Yes	IBD	Yes	Yes	Yes	 	c.[310 T>C];[=,200,50,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,I.23	29	M	486	53	59	No	Yes	IBD	Yes	Yes	Yes	 	c.[310 T>C];[=,200,50,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
542 C>A,...59	25	M	Na	Na 	Na	No	No	 	No	No	No	 	c.[310 T>C];[542 C>A,210,53,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
215 G>A,...	M	208	0	33	No	No	 	No	No	No	NHL	c.[204_205insA];[215 G>A,212,58,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
310 T>C,...	No	No	 	Yes	Yes	No	Ovaric Theratoma	c.[310 T>C];[310 T>C,214,70,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
260 T>A,I.78	19	M	983	18	169	No	Yes	 	No	No	No	 	c.[260 T>A];[=,218,45,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
492 C>G,...80	54	24	No	No	 	Yes	Yes	No	Sarcomas	c.[260 T>A];[492 C>G,226,64,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
579 C>A,"...250	64	90	No	No	 	No	No	No	 	c.[306 C>G];[431 C>G,579 C>A",230,62,J_Immunol_Res_2016_Mar_30_2016_8390356.txt
9185T>C,...ariable phenotype including Leigh syndrome with a 9185T>C mutation in the MTATP6 gene Neuropediatric...,199,82,J_Inherit_Metab_Dis_2012_Mar_27_35(2)_211-225.txt
785A>G,"...6, CYP3A5*3, CYP2B6 983T>C, CYP2B6 516G>T, CYP2B6 785A>G in 89/180 patients obtained by Sequenom iPL...",9,659,J_Int_AIDS_Soc_2010_Nov_8_13(Suppl_4)_P181.txt
2A>G,"...d a maternal acceptor splice site mutation g.6751-2A>G (IVS85-2A>G). Therefore, one truncated (pater...",18,332,J_Invest_Dermatol_2014_May_6_134(5)_1246-1254.txt
2A>G,"...d a maternal acceptor splice site mutation g.6751-2A>G (IVS85-2A>G). Therefore, one truncated (pater...",18,332,J_Invest_Dermatol_2014_May_6_134(5)_1246-1254.txt
2A>G,...the COL7A1 region surrounding the maternal g.6751-2A>G mutation located in intron 85 indicated skipp...,18,714,J_Invest_Dermatol_2014_May_6_134(5)_1246-1254.txt
5G>A,"...1699C>T, c.466_467 insAC, c.1174-1G>A, and c.1768+5G>A were novel mutations. To analyze the correlat...",4,1092,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1G>A,"...these, c.64G>T, c.1699C>T, c.466_467insAC, c.1174-1G>A, and c.1768+5G>A were novel mutations identif...",34,171,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
5G>A,"....1699C>T, c.466_467insAC, c.1174-1G>A, and c.1768+5G>A were novel mutations identified in this study...",34,188,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1G>A,"... codon at amino acid 222. Three mutations, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and ...",36,352,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1G>A,"... codon at amino acid 222. Three mutations, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and ...",36,352,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
1G>A,"... codon at amino acid 222. Three mutations, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and ...",36,352,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
17+5G >A,"...ations, c.1174-1G>A (IVS10-1G>A), c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A (IVS19+1G>A), occur at ...",36,387,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
19+1G>A,"...), c.1768+5G>A (IVS17+5G >A), and c.1965+1G>A (IVS19+1G>A), occur at splicing acceptor/donor sites; ...",36,418,J_Korean_Med_Sci_2007_Dec_20_22(6)_981-986.txt
677 C>T,...lis D  Stefanadis C  Refsum H  Channon KM   MTHFR 677 C>T Polymorphism reveals functional importance...,68,163,J_Korean_Med_Sci_2011_Mar_25_26(3)_461-465.txt
896A>G,39 Chen S   Association between the TLR4 +896A>G (Asp299Gly) polymorphism and asthma: a syst...,142,43,J_Korean_Med_Sci_2014_May_25_29(5)_662-668.txt
896A>G,39 Chen S   Association between the TLR4 +896A>G (Asp299Gly) polymorphism and asthma: a syst...,142,43,J_Korean_Med_Sci_2014_May_25_29(5)_662-668.txt
9101C>T,"The genotype and allele frequencies of g.-9101C>T, g.-8748C>T, and g.72C>T did not differ be...",10,43,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"...up. Further, the haplotype of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ between patien...",10,186,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"... samples from 533 healthy volunteers. The CTTN g.-9101C>T, g.-8748C>T, and g.72C>T polymorphisms wer...",27,249,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...e patient and control groups and the CTTN gene g.-9101C>T, g.-8748C>T polymorphisms were analyzed us...",30,123,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"The genotype frequencies of the CTTN g.-9101C>T polymorphism were 97.0% (TT), 3.0% (TC), a...",43,41,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,"The major haplotype of CTTN g.-9101 C>T, g.-8748C>T, and g. 72C>T was T-T-C, T-T-T. The haplot...",49,45,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"The haplotype frequencies of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ be...",52,38,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...h the controls. Although the haplotype of CTTN g.-9101C>T, g.-8748C>T, and g.72C>T did not differ be...",67,1162,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
9101C>T,"...n, the genotype and allele frequencies of CTTN g.-9101C>T were significantly higher in lymph node-po...",69,63,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
8748C>T,... reaction products for g.-9101C>T (630 bp) and g.-8748C>T (630 bp) yielded 2 fragments of 490 bp and...,73,175,J_Korean_Surg_Soc_2012_Mar_27_82(3)_156-164.txt
677 C>T,MTHFR 677 C>T Polymorphism reveals functional importance...,333,7,J_Lipid_Res_2011_Jan_52(1)_104-112.txt
18-1G>A,...at this patient harbored an intronic mutation (IVS18-1G>A) that would affect ribonucleic acid (RNA) ...,87,1115,J_Med_Case_Rep_2013_Mar_18_7_78.txt
4-2A>G,253	4		IVS4-2A>G		Splice site	1	1		0	1	1 (n = 1),54,11,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
4-2A>G,"240	4		IVS4-2A>G		Splice site	10	9	TD, PFF	1	4	0",55,11,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
7+1 G>T,261	7		IVS7+1 G>T		Splice site	1	1	L	1	1	1 (n = 3),65,11,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
7+1 G>T,"262	7		IVS7+1 G>T		Splice site	5	4	AF, DFSP, LS, TD	4	5	1 (n...",66,11,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
1884C>T,"...(c.1065-6delGCinsTA, c. 1733insC, c. 1733delC and 1884C>T) were reported by both the NCI BHDS group ...",180,376,J_Med_Genet_2008_Jun_30_45(6)_321-331.txt
55665408 A>G,Patient 1	F	64	?	TNNI3	55665408 A>G	NM_000363.4	539A>G	p.Asp180Gly	Probab...,119,24,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
539A>G,Patient 1	F	64	?	TNNI3	55665408 A>G	NM_000363.4	539A>G	p.Asp180Gly	Probably damaging	Possibly dama...,119,49,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
415G>T,Patient 10	F	27	30	MYH7	23901935 G>T	NM_000257.2	415G>T	p.Val139Leu	Probably damaging	Probably dama...,129,50,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
119581776 G>A,F	–	–	LAMP2	119581776 G>A	NM_002294.2	661G>A	p.Gly221Arg	Proba...,130,14,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
661G>A,F	–	–	LAMP2	119581776 G>A	NM_002294.2	661G>A	p.Gly221Arg	Probably damaging	Probably dama...,130,40,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
4859C>T,...atient 14	M	35	21	SCN5A	38593004  C>T	NM_198056.2	4859C>T	p.Thr1620Met	Probably damaging	Probably da...,134,52,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
764A>G,Patient 16	F	73	?	LDB3	88451727 A>G	NM_007078.2	764A>G	p.Lys255Arg	Benign	Benign	26	0.00	C25	Not f...,136,49,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
566C>T,...atient 25	M	44	20	?	LDB3	88441437 C>T	NM_007078.2	566C>T	p.Ser189Leu	Benign	Benign	145	0.1	C0	2/10 8...,165,52,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
877C>T,...ient 28	M	67	28	?	TNNT2	201328349 C>T	NM_000364.2	877C>T	p.Arg293Cys	Probably damaging	Probably dama...,170,54,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
111356964G>A,Patient 31†	M	65	11	No	MYL2	111356964G>A	NM_000432.3	37G>A	Ala13Thr	Possibly d...,197,29,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
111356964G>A,Patient 31†	M	65	11	No	MYL2	111356964G>A	NM_000432.3	37G>A	Ala13Thr	Possibly d...,197,29,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
253C>T,...atient 32	M	?	?	?	PRKAG2	151478451C>T	NM_016203.3	253C>T	Pro85Ser	Possibly damaging	Benign	74	0.12	C...,198,52,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
2827C>T,...nt 35	M	16	18	Yes	MYBPC3	47356671 C>T	NM_000256.3	2827C>T	Arg943X	–	–	–	–	–	Not found	Pathogenic	Dut...,201,56,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
23898464 G>A,Patient 38	F	58	15	No	MYH7	23898464 G>A	NM_000257.2	1231G>A	Val411Ile	Possibl...,204,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1231G>A,...tient 38	F	58	15	No	MYH7	23898464 G>A	NM_000257.2	1231G>A	Val411Ile	Possibly damaging	Probably damag...,204,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1231G>A,...tient 38	F	58	15	No	MYH7	23898464 G>A	NM_000257.2	1231G>A	Val411Ile	Possibly damaging	Probably damag...,204,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
2002C>A,...tient 39	M	31	?	Yes	MYH7	23896028 C>A	NM_000257.2	2002C>A	His668Asn	Probably damaging	Probably damag...,205,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
5135G>A,...tient 44	F	74	21	No	MYH7	23884860 G>A	NM_000257.2	5135G>A	Arg1712Gln	Possibly damaging	Probably dama...,210,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
5135G>A,...tient 44	F	74	21	No	MYH7	23884860 G>A	NM_000257.2	5135G>A	Arg1712Gln	Possibly damaging	Probably dama...,210,53,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
1804G>A,...ient 48	F	56	15	Yes	LMNA	156108384G>A	NM_170707.2	1804G>A	Gly602Ser	Benign	Benign	56	1.00	C0	12/12 9...,214,54,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
23896043C>T,Patient 52	F	38	26	No	MYH7	23896043C>T	NM_000257.2	1987C>T	Arg663Cys	Probably...,219,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
220285587A>C,Patient 53	F	32	20	Yes	DES	220285587A>C	NM_001927.3	935A>C	Asp312Ala	Probably...,220,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
220285587A>C,Patient 53	F	32	20	Yes	DES	220285587A>C	NM_001927.3	935A>C	Asp312Ala	Probably...,220,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
220285587A>C,Patient 53	F	32	20	Yes	DES	220285587A>C	NM_001927.3	935A>C	Asp312Ala	Probably...,220,28,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
3004C>T,MYBPC3	47355294C>T	NM_000256.3	3004C>T	Arg1002Trp	Probably damaging	Probably dama...,221,37,J_Med_Genet_2013_Sep_19_50(9)_614-626.txt
815G>A,"...ic, hypomineralised	WDR72	NM_182758.3	c.[182A>G];[815G>A]	p.[H61R];[W272*]	Compound heterozygous	Nov...",97,74,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1495G>A, V2.05	M	6	AR	N/A	CNNM4	NM_020184.3	c.[1495G>A];[1495G>A]	p.[V499M];[V499M]	Homozygous (C...,98,40,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1495G>A, V2.05	M	6	AR	N/A	CNNM4	NM_020184.3	c.[1495G>A];[1495G>A]	p.[V499M];[V499M]	Homozygous (C...,98,40,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
2407G>T, V2.09	F	16	AD	Hypoplastic	COL17A1	NM_000494.3	c.[2407G>T]; [=]	p.[G803*];[=]	Maternal	73	S4,100,51,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
124C>T, V2.18	M	13	?	Hypoplastic	LAMB3	NM_000228.2	c.[124C>T]; [=]	p.[R42*];[=]	?	74	S5,101,48,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
155C>T, V2.28	M	14	?	Hypoplastic	AMELX	NM_182680.1	c.[155C>T];[=]	p.[P52L];[=]	De novo	Novel	S8,104,48,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
123+1G>A, V2.29	M	14	AD	N/A	ENAM	NM_031889.2	c.[123+1G>A];[=]	p.[0?];[=]	Paternal	Novel	S9,105,40,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
532-1G>C,...F	19	?	Hypoplastic	AMBN	NM_016519.5	c.[532-1G>C];[532-1G>C]	p.[0?];[(0?)]	Homozygous	Novel	S11,107,58,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
343A>C,"... 37, 38, 41, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[343A>C](;)[682T>A]	p.[K115Q](;)[F228I]	?	Novel and...",115,103,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 32, 37, 38, 41, 42, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S...",118,91,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 32, 37, 38, 41, 42, 47, 48	WNT10A	NM_025216.2	c.[682T>A ](;)[321C>A]	p.[F228I](;)[C107*]	?	78	S23",122,87,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 41, 42, 43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S...",123,119,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 41, 42, 43, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S...",123,119,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
467G>A,"...	Ag 12, 14, 22, 31, 32, 35, 41	EDA	NM_001399.4	c.[467G>A];[=]	p.[R156H];[=]	De novo	17	S26",125,63,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 37, 33, 31, 41, 43, 45, 47	WNT10A	NM_025216.2	c.[682T>A];[=]	p.[F228I];[=]	Maternal	78	S28",127,98,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
682T>A,"... 35, 37, 38, 44, 45, 47, 48	WNT10A	NM_025216.2	c.[682T>A];[682T>A]	p.[F228I];[F228I]	Homozygous	78	S...",128,99,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
396+5G>A,...12	M	11	?	Ectodermal dysplasia	EDA	NM_001399.4	c.[396+5G>A];[=]	p.[0?];[=]	Maternal	Novel	S39,151,55,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1294G>A,...stic	FAM20A	NM_017565.3	c.[590-2A>G;590-3C>A](;) [1294G>A]	p.[0?](;)[A432T]	Maternal and de novo	82 ...,155,92,J_Med_Genet_2016_Feb_26_53(2)_98-110.txt
1746T>C,14	c.-1746T>C	associatio,124,7,J_Mol_Genet_Med_2016_Jun_29_10(2)_218.txt
3291T>C,...ng Y.  Leng J.H.   Is mitochondrial tRNALeu(UUR)  3291T>C mutation pathogenic? Mitochondrial DNA 23 ...,82,55,J_Neurol_Sci_2013_Feb_15_325(1-2)_165-169.txt
1G>T,"...ic mutation database, with the exception of c.672+1G>T, c.783‐1G>A and R333C. There is no apparent d...",161,203,J_Pathol_Clin_Res_2015_Mar_30_1(3)_125-133.txt
430C>T,"...warfarin dose. We tested SNPs in CYP2C9 (3 sites: 430C>T (rs1799853), 1075A>C (rs1057910), 1076T>C) ...",7,345,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"...sted SNPs in CYP2C9 (3 sites: 430C>T (rs1799853), 1075A>C (rs1057910), 1076T>C) and VKORC1 (14 sites...",7,365,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"...sted SNPs in CYP2C9 (3 sites: 430C>T (rs1799853), 1075A>C (rs1057910), 1076T>C) and VKORC1 (14 sites...",7,365,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"...sted SNPs in CYP2C9 (3 sites: 430C>T (rs1799853), 1075A>C (rs1057910), 1076T>C) and VKORC1 (14 sites...",7,365,J_Stroke_2013_May_31_15(2)_115-121.txt
1076T>C,"...3 sites: 430C>T (rs1799853), 1075A>C (rs1057910), 1076T>C) and VKORC1 (14 sites: 381C>T, 861C>A (rs1...",7,386,J_Stroke_2013_May_31_15(2)_115-121.txt
861C>A,"...s1057910), 1076T>C) and VKORC1 (14 sites: 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 58...",7,425,J_Stroke_2013_May_31_15(2)_115-121.txt
2653G>C,"...nd VKORC1 (14 sites: 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 60...",7,446,J_Stroke_2013_May_31_15(2)_115-121.txt
5496G>T,"...s: 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs...",7,464,J_Stroke_2013_May_31_15(2)_115-121.txt
5808T>G,"..., 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs9934438),...",7,473,J_Stroke_2013_May_31_15(2)_115-121.txt
6009C>T,"..., 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs9934438), 6853C>T (rs17886369)...",7,494,J_Stroke_2013_May_31_15(2)_115-121.txt
7566T>C,"...09C>T, 6484T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), a...",7,546,J_Stroke_2013_May_31_15(2)_115-121.txt
8767G>C,"...84T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), and 9071G>...",7,555,J_Stroke_2013_May_31_15(2)_115-121.txt
8814T>C,"...9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), and 9071G>T) using ...",7,564,J_Stroke_2013_May_31_15(2)_115-121.txt
9071G>T,"...6T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), and 9071G>T) using a standard sequencing method. Multi...",7,599,J_Stroke_2013_May_31_15(2)_115-121.txt
381T>C,"...VRORC1 (P<0.001), which were tightly interlinked (381T>C, 3673G>A, 6484T>C, 6853C>G. 7566C>T, 9041G>...",10,374,J_Stroke_2013_May_31_15(2)_115-121.txt
3673G>A,"...P<0.001), which were tightly interlinked (381T>C, 3673G>A, 6484T>C, 6853C>G. 7566C>T, 9041G>A) (r2=1...",10,382,J_Stroke_2013_May_31_15(2)_115-121.txt
6484T>C,"... which were tightly interlinked (381T>C, 3673G>A, 6484T>C, 6853C>G. 7566C>T, 9041G>A) (r2=1). Based ...",10,391,J_Stroke_2013_May_31_15(2)_115-121.txt
6484T>C,"... which were tightly interlinked (381T>C, 3673G>A, 6484T>C, 6853C>G. 7566C>T, 9041G>A) (r2=1). Based ...",10,391,J_Stroke_2013_May_31_15(2)_115-121.txt
430C>T,"...oups. We selected 26 SNPs in CYP2C9 (three sites; 430C>T (rs1799853), 1075A>C (rs10 57910), 1076T>C)...",36,310,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"... SNPs in CYP2C9 (three sites; 430C>T (rs1799853), 1075A>C (rs10 57910), 1076T>C), VKORC1 (14 sites; ...",36,330,J_Stroke_2013_May_31_15(2)_115-121.txt
2653G>C,"...), VKORC1 (14 sites; 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 60...",36,409,J_Stroke_2013_May_31_15(2)_115-121.txt
3673A>G,"... (14 sites; 381C>T, 861C>A (rs17880887), 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 64...",36,418,J_Stroke_2013_May_31_15(2)_115-121.txt
6009C>T,"..., 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs9934438), 6853C>T (rs17886369)...",36,457,J_Stroke_2013_May_31_15(2)_115-121.txt
6009C>T,"..., 2653G>C, 3673A>G, 5496G>T, 5808T>G (r17882154), 6009C>T, 6484T>C (rs9934438), 6853C>T (rs17886369)...",36,457,J_Stroke_2013_May_31_15(2)_115-121.txt
8767G>C,"...84T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), 9071G>T), ...",36,518,J_Stroke_2013_May_31_15(2)_115-121.txt
8767G>C,"...84T>C (rs9934438), 6853C>T (rs17886369), 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), 9071G>T), ...",36,518,J_Stroke_2013_May_31_15(2)_115-121.txt
9071G>T,"... 7566T>C, 8767G>C, 8814T>C, 9041G>A (rs17880624), 9071G>T), gamma-glutamyl carboxylase (GGCX, nine s...",36,558,J_Stroke_2013_May_31_15(2)_115-121.txt
268A>T,"...X, nine sites; eight SNPs and one microsatellite; 268A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G...",36,649,J_Stroke_2013_May_31_15(2)_115-121.txt
412G>A,"...sites; eight SNPs and one microsatellite; 268A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C>...",36,657,J_Stroke_2013_May_31_15(2)_115-121.txt
6258A>G,"...ight SNPs and one microsatellite; 268A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C> T, 1387...",36,665,J_Stroke_2013_May_31_15(2)_115-121.txt
8016G>A,"...microsatellite; 268A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C> T, 13875A>G, CAA repeat)",36,683,J_Stroke_2013_May_31_15(2)_115-121.txt
8445C> T,"...8A>T, 412G>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C> T, 13875A>G, CAA repeat)",36,701,J_Stroke_2013_May_31_15(2)_115-121.txt
13875A>G,"...>A, 6258A>G, 8015C>T, 8016G>A, 8240A>G, 8445C> T, 13875A>G, CAA repeat)",36,711,J_Stroke_2013_May_31_15(2)_115-121.txt
381T>C,"...cant difference of WRI (6 SNPs located in VKORC1 (381T>C, 3673G>A, 6484T>C [rs9934438], 6853C>G [rs1...",50,158,J_Stroke_2013_May_31_15(2)_115-121.txt
3673G>A,"...ference of WRI (6 SNPs located in VKORC1 (381T>C, 3673G>A, 6484T>C [rs9934438], 6853C>G [rs17886369]...",50,166,J_Stroke_2013_May_31_15(2)_115-121.txt
6853C>G,"... in VKORC1 (381T>C, 3673G>A, 6484T>C [rs9934438], 6853C>G [rs17886369]. 7566C>T, 9041G>A [rs17880624...",50,196,J_Stroke_2013_May_31_15(2)_115-121.txt
7566C>T,"...73G>A, 6484T>C [rs9934438], 6853C>G [rs17886369]. 7566C>T, 9041G>A [rs17880624]) and one in CYP2C9 [...",50,218,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"...7566C>T, 9041G>A [rs17880624]) and one in CYP2C9 [1075A>C]). In terms of genotype prevalence, 24 pat...",50,268,J_Stroke_2013_May_31_15(2)_115-121.txt
9041G>A,"...tients. Young age, high BMI, heterozygote VKORC1 (9041G>A, rs17880624), and/or homozygote CYP2C9 (10...",55,175,J_Stroke_2013_May_31_15(2)_115-121.txt
1075A>C,"... (9041G>A, rs17880624), and/or homozygote CYP2C9 (1075A>C, rs1057910) contributed to low WRI, indica...",55,223,J_Stroke_2013_May_31_15(2)_115-121.txt
1076T>C,...e could not find significant influence of CYP2C9 (1076T>C or 430C>T) on warfarin dose although this ...,59,483,J_Stroke_2013_May_31_15(2)_115-121.txt
652A>G,"...6), CFH c.2808G>T; p.Glu936Asp (rs1065489), CD46 −652A>G (rs2796267), CD46 −366A>G (rs2796268), CD46...",220,330,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
78G>A,"...(rs2796267), CD46 −366A>G (rs2796268), CD46 IVS9 −78G>A (rs1962149), CD46 IVS12 +638G>A (rs859705), ...",220,387,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
2T>C,"...owed a compound heterozygote CD46 mutation (c.286+2T>C, c.286+2T>G), which resulted in complete CD46...",246,102,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
2T>G,"...C variant was of maternal origin, while the c.286+2T>G was paternal. Flow cytometry analysis confirm...",246,228,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
5T>C,...ysis of cDNA from the patient with the CFH c.3134‐5T>C genetic variant (patient 6) did not detect an...,248,157,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
5T>C,...1. FH analysis from the patient with a CFH c.3134‐5T>C genetic variant. Western blot using a polyclo...,298,57,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
5T>C,...1. FH analysis from the patient with a CFH c.3134‐5T>C genetic variant. Western blot using a polyclo...,298,57,J_Thromb_Haemost_2016_Jan_11_14(1)_175-185.txt
538C > T,"...ding 35delG, 176-191del16, 235delC, 299-300delAT, 538C > T, 1555A > G, 1494C > T, 2168A > G, and IVS...",7,444,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,"...538C > T, 1555A > G, 1494C > T, 2168A > G, and IVS7-2A > G. The samples that showed the absence of b...",7,494,J_Transl_Med_2011_Sep_14_9_154.txt
1503G > A,"...7delG for GJB2 in three patients (Figure 1A), and 1503G > A for mtDNA 12S rRNA in one patient (Figur...",36,440,J_Transl_Med_2011_Sep_14_9_154.txt
1503G > A,1494C > T (12S rRNA)	1503G > A	1,44,22,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,IVS7-2A > G/-	0	7	0	0,75,4,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,IVS7-2A > G/-	0	7	0	0,75,4,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,IVS7-2A > G/IVS7-2A > G	2	7	0	0,76,4,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,2168A > G/IVS7-2A > G	1	1	0	0,78,14,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,2168A > G/IVS7-2A > G	1	1	0	0,78,14,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,235delC/IVS7-2A > G	0	1	0	0,82,12,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,IVS7-2A > G	0	1	0	0,85,4,J_Transl_Med_2011_Sep_14_9_154.txt
1503G > A,1503G > A	1	0	0	0,90,1,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"The frequencies of SLC26A4 mutation, including 2168A > G (H723R) and IVS7-2A > G, were 2.01% (4/1...",94,48,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,"...26A4 mutation, including 2168A > G (H723R) and IVS7-2A > G, were 2.01% (4/199) in Uyghur patients an...",94,73,J_Transl_Med_2011_Sep_14_9_154.txt
1503 G > A,"...atients, respectively. The homozygous mutation of 1503 G > A was an unreported gene mutation. The mu...",96,203,J_Transl_Med_2011_Sep_14_9_154.txt
8+1G > A,"...tern deaf population, L236P, T416P, E384G, and IVS8+1G > A are common mutant loci of SLC26A4 [21], w...",106,307,J_Transl_Med_2011_Sep_14_9_154.txt
7-2 A > G,"... in Japanese and Korean deaf patients [27,28]. IVS7-2 A > G is reported to be the major mutant locus...",106,451,J_Transl_Med_2011_Sep_14_9_154.txt
7-2 A > G,"... in Japanese and Korean deaf patients [27,28]. IVS7-2 A > G is reported to be the major mutant locus...",106,451,J_Transl_Med_2011_Sep_14_9_154.txt
7-2A > G,"...y, the two locus mutations of SLC26A4, namely, IVS7-2A > G and 2168A > G (H723R), are less frequentl...",106,622,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"...cus mutations of SLC26A4, namely, IVS7-2A > G and 2168A > G (H723R), are less frequently found in Uy...",106,635,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"...cus mutations of SLC26A4, namely, IVS7-2A > G and 2168A > G (H723R), are less frequently found in Uy...",106,635,J_Transl_Med_2011_Sep_14_9_154.txt
2168A > G,"...cus mutations of SLC26A4, namely, IVS7-2A > G and 2168A > G (H723R), are less frequently found in Uy...",106,635,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,...rted by Li et al. [11]. The mutation frequency of 1494C > T is even lower than that of 1555A > G. 14...,108,565,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,...rted by Li et al. [11]. The mutation frequency of 1494C > T is even lower than that of 1555A > G. 14...,108,565,J_Transl_Med_2011_Sep_14_9_154.txt
1494C > T,...f 1494C > T is even lower than that of 1555A > G. 1494C > T mutation is detected in only one Han Chi...,108,613,J_Transl_Med_2011_Sep_14_9_154.txt
1503G > A,...rable between the two ethnicities. The unreported 1503G > A homogenous mutation that is found in one...,108,843,J_Transl_Med_2011_Sep_14_9_154.txt
1503G > A,...rable between the two ethnicities. The unreported 1503G > A homogenous mutation that is found in one...,108,843,J_Transl_Med_2011_Sep_14_9_154.txt
2A > G,...X Han B Yuan H Platt OS Han D Wu BL SLC26A4 c.919-2A > G varies among Chinese ethnic groups as a cau...,140,121,J_Transl_Med_2011_Sep_14_9_154.txt
421C > A,"...f MDR1 1236C > T (assay ID: C__7586662_10), ABCG2 421C > A (assay ID: C__15854163_70) and ABCC2 1249...",33,682,Korean_J_Anesthesiol_2012_Apr_23_62(4)_332-336.txt
1249G > A,...CG2 421C > A (assay ID: C__15854163_70) and ABCC2 1249G > A (assay ID: C__22272980_20) SNPs was anal...,33,728,Korean_J_Anesthesiol_2012_Apr_23_62(4)_332-336.txt
2677G > T,"...n of a haplotype in three genotypes of 1236C > T, 2677G > T/A, 3435C > T in MDR-1 gene, TGC, CAC, CG...",49,270,Korean_J_Anesthesiol_2012_Apr_23_62(4)_332-336.txt
118A>G,...morphism of the micro-opioid receptor gene (OPRM1 118A>G) affects fentanyl-induced analgesia during ...,78,91,Korean_J_Pain_2016_Jan_4_29(1)_34-39.txt
118A>G,...tsch J   The mu-opioid receptor gene polymorphism 118A>G depletes alfentanil-induced analgesia and p...,79,105,Korean_J_Pain_2016_Jan_4_29(1)_34-39.txt
207G>C,...the haplotype consisting of L503F of OCTN1 and g.-207G>C of OCTN2 was significantly associated with ...,11,510,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
538C>G,"...2) includes three minor alleles at g.-1145A>G, g.-538C>G, and g.-248C>G, and contains a reference se...",37,549,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1745A>G,"...ypes. Two of the five variants (g.-1875T>A and g.-1745A>G) showed increased promoter activities, whe...",40,1217,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1145A>G,"...ed increased promoter activities, whereas two (g.-1145A>G and g.-248C>G) had decreased promoter acti...",40,1280,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
538C>G,...decreased promoter activities; the activity of g.-538C>G was comparable with the reference (Fig. 1b)...,40,1357,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1745A>G,"...8C>G. However, H1 and H3 also had the variants g.-1745A>G and g.-1875T>A, respectively, which showed...",40,1704,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,Effect of the variant g.-1875T>A on the binding affinity of NF-Y to the OCT...,42,26,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
256C>G,"...n the current study. However, the rare variant g.-256C>G, which had a frequency of 1.5% in the Tahar...",51,707,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
510C>T,"... identified two novel variants, g.-2063A>C and g.-510C>T. The region from -104 bp to -1 bp upstream ...",51,1001,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1145A>G,"... These three haplotypes contained the variants g.-1145A>G, g.-538C>G, and g.-248C>G. Of these varian...",53,195,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
248C>G,"...tained the variants g.-1145A>G, g.-538C>G, and g.-248C>G. Of these variants, g.-1145A>G and g.-248C>...",53,222,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1745A>G,"...hat of H4, possibly because of the presence of g.-1745A>G and g.-1875T>A, respectively, which showed...",53,510,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
207G>C,... the OCTN1 variant L503F and the OCTN2 variant g.-207G>C was significantly associated with susceptib...,59,116,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1875T>A,...lity shift analysis of the OCTN1 reference and g.-1875T>A variant sequences. (a) Labeled oligonucleo...,87,78,Korean_J_Physiol_Pharmacol_2014_Apr_3_18(2)_169-175.txt
1298A>C,"...s been studied extensively. Along with C677T, the 1298A>C and 1793G>A polymorphism were associated w...",252,421,Lipids_Health_Dis_2006_Jan_23_5_1.txt
1793G>A,"...lassmann G Fodinger M  Associations between MTHFR 1793G>A and plasma total homocysteine, folate, and...",453,100,Lipids_Health_Dis_2006_Jan_23_5_1.txt
80G->A,...ister M Rosenblatt DS Nicolas JP  A Polymorphism (80G->A) in the Reduced Folate Carrier Gene and Its...,464,100,Lipids_Health_Dis_2006_Jan_23_5_1.txt
677C > T,...peats and the methylenetetrahydrofolate reductase 677C > T polymorphism on homocysteine levels and r...,476,224,Lipids_Health_Dis_2006_Jan_23_5_1.txt
894G>T,"...ndothelial nitric oxide synthase -786T>C, but not 894G>T and 4a4b, polymorphism influences plasma ho...",487,146,Lipids_Health_Dis_2006_Jan_23_5_1.txt
3238C>G,...mized cluster samples. Genotyping of the ApoC-III 3238C>G was performed by polymerase chain reaction...,7,173,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...was to determine the interactions of the ApoC-III 3238C>G (rs5128) polymorphism and alcohol consumpt...,18,1508,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...rg expectations. Interaction between the ApoC-III 3238C>G genotype and alcohol consumption was asses...,40,647,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...A part of the nucleotide sequence of the ApoC-III 3238C>G. (A) CC genotype; (B) CG genotype; (C) GG ...,85,60,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.324	6.542	0.011	1.068-1.642,137,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	2.200	12.048	0.044	1.410-3.434,165,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.574	6.223	0.013	1.102-2.248,175,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.874	16.157	0.000	1.380-2.545,179,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,ApoC-III 3238C>G genotype	1.863	11.039	0.001	1.291-2.689,190,11,Lipids_Health_Dis_2010_Aug_17_9_86.txt
3238C>G,...allelic and genotypic frequencies of the ApoC-III 3238C>G between the nondrinkers and drinkers. The ...,196,123,Lipids_Health_Dis_2010_Aug_17_9_86.txt
214C>A,...n and polymorphism or SNP or Leu72Met  or 214C>A and type 2 diabetes,33,217,Lipids_Health_Dis_2014_Aug_5_13_124.txt
214C>A,...und an association of MTLRP genetic polymorphism (214C>A) with Type 2 diabetes in Caucasian populati...,101,78,Lipids_Health_Dis_2014_Aug_5_13_124.txt
34383331 T>A,... of promoter variant -794CATT and ncRNA variant rs34383331 T>A show that the diplotype 5 T is signif...,128,88,Malar_J_2013_Sep_25_12_345.txt
376 A>G,"A+ (376 A>G)	585	402, 187	289, 187, 117	[22, 35]",90,5,Malar_J_2015_Aug_7_14_308.txt
896 A>G,...D  Prodromou ML  El Khoury J    The role of TLR4  896 A>G and 1196 C>T in susceptibility to infectio...,120,62,Med_Sci_Monit_2015_Feb_27_21_625-629.txt
896 A>G,...D  Prodromou ML  El Khoury J    The role of TLR4  896 A>G and 1196 C>T in susceptibility to infectio...,120,62,Med_Sci_Monit_2015_Feb_27_21_625-629.txt
894G > T,19 Ferlazzo N  Gorgone G  Caccamo D    The 894G > T (Glu298Asp) Variant in the Endothelial NO...,171,44,Med_Sci_Monit_2015_Jan_27_21_326-332.txt
896A>G,47 Chen S   Association between the TLR4 +896A>G (Asp299Gly) polymorphism and asthma: a syst...,222,43,Med_Sci_Monit_2015_Nov_20_21_3591-3599.txt
896A>G,48 Yao Y  Ren X  He L    TLR4 +896A>G (Asp299Gly) polymorphism is not associated ...,223,32,Med_Sci_Monit_2015_Nov_20_21_3591-3599.txt
1501299 G>T,"...iponectin gene (including ADIPOQ rs2241766 T>G, rs1501299 G>T, and rs266729 C>G SNPs) are correlated...",37,470,Med_Sci_Monit_2016_Sep_26_22_3419-3425.txt
786T>C,...A −2.5 kb (CCTTT)n as well as Ser608Leu and NOS3 −786T>C variants and their correlation with nitrite...,25,718,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,"...s/nitrates. Here, we first demonstrate that NOS3 −786T>C variant affects nitrite/nitrate levels in I...",25,1523,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,"...zed in patients and controls with different NOS3 −786T>C genotypes, some statistically significant d...",129,89,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,"...ide microsatellite −2.5 kb (CCTTT)n and the NOS3 −786T>C, were associated with either increased nitr...",140,441,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,"...ide microsatellite −2.5 kb (CCTTT)n and the NOS3 −786T>C, were associated with either increased nitr...",140,441,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,"...ide microsatellite −2.5 kb (CCTTT)n and the NOS3 −786T>C, were associated with either increased nitr...",140,441,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,...nts NOS2 −2.5 kb (CCTTT)n and Ser608Leu and NOS3 −786T>C in IEI patients,142,344,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,...nts NOS2 −2.5 kb (CCTTT)n and Ser608Leu and NOS3 −786T>C in IEI patients,142,344,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,"...ents and healthy subjects, having different NOS3 −786T>C genotypes, through their quartiles. The bot...",169,345,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
786T>C,−786T>C NOS3	 	 	 	 ,189,2,Mediators_Inflamm_2015_Mar_24_2015_245308.txt
705382-1434C>G,.... Previous work revealed that variant allele of rs705382-1434C>G was independently associated with h...,21,1252,Medicine_(Baltimore)_2015_Dec_7_94(48)_e2179.txt
684G>A,We found that the 684G>A polymorphism affects the tumor NOTCH3 expre...,8,19,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,We found that the 684G>A polymorphism affects the tumor NOTCH3 expre...,8,19,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...ed by western blot assay. Figure 1 shows only the 684G>A polymorphism significantly affected the tum...,45,126,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
474C>A,"...A and 684AA carriers. In contrast, the 381C>T and 474C>A did not affect the NOTCH3 expression levels...",45,320,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,... from the 684GA and 684AA carriers. Meanwhile the 684G>A polymorphism also dramatically affects tumo...,47,323,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,... from the 684GA and 684AA carriers. Meanwhile the 684G>A polymorphism also dramatically affects tumo...,47,323,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
474C>A,...milar among the tumor samples from the 381C>T and 474C>A genotype carriers,47,499,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,... survival curves for glioma patients based on the 684G>A polymorphism in patients receiving differen...,52,76,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...of gliomas in Chinese patients. We found that the 684G>A polymorphism affects the tumor NOTCH3 expre...,57,176,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...of gliomas in Chinese patients. We found that the 684G>A polymorphism affects the tumor NOTCH3 expre...,57,176,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
381C>T,"...significantly associated with migraine, while the 381C>T does not affect the migraine risk.21 A rece...",63,726,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...d with human cancers.24 Our study showed that the 684G>A polymorphism affects the tumor NOTCH3 expre...,65,586,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...d with human cancers.24 Our study showed that the 684G>A polymorphism affects the tumor NOTCH3 expre...,65,586,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
684G>A,...did not have in vitor study to show the effect of 684G>A polymorphism of NOTCH3 on the biological be...,67,307,Medicine_(Baltimore)_2015_Mar_6_94(9)_e482.txt
6C>G,"... proband, namely c.265T>C (p.C89R). Also HJV c.98-6C>G (rs56025621) polymorphic variant was found in...",317,398,Middle_East_J_Dig_Dis_2014_Apr_6(2)_87-92.txt
1+186C>T,"...genotypes, compared to controls [11]. The SOD3 IVS1+186C>T polymorphism is associated with a signifi...",22,537,Mol_Biol_Int_2013_Dec_16_2013_189237.txt
19G>C,"...version at the 19 position in the HMOX1 gene (the 19G>C-HMOX1 polymorphism, rs2071747) and a A → G t...",3,1606,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19 G>C,...tion by some clinical and life-style factors. The 19 G>C-HMOX1 polymorphism is located in the coding...,18,606,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,... was used to determine the genotypes of the −42 + 1444A>G-HMOX2 polymorphism. PCR assay was performe...,33,139,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...nd the G/G genotype and the G allele of the −42 + 1444A>G-HMOX2 polymorphism increased progression o...,52,357,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...nd the G/G genotype and the G allele of the −42 + 1444A>G-HMOX2 polymorphism increased progression o...,52,357,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...nd the G/G genotype and the G allele of the −42 + 1444A>G-HMOX2 polymorphism increased progression o...,52,357,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
19G>C,... progression of AMD and combined genotypes of the 19G>C-HMOX1 and −42 + 1444A>G-HMOX2 polymorphisms....,55,110,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...d combined genotypes of the 19G>C-HMOX1 and −42 + 1444A>G-HMOX2 polymorphisms. The distribution of c...,55,132,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...ion between AMD and the 19G>C-HMOX1 and the −42 + 1444A>G-HMOX2 polymorphism was subjected to strati...,60,63,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,"...opulation [44, 45]. The other polymorphism, −42 + 1444A>G-HMOX2, is located in the 5′ flanking regio...",71,1472,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1444A>G,...9G>C polymorphism of the HMOX1 gene and the −42 + 1444A>G polymorphism of the HMOX2 gene may be asso...,73,93,Mol_Biol_Rep_2012_Mar_7_39(3)_2081-2087.txt
1215T>C,"...ucleotide polymorphisms (SNPs) at nucleotides g. +1215T>C, g. +3377C>T, and g. +28625C>T were in lin...",3,1296,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
1878C>T,... this study and shown in Table 2. The SNPs of g. +1878C>T and g. +7315C>T resulted in synonymous mut...,97,587,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
7315C>T,...shown in Table 2. The SNPs of g. +1878C>T and g. +7315C>T resulted in synonymous mutations of Tyr626...,97,603,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
7294C>T,"...nd Val2439Val, respectively, while the SNP of g. +7294C>T brought a missense mutation Arg2432Cys. In...",97,708,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
7294C>T,"...nd Val2439Val, respectively, while the SNP of g. +7294C>T brought a missense mutation Arg2432Cys. In...",97,708,Mol_Biol_Rep_2013_Jan_17_40(1)_417-426.txt
1544C>T,"...ast cancer. However, point mutations (1163T>C and 1544C>T) have, so far, only been detected in a sin...",15,357,Mol_Cancer_2010_Jul_1_9_173.txt
3G>C,c.7395+3G>C			Homozygous	Severe to profound	Belguith et a...,130,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
3G>C,c.7395+3G>C			Homozygous	Severe to profound	Belguith et a...,130,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
1G>T,c.9229+1G>T			Homozygous	Severe to profound	Belguith et a...,138,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
1G>T,c.9229+1G>T			Homozygous	Severe to profound	Belguith et a...,138,8,Mol_Cells_2015_Sep_30_38(9)_781-788.txt
68G>A,"...682G>T) and 3 (c.947-20G>C, c.1140+14G>A & c.1289+68G>A) are intronic variants. In BMP4, 3 sequence ...",12,479,Mol_Cytogenet_2014_Jan_21_7(Suppl_1)_P32.txt
1639G>A,"...genotyping of CYP450 2C9 (*2 and *3) and VKORC1 (−1639G>A), with a result produced in approximately ...",234,157,Mol_Diagn_Ther_2013_Jun_16_17(3)_165-184.txt
1G>A,"...M_002072.2:c.735+1C>T), ABCC3 (NM_003786.3:c.1783-1G>A), KLHDC1 (NM_172193.1:c.568-2A>G), HOOK1 (NM_...",5,1117,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
5G>A,"... the intron between exon 10 and 11 of APC (c.1312+5G>A, OMIM# 611731, NM_000038, NCBI36.1 nomenclatu...",64,542,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,"GNAQ	Ph+001	9,79599197,79599198,1,C/T	c.735+1C>T	23 (65)	8 (0)	35% (0%)	Donor lost",71,45,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,"ABCC3	Ph+004	17,46100788,46100789,1,G/A	c.1783-1G>A	59 (36)	30 (0)	51% (1%)	Acceptor lost",72,48,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,"SMAD9	Ph-005	13,36325812,36325813,1,C/T	c.1004-1C>T	27 (16)	14 (0)	52% (0%)	Acceptor lost",74,48,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,"HOOK1	Ph-006	1,60103421,60103422,1,G/A	c.1662-1G>A	186 (153)	87 (0)	47% (0%)	Acceptor lost",75,47,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
5G>A,"DNAH9	Ph-007	17,11715832,11715833,1,G/A	c.10242+5G>A	37 (43)	19 (0)	51% (0%)	Donor lost",76,49,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
5G>A,"DNAH9	Ph-007	17,11715832,11715833,1,G/A	c.10242+5G>A	37 (43)	19 (0)	51% (0%)	Donor lost",76,49,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,"... (OMIM# 600998) proto-oncogene (NM_002072.2:c.735+1C>T, NCBI36.1 nomenclature). The somatic variant ...",79,207,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,"... (OMIM# 600998) proto-oncogene (NM_002072.2:c.735+1C>T, NCBI36.1 nomenclature). The somatic variant ...",79,207,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,"ABCC3	Ph+004	c.1783-1G>A	1	0.91/–	0.390/–	5155	859	6.109	58% wt RNA, 3...",85,21,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,SMAD9	Ph-005	c.1004-1C>T	1	0.98/–	0.988/–	5558	42	0.379	Low expression...,87,21,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
2A>G,"... the KLHDC1 (OMIM#611281) gene (NM_172193.1:c.568-2A>G), near the 3’ acceptor splice site at positio...",102,92,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
2A>G,"... the KLHDC1 (OMIM#611281) gene (NM_172193.1:c.568-2A>G), near the 3’ acceptor splice site at positio...",102,92,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1C>T,"...e SMAD9 (OMIM#603295) gene (NM_001127217.2:c.1004-1C>T), causing a loss of acceptor site. Despite th...",106,185,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,"... of HOOK1 (OMIM# 607820) gene (NM_015888.4:c.1662-1G>A) with a frequency of 47% (Table 1, Fig. S5A a...",108,206,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
2T>C,"...sversion (c.1312+4T>G) and the transition (c.1312+2T>C) affected, respectively, position +4 (chr5:11...",119,653,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
5G>A,APC (NM_000038.4:c.1312+5G>A) splicing mutation detected by whole-exome se...,146,25,Mol_Genet_Genomic_Med_2013_Nov_7_1(4)_246-259.txt
1G>A,"...n order to analyze the effects of the CCM1:c.2025+1G>A splice site mutation, RNA was extracted from ...",19,52,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,IVS9	c.730-1G>A	p.?	i	Davenport et al. (2001)	27,40,12,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>T,IVS10	c.845+1G>T	p.?	f	Novel	77,43,13,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,IVS13	c.1255-1G>A	p.Y419Ffs*153	f	Cavé-Riant et al. (2002)	31,48,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>C,IVS14	c.1412-1G>C	p.?	i	Novel	26,52,14,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
1G>A,...d out to be a heterozygous carrier of CCM1:c.2025+1G>A (Fig. 2B and C),103,548,Mol_Genet_Genomic_Med_2014_Mar_14_2(2)_176-185.txt
489C>T,Possible protective role of the 489C>T P2X7R polymorphism in Alzheimer’s disease ....,351,33,Mol_Pain_2016_May_12_12_1744806916646786.txt
677C>T,...oung IS  Folate/homocysteine phenotypes and MTHFR 677C>T genotypes are associated with serum levels ...,246,106,Mol_Psychiatry_2013_Jan_31_18(1)_15-37.txt
874 T>A,...VN Dias-Baptista IM Maniero VC Venturini J  IFNG +874 T>A single nucleotide polymorphism is associat...,463,88,Mol_Psychiatry_2013_Jan_31_18(1)_15-37.txt
369 G > C,"3	1 of 1	1 of 5	1p12:118,509,369 G > C	A2132G	Deleterious (1)",167,31,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
880 T > G,"3	1 of 1	1 of 5	7q22.1:99,794,880 T > G	I348S	Deleterious (1)",183,32,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
880 T > G,"3	1 of 1	1 of 5	7q22.1:99,794,880 T > G	I348S	Deleterious (1)",183,32,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
839 A > G,"3	1 of 1	1 of 5	18q11.2:19,093,839 A > G	N1598S	Deleterious (1)",217,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
130 C > G,"6	1 of 1	1 of 2	11q13.1:63,963,130 C > G	P173A	Neutral (0.97)",233,33,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
916 T > C,"4	1 of 2	0 of 0	3q13.13:108,301,916 T > C	T89A	Neutral (0.85)",273,34,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
202 C > T,"4	1 of 2	0 of 0	15q14:34,331,202 C > T	G16S	Deleterious (1)",281,31,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
202 C > T,"4	1 of 2	0 of 0	15q14:34,331,202 C > T	G16S	Deleterious (1)",281,31,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
217 C > T,"4	1 of 1	3 of 3	6q22.31:119,670,217 C > T	G5D	Neutral (0.87)",314,34,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
853 G > T,"2	1 of 2	2 of 3	10p13:13,534,853 G > T	P147T	Neutral (0.92)",331,31,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
576 T > A,"2	1 of 2	2 of 3	10q11.23:49,982,576 T > A	V876D	Deleterious (1)",339,34,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
319 G > A,"2	1 of 2	2 of 3	14q32.2:100,992,319 G > A	R405H	Deleterious (1)",347,34,Mol_Psychiatry_2016_Mar_22_10_1038_mp_2016_24.txt
583A>G,2	583A>G	Ile195Val*	6,63,3,Mol_Vis_2007_Apr_19_13_611-617.txt
583A>G,2	583A>G	Ile195Val*	6,63,3,Mol_Vis_2007_Apr_19_13_611-617.txt
-156C>G,1	5'UTR-156C>G	1 ARRP (003-182)	0,52,8,Mol_Vis_2007_Apr_5_13_588-593.txt
3T>G,3	3'UTR+3T>G	1 ARRP (003-064)	0,55,9,Mol_Vis_2007_Apr_5_13_588-593.txt
1G>A,Intron 2	c.99+1G>A	Aberrant splicing	LCA/Early onset RP	Found in...,45,15,Mol_Vis_2008_Apr_21_14_675-682.txt
5G>C,Intron 10	c.999+5G>C	Aberrant splicing	Juvenile RP		 [16],50,17,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,...2X	LCA	Found in compound heterozygosity with c.99+1G>A	 [2],54,74,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,...2X	LCA	Found in compound heterozygosity with c.99+1G>A	 [2],54,74,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,...2X	LCA	Found in compound heterozygosity with c.99+1G>A	 [2],54,74,Mol_Vis_2008_Apr_21_14_675-682.txt
4A>G,"Intron 12	c.1224+4A>G, (IVS12+4A>G)	Aberrant splicing	RP	Found in h...",55,18,Mol_Vis_2008_Apr_21_14_675-682.txt
14+1G>A,"Intron 14	c.1495+1G>A, (IVS14+1G>A)	Aberrant splicing	Early onset RP		 [9,24]...",63,28,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>A,"...utation identified in family TB13; and the c.1495+1G>A (IVS14+1G>A) mutation, which was previously i...",95,615,Mol_Vis_2008_Apr_21_14_675-682.txt
14+1G>A,"...which have been reported to date, c.1495+1G>A (IVS14+1G>A) and c.1496–6C>A (IVS14–6C>A), affect the ...",102,738,Mol_Vis_2008_Apr_21_14_675-682.txt
6C>A,"...rted to date, c.1495+1G>A (IVS14+1G>A) and c.1496–6C>A (IVS14–6C>A), affect the donor and acceptor s...",102,758,Mol_Vis_2008_Apr_21_14_675-682.txt
1G>C,"...ne frameshift, causing splice site mutation (c.78+1G>C) were detected. These mutations were absent i...",15,1615,Mol_Vis_2008_Dec_12_14_2321-2332.txt
1G>C,c.78+1G>C	splice site	frameshift→ truncated protein	int...,88,6,Mol_Vis_2008_Dec_12_14_2321-2332.txt
1G>C,...utations were found: a splice site mutation (c.78+1G>C) in intron 2 of family 2 (7.14%) and an inser...,121,1008,Mol_Vis_2008_Dec_12_14_2321-2332.txt
1G>C,...utations were found: a splice site mutation (c.78+1G>C) in intron 2 of family 2 (7.14%) and an inser...,121,1008,Mol_Vis_2008_Dec_12_14_2321-2332.txt
2A>G,...zygous mutations: a splicing site mutation c.985 −2A>G in family F1 and a nonsense mutation c.2197C>...,111,113,Mol_Vis_2008_Dec_29_14_2451-2457.txt
2A>G,...ows the heterozygous splicing site mutation c.985–2A>G; B: Sequence shows the heterozygous nonsense ...,113,140,Mol_Vis_2008_Dec_29_14_2451-2457.txt
1G>A,"...lettre et al. reported a recurrent mutation c.985–1G>A, which has a similar consequence [9,11]. This...",122,849,Mol_Vis_2008_Dec_29_14_2451-2457.txt
2A>G,...ed member of family F1 carried the mutation c.985–2A>G; he was also found to harbor the affected hap...,124,1069,Mol_Vis_2008_Dec_29_14_2451-2457.txt
53T>C,"...+35A>G, OPTN Met98Lys, OPTN IVS5+38T>G, OPTN IVS8–53T>C, WDR36 IVS5+30C>T, and APOE −491A>T",15,385,Mol_Vis_2009_Jan_16_15_89-98.txt
5+30C>T,"...98Lys, OPTN IVS5+38T>G, OPTN IVS8–53T>C, WDR36 IVS5+30C>T, and APOE −491A>T",15,401,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...T>G, OPTN IVS8–53T>C, WDR36 IVS5+30C>T, and APOE −491A>T",15,420,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...CTC CA-3′). In APOE, the promoter polymorphisms (−491A>T, −427T>C, and −219T>G) and the ε2/ε3/ε4 pol...",40,969,Mol_Vis_2009_Jan_16_15_89-98.txt
1+16G>T,"...e level). Four variants (Gln161Arg, Gly183Ser, IVS1+16G>T, and Asn428Ser) were novel. They were dete...",53,353,Mol_Vis_2009_Jan_16_15_89-98.txt
34 G>C,Exon 1	c. 34 G>C	G12R*	3(0.85)	0 (0)	0/3/173	0/0/200,61,11,Mol_Vis_2009_Jan_16_15_89-98.txt
136 C>T,Exon 1	c. 136 C>T	R46X	2 (0.57)	3 (0.75)	0/2/174	0/3/197,63,11,Mol_Vis_2009_Jan_16_15_89-98.txt
136 C>T,Exon 1	c. 136 C>T	R46X	2 (0.57)	3 (0.75)	0/2/174	0/3/197,63,11,Mol_Vis_2009_Jan_16_15_89-98.txt
227 G>A,Exon 1	c. 227 G>A	R76K	13 (3.69)	28 (7)	0/13/163	1/26/173,65,11,Mol_Vis_2009_Jan_16_15_89-98.txt
624 C>G,Exon 2	c. 624 C>G	D208E	1 (0.28)	3 (0.75)	0/1/175	0/3/197,71,11,Mol_Vis_2009_Jan_16_15_89-98.txt
624 C>G,Exon 2	c. 624 C>G	D208E	1 (0.28)	3 (0.75)	0/1/175	0/3/197,71,11,Mol_Vis_2009_Jan_16_15_89-98.txt
2+172 C>A,Intron 2	IVS 2+172 C>A	-	4 (1.14)	1 (0.25)	0/4/172	0/1/199,73,14,Mol_Vis_2009_Jan_16_15_89-98.txt
2+172 C>A,Intron 2	IVS 2+172 C>A	-	4 (1.14)	1 (0.25)	0/4/172	0/1/199,73,14,Mol_Vis_2009_Jan_16_15_89-98.txt
1515+73 G>C,3′UTR	1515+73 G>C	-	3 (0.85)	1 (0.25)	0/3/173	0/1/199,80,7,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"...es of OPTN (Met98Lys, Arg545Gln, IVS5+38T>G, IVS8–53T>C, and IVS15+10G>A) and WDR36 (IVS5+30C>T) fol...",84,70,Mol_Vis_2009_Jan_16_15_89-98.txt
15+10G>A,"...t98Lys, Arg545Gln, IVS5+38T>G, IVS8–53T>C, and IVS15+10G>A) and WDR36 (IVS5+30C>T) followed HWE in c...",84,84,Mol_Vis_2009_Jan_16_15_89-98.txt
5+38 T>G,OPTN	IVS5+38 T>G	-	118 (33.5)	121 (30.25)	17/84/75	14/93/9...,93,9,Mol_Vis_2009_Jan_16_15_89-98.txt
53 T>C,OPTN	IVS8 −53 T>C	-	27 (7.67)	24 (6)	1/25/150	1/22/177,94,12,Mol_Vis_2009_Jan_16_15_89-98.txt
15+10G>A,OPTN	IVS15+10G>A	-	8 (2.27)	7 (1.75)	0/8/168	0/7/193,95,9,Mol_Vis_2009_Jan_16_15_89-98.txt
5+30 C>T,WDR36	IVS 5+30 C>T	-	134 (38.1)	170 (42.5)	22/90/64	33/104/6...,96,11,Mol_Vis_2009_Jan_16_15_89-98.txt
427T>C,"...es of all the APOE polymorphisms, i.e., −491A>T, −427T>C, −219T>G, and the ε2/ε3/ε4 polymorphism, fo...",100,58,Mol_Vis_2009_Jan_16_15_89-98.txt
427T>C,"...es of all the APOE polymorphisms, i.e., −491A>T, −427T>C, −219T>G, and the ε2/ε3/ε4 polymorphism, fo...",100,58,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,"... the APOE polymorphisms, i.e., −491A>T, −427T>C, −219T>G, and the ε2/ε3/ε4 polymorphism, followed th...",100,67,Mol_Vis_2009_Jan_16_15_89-98.txt
491 A>T,−491 A>T	T	8 (2.3)	13 (3.25)	TT	0 (0)	0 (0),108,2,Mol_Vis_2009_Jan_16_15_89-98.txt
491 A>T,−491 A>T	T	8 (2.3)	13 (3.25)	TT	0 (0)	0 (0),108,2,Mol_Vis_2009_Jan_16_15_89-98.txt
219 T>G,−219 T>G	G	93 (26.4)	117 (29.25)	GG	10 (5.7)	15 (7....,114,2,Mol_Vis_2009_Jan_16_15_89-98.txt
219 T>G,−219 T>G	G	93 (26.4)	117 (29.25)	GG	10 (5.7)	15 (7....,114,2,Mol_Vis_2009_Jan_16_15_89-98.txt
2+35A>G,...aplotype A-A was not associated with glaucoma. IVS2+35A>G was the only other MYOC polymorphism that ...,126,502,Mol_Vis_2009_Jan_16_15_89-98.txt
2+35A>G,...aplotype A-A was not associated with glaucoma. IVS2+35A>G was the only other MYOC polymorphism that ...,126,502,Mol_Vis_2009_Jan_16_15_89-98.txt
427T>C,"...are defined by the three promoter SNPs (−491A>T, −427T>C, and −219T>G), were not associated with POA...",130,251,Mol_Vis_2009_Jan_16_15_89-98.txt
5+30C>T,"... Met98Lys, IVS5+38T>G, and IVS8–53T>C in OPTN; IVS5+30C>T in WDR36; and −491A>T in APOE. The combina...",133,352,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"... cluster analysis placed IVS5+30C>T (WDR36), IVS8–53T>C (OPTN), and Met98Lys (OPTN) on the same bran...",133,779,Mol_Vis_2009_Jan_16_15_89-98.txt
5+38T>G,...interaction effect on modulating risk of POAG. IVS5+38T>G (OPTN) and IVS2+35A>G (MYOC) were on anoth...,133,982,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...r branch, revealing an interaction between them. −491A>T (APOE) was located on a different remote br...",133,1083,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...r branch, revealing an interaction between them. −491A>T (APOE) was located on a different remote br...",133,1083,Mol_Vis_2009_Jan_16_15_89-98.txt
219T>G,−219T>G	43.61	0.999	5/10,137,2,Mol_Vis_2009_Jan_16_15_89-98.txt
5+30C>T,IVS8–53T>C and IVS5+30C>T	52.5	0.377	7/10,138,19,Mol_Vis_2009_Jan_16_15_89-98.txt
5+30C>T,"IVS2+35A>G, IVS5+30C>T, and −219T>G	43.59	1.0	4/10",139,16,Mol_Vis_2009_Jan_16_15_89-98.txt
5+30C>T,"IVS2+35A>G, IVS5+30C>T, and −219T>G	43.59	1.0	4/10",139,16,Mol_Vis_2009_Jan_16_15_89-98.txt
2+35A>G,"IVS2+35A>G, M98K, IVS5+38T>G, IVS8–53T>C, IVS5+30C>T,...",142,4,Mol_Vis_2009_Jan_16_15_89-98.txt
5+30C>T,"IVS2+35A>G, M98K, IVS5+38T>G, IVS8–53T>C, IVS5+30C>T, and −491A>T	55.14	0.0107	10/10",142,46,Mol_Vis_2009_Jan_16_15_89-98.txt
83G>A,"...riants, the three common polymorphisms (MAF>1%), −83G>A, R76K, and IVS2+35A>G, were not statisticall...",148,1905,Mol_Vis_2009_Jan_16_15_89-98.txt
2+35A>G,"...mmon polymorphisms (MAF>1%), −83G>A, R76K, and IVS2+35A>G, were not statistically associated with PO...",148,1925,Mol_Vis_2009_Jan_16_15_89-98.txt
2+35A>G,Intron 2	IVS2+35A>G	-	119 (20.2)	69 (19.6)	0.81	91 (16.2)	84 (...,157,13,Mol_Vis_2009_Jan_16_15_89-98.txt
15+10G>A,"... variant, Arg545Gln, and the intronic variant, IVS15+10G>A, also showed comparable allelic distribut...",171,1127,Mol_Vis_2009_Jan_16_15_89-98.txt
5+38T>G,"...ns among the two Chinese populations. However, IVS5+38T>G, which was significantly associated with P...",171,1229,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...t al. [35] found the APOE promoter polymorphism, −491A>T, interacted with MYOC −1000C>G (MYOC.mt1) t...",175,1016,Mol_Vis_2009_Jan_16_15_89-98.txt
1000C>G,"...oter polymorphism, −491A>T, interacted with MYOC −1000C>G (MYOC.mt1) to increase IOP in POAG patient...",175,1046,Mol_Vis_2009_Jan_16_15_89-98.txt
15+10G>A,...ions for POAG (between MYOC Thr353Ile and OPTN IVS15+10G>A and between OPTN IVS5+38T>G and APOE −491...,175,1655,Mol_Vis_2009_Jan_16_15_89-98.txt
491A>T,"...IVS15+10G>A and between OPTN IVS5+38T>G and APOE −491A>T). In this present study, a best interaction...",175,1702,Mol_Vis_2009_Jan_16_15_89-98.txt
53T>C,"...ram, the variants, WDR36 IVS5+30C>T and OPTN IVS8–53T>C, are expected to have a strong synergistic i...",175,2115,Mol_Vis_2009_Jan_16_15_89-98.txt
5+38T>G,"...nteraction with both. Similarly, variants OPTN IVS5+38T>G and MYOC IVS2+35A>G also have strong syner...",175,2265,Mol_Vis_2009_Jan_16_15_89-98.txt
2+35A>G,".... Similarly, variants OPTN IVS5+38T>G and MYOC IVS2+35A>G also have strong synergistic interaction t...",175,2285,Mol_Vis_2009_Jan_16_15_89-98.txt
98T>A,SNORD17 (NR_003045)	98T>A	Non-coding microRNA	rs753213	N	Y(hetero) Sco...,81,21,Mol_Vis_2010_Dec_18_16_2829-2838.txt
172C>T,LOC100270804	172C>T	p.Pro58Ser	rs41309831	Y (hetero) Score=13	N...,131,14,Mol_Vis_2010_Dec_18_16_2829-2838.txt
846T>C,...g regions of the 13 known genes. Two variants (c. 846T>C in C20orf72 and c.843C>T in PTMAP3) that we...,168,1671,Mol_Vis_2010_Dec_18_16_2829-2838.txt
1702G>C,...not detect gross structural changes. Mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu) an...,13,577,Mol_Vis_2010_Feb_15_16_224-230.txt
1702G>C,"The novel mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu), c...",16,24,Mol_Vis_2010_Feb_15_16_224-230.txt
1702G>C,"The novel mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu), c...",16,24,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,"The novel mutations c.(1702G>C and 1706T>A; p.Arg514Pro and Phe515Leu), c. 531C>T (p....",16,36,Mol_Vis_2010_Feb_15_16_224-230.txt
531C>T,...d 1706T>A) (p.Arg514Pro and Phe515Leu) and the c. 531C>T (p. Arg124Cys) were associated with more se...,16,249,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,... results of the two novel mutations c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu) of TGFBI in Fa...,63,70,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,... results of the two novel mutations c.1702G>C and 1706T>A (p.Arg514Pro and Phe515Leu) of TGFBI in Fa...,63,70,Mol_Vis_2010_Feb_15_16_224-230.txt
1706T>A,...20s. This indicates that mutations c.(1702G>C and 1706T>A) (p.Arg514Pro and Phe515Leu) and c. 531C>T...,77,228,Mol_Vis_2010_Feb_15_16_224-230.txt
531C>T,...C and 1706T>A) (p.Arg514Pro and Phe515Leu) and c. 531C>T (p. Arg124Cys) have more phenotypic effects...,77,272,Mol_Vis_2010_Feb_15_16_224-230.txt
34T>C,"... the RP1 protein. The other three variants (c.787+34T>C, p.I408L and p.L2015L) were considered benig...",15,301,Mol_Vis_2010_Jul_15_16_1353-1360.txt
34T>C,"... the RP1 protein. The other three variants (c.787+34T>C, p.I408L and p.L2015L) were considered benig...",15,301,Mol_Vis_2010_Jul_15_16_1353-1360.txt
34T>C,Intron 3	c.787+34T>C	/	Novel	20090	0/190,53,16,Mol_Vis_2010_Jul_15_16_1353-1360.txt
34T>C,"...f China. Two of them (p.L2015L and intronic c.787+34T>C) did not lead to amino acid change, while th...",69,286,Mol_Vis_2010_Jul_15_16_1353-1360.txt
34T>C,"...f China. Two of them (p.L2015L and intronic c.787+34T>C) did not lead to amino acid change, while th...",69,286,Mol_Vis_2010_Jul_15_16_1353-1360.txt
1 G>A,IVS3–1 G>A		AD	COOH-terminus	Snail-like	Chinese	[13],72,6,Mol_Vis_2010_Mar_25_16_534-539.txt
1 G>A,IVS3–1 G>A		AD	COOH-terminus	Snail-like	Chinese	[13],72,6,Mol_Vis_2010_Mar_25_16_534-539.txt
266A>G,c266A>G	Q89R	FEVR; LBM; spinal osteoarthritis	Unkno...,29,2,Mol_Vis_2011_Apr_8_17_894-902.txt
640G>A,c640G>A	A214T	HBM	Increase	Decreases Dkk1 and SOST ...,35,2,Mol_Vis_2011_Apr_8_17_894-902.txt
640G>A,c640G>A	A214T	HBM	Increase	Decreases Dkk1 and SOST ...,35,2,Mol_Vis_2011_Apr_8_17_894-902.txt
758C>T,c758C>T	T253I	HBM	Increase	Decreases Dkk1 and SOST ...,37,2,Mol_Vis_2011_Apr_8_17_894-902.txt
844A>G,c844A>G	M282V	HBM	Increase	Decreases Dkk1 and SOST ...,38,2,Mol_Vis_2011_Apr_8_17_894-902.txt
844A>G,c844A>G	M282V	HBM	Increase	Decreases Dkk1 and SOST ...,38,2,Mol_Vis_2011_Apr_8_17_894-902.txt
1564G>A,c1564G>A	A522T	FEVR	Decrease	Inhibits norrin-FZD4 m...,41,2,Mol_Vis_2011_Apr_8_17_894-902.txt
4619C>T,c4619C>T	T1540M	FEVR	Decrease	Inhibits norrin-FZD4 ...,45,2,Mol_Vis_2011_Apr_8_17_894-902.txt
4643G>T,c4643G>T	C1548F	FEVR	Decrease	Inhibits norrin-FZD4 ...,46,2,Mol_Vis_2011_Apr_8_17_894-902.txt
144 G>T,...variation (Figure 1). The Gln48His variation is a 144 G>T transversion which resulted in a non-conse...,89,126,Mol_Vis_2011_Dec_15_17_3243-3253.txt
2A>G,"...17insGC in exon 7, c.992A>C in exon 8, and c.1091–2A>G in an intronic, accounting for 83.3% of the m...",22,544,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2A>G,"...17insGC in exon 7, c.992A>C in exon 8, and c.1091–2A>G in an intronic, accounting for 83.3% of the m...",22,544,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T>G,"...1/F	55	55		RE:20/400	c.802–8_810del17insGC+ c.413+2T>G,del﹡",48,55,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T>G,3	c.413+2T>G	Splicing acceptor	0/1	0/200	1/184	novel,71,9,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2A>G,"...tion accounted for 11.9% (22/184), and the c.1091–2A>G accounted for 9.8% (17/184). Collectively, th...",82,190,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2A>G,"...tion accounted for 11.9% (22/184), and the c.1091–2A>G accounted for 9.8% (17/184). Collectively, th...",82,190,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T >G,"...ne novel heterozygous splice-site mutation, c.413+2T >G, was detected in the 3′- acceptor in intron ...",84,1050,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T >G,"...ne novel heterozygous splice-site mutation, c.413+2T >G, was detected in the 3′- acceptor in intron ...",84,1050,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T>G,"...: DNA-MT of the heterozygous splice change (c.413+2T>G). H: Control (WT). I: cDNA sequence, from the...",88,344,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T>G,...The cDNA of the heterozygous splice change (c.413+2T>G). The deletion is indicated with an arrow and...,88,484,Mol_Vis_2014_Dec_31_20_1806-1814.txt
2T>G,"...810del17insGC) and a novel splice mutation (c.413+2T>G), exhibited a late age of onset, rapid diseas...",107,115,Mol_Vis_2014_Dec_31_20_1806-1814.txt
768 G>T,"...y 1, the proband (age 23) was homozygote for the c768 G>T mutation. She was diagnosed with cone rod ...",10,59,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,"...y 1, the proband (age 23) was homozygote for the c768 G>T mutation. She was diagnosed with cone rod ...",10,59,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,"...y 1, the proband (age 23) was homozygote for the c768 G>T mutation. She was diagnosed with cone rod ...",10,59,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,... aunt (age 69) was compound heterozygote for the c768 G>T and c2894 A>G mutations and had autosomal ...,10,184,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,"...of the proband were asymptomatic carriers of the c768 G>T mutation. In family 2, the proband (age 25...",10,367,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,"...of the proband were asymptomatic carriers of the c768 G>T mutation. In family 2, the proband (age 25...",10,367,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,... were compound heterozygote for the c5917del and c5882 G>A mutations. The eldest sister (age 23) suf...,10,556,Mol_Vis_2014_Jan_7_20_89-104.txt
3113 C>T,...e 43) was compound heterozygote for c768 G>T and c3113 C>T and had been diagnosed with STGD. Her son...,10,1039,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,...ge 45) was asymptomatic and heterozygote for the c768 G>T mutation. The patients with progressive di...,10,1401,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,1 Ic	c768 G>T	V256V/splice	─	─	NVP,77,7,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,1 Ic	c768 G>T	V256V/splice	─	─	NVP,77,7,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,1 IIa	c768 G>T	V256V/splice	c768 G>T	V256V/splice	CRD,78,8,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,1 IIa	c768 G>T	V256V/splice	c768 G>T	V256V/splice	CRD,78,30,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,2 IIc	c5917 delG	V1973X/frameshift	c5882 G>A	G1961E/missense	STGD,83,37,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,2 IIc	c5917 delG	V1973X/frameshift	c5882 G>A	G1961E/missense	STGD,83,37,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,2 II d	c5882 G>A	G1961E/missense	─	─	NVP,84,9,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,2 II d	c5882 G>A	G1961E/missense	─	─	NVP,84,9,Mol_Vis_2014_Jan_7_20_89-104.txt
3113 C>T,3 Ia	c768 G>T	V256V/splice	c3113 C>T	A1038V/missense	STGD,85,29,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,3 Ib	c768 G>T	V256V/splice	─	─	NVP,86,7,Mol_Vis_2014_Jan_7_20_89-104.txt
768 G>T,3 IIa	c768 G>T	V256V/splice	c768 G>T	V256V/splice	STGD,87,8,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,...e same mutations (c5917 delG and c5882 G>A). The c5882 G>A mutation is mild [37] and has previously ...,172,231,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,"...onset for her. Family 2 is from Hungary, and the c5882 G>A mutation is common in Hungarian patients ...",172,651,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,"...d by other authors [8,23,38] in association with c5882 G>A. In one study [38], however, a combinatio...",172,1522,Mol_Vis_2014_Jan_7_20_89-104.txt
5882 G>A,...nts 2Ib and 2IIa. The elder generation (with the c5882 G>A and c5917 delG mutations) showed similar ...,172,1946,Mol_Vis_2014_Jan_7_20_89-104.txt
768G>T,".... Patients 1IIa and 3IIa were homozygote for the c768G>T mutation. Patient 1IIa, accordingly, had la...",176,179,Mol_Vis_2014_Jan_7_20_89-104.txt
768G>T,".... Patients 1IIa and 3IIa were homozygote for the c768G>T mutation. Patient 1IIa, accordingly, had la...",176,179,Mol_Vis_2014_Jan_7_20_89-104.txt
768G>T,Patients with homozygote c768G>T and c5917 delG mutations seem to have worse...,178,27,Mol_Vis_2014_Jan_7_20_89-104.txt
768G>T,"... residual function of the ABCA4 protein [11,29]. c768G>T is a splice site mutation leading to loss o...",178,190,Mol_Vis_2014_Jan_7_20_89-104.txt
2894A>G,"...ciated retinal degeneration, a form of arRP. The c2894A>G also previously has been described in pati...",180,167,Mol_Vis_2014_Jan_7_20_89-104.txt
2894A>G,"...ciated retinal degeneration, a form of arRP. The c2894A>G also previously has been described in pati...",180,167,Mol_Vis_2014_Jan_7_20_89-104.txt
1G>A,"...mutations [c.2458_2459insG (p.E820Gfs*23), c.1721+1G>A and c.760C>T (p.Q254*)] in the ADAMTS17 gene ...",72,112,Mol_Vis_2014_Jun_12_20_790-796.txt
857C>T,...ations identified in TRPM1 was corrected to be c.[857C>T];[857C>T] p.(S286L),7,108,Mol_Vis_2014_Jun_2_20_780.txt
1 G>A,"6: 64,574,078	c.7228+1 G>A	p.A2410Gfs*4	splice site	Het	I36–37	NA	NA	NA...",73,22,Mol_Vis_2016_Jun_16_22_646-657.txt
6557G>A,"... patient ARRP08-II:2, biallelic EYS mutations, c.[6557G>A];[7228+1G>A], were found to be carried by ...",80,61,Mol_Vis_2016_Jun_16_22_646-657.txt
6557G>A,"... patient ARRP08-II:2, biallelic EYS mutations, c.[6557G>A];[7228+1G>A], were found to be carried by ...",80,61,Mol_Vis_2016_Jun_16_22_646-657.txt
1G>A,...RP07-II:1. The novel splice-site variation c.7228+1G>A was predicted to abolish the regular splice d...,80,258,Mol_Vis_2016_Jun_16_22_646-657.txt
1G>A,...RP07-II:1. The novel splice-site variation c.7228+1G>A was predicted to abolish the regular splice d...,80,258,Mol_Vis_2016_Jun_16_22_646-657.txt
1G>A,...RP07-II:1. The novel splice-site variation c.7228+1G>A was predicted to abolish the regular splice d...,80,258,Mol_Vis_2016_Jun_16_22_646-657.txt
1G>A,...RP07-II:1. The novel splice-site variation c.7228+1G>A was predicted to abolish the regular splice d...,80,258,Mol_Vis_2016_Jun_16_22_646-657.txt
7228+1G>A,... who carried biallelic heterozygous c.[4957dupA];[7228+1G>A]. The first variant was a reported frame...,80,520,Mol_Vis_2016_Jun_16_22_646-657.txt
7228+1G>A,... who carried biallelic heterozygous c.[4957dupA];[7228+1G>A]. The first variant was a reported frame...,80,520,Mol_Vis_2016_Jun_16_22_646-657.txt
490C>T,2#	c.[490C>T];[6416G>A]	p.[R614*];[C2139Y]	ARRP05-II:3	R...,93,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,2#	c.[490C>T];[6416G>A]	p.[R614*];[C2139Y]	ARRP05-II:5	RP	37/M	20...,94,16,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,2#	c.[490C>T];[6416G>A]	p.[R614*];[C2139Y]	ARRP05-II:7	RP	32/M	25...,95,16,Mol_Vis_2016_Jun_16_22_646-657.txt
7919G>A,2#	c.[7919G>A];[8861T>C]	p.[W2640*];[F2954S]	ARRP06-II:2...,96,7,Mol_Vis_2016_Jun_16_22_646-657.txt
8861T>C,2#	c.[7919G>A];[8861T>C]	p.[W2640*];[F2954S]	ARRP06-II:4	RP	52/M	3...,97,17,Mol_Vis_2016_Jun_16_22_646-657.txt
8861T>C,2#	c.[7919G>A];[8861T>C]	p.[W2640*];[F2954S]	ARRP06-II:8	RP	49/F	3...,98,17,Mol_Vis_2016_Jun_16_22_646-657.txt
8107G>T,2#	c.[2510G>T];[8107G>T]	p.[C837F];[E2703*]	F11–1	IRDs	48/M	41	20/...,102,17,Mol_Vis_2016_Jun_16_22_646-657.txt
8107G>T,2#	c.[2510G>T];[8107G>T]	p.[C837F];[E2703*]	F11–1	IRDs	48/M	41	20/...,102,17,Mol_Vis_2016_Jun_16_22_646-657.txt
6416G>A,3$	c.[6416G>A];[6557G>A]	p.[C2139Y];[G2186E]	No.10-II:3	...,107,7,Mol_Vis_2016_Jun_16_22_646-657.txt
6557G>A,3$	c.[6416G>A];[6557G>A]	p.[C2139Y];[G2186E]	No.10-II:4	RP	35/F	20...,108,17,Mol_Vis_2016_Jun_16_22_646-657.txt
7609G>A,3$	c.[7609G>A];[7949C>T]	p.[A2537T];[S2650F]	W171–1	IRDs...,111,7,Mol_Vis_2016_Jun_16_22_646-657.txt
1G>A,"... ARRP10-II:3, the same patient who carries c.7228+1G>A. This mutation has not been previously report...",118,912,Mol_Vis_2016_Jun_16_22_646-657.txt
1G>A,"... ARRP10-II:3, the same patient who carries c.7228+1G>A. This mutation has not been previously report...",118,912,Mol_Vis_2016_Jun_16_22_646-657.txt
34G>A,...cts on gefitinib toxicities were evaluated. ABCG2 34G>A was statistically associated with occurrence...,10,430,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,...f the 32 patients with at least one variant ABCG2 34G>A allele (G/A and A/A) developed grade 2 or wo...,10,555,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"...se variants, two major functional variants, ABCG2 34G>A (rs2231137), resulting in a Val12Met substit...",22,214,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,...ransition at nucleotide position 3435 in exon 26 (3435C>T) (rs1045642).14) Although this transition ...,25,125,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,ABCG2 421C>A polymorphism was statistically significantl...,28,7,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,"...aluated the association between three SNPs, ABCG2 421C>A, 34G>A and ABCB1 3435C>T polymorphisms and ...",32,255,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...between three SNPs, ABCG2 421C>A, 34G>A and ABCB1 3435C>T polymorphisms and moderate or severe toxic...",32,279,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C > A,"... GmbH, Hilden, Germany). The polymorphisms, ABCG2 421C > A and ABCB1 3435C > T were genotyped by the...",58,140,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C > T,"...any). The polymorphisms, ABCG2 421C > A and ABCB1 3435C > T were genotyped by the TaqMan assay (Appl...",58,159,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,...n 1.4.1 of Applied Biosystems. We sequenced ABCG2 34G>A after performing a single polymerase chain r...,58,363,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"Genotyping of ABCG2 34G>A, ABCG2 421C>A and ABCB1 3435C>",75,21,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,"...s in 31 (38%), and A/A allele in 7 (8%) for ABCG2 421C>A. C/C alleles were found in 23 patients (28%...",76,224,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,ABCG2 421C>A	CC	CA	AA,82,7,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,ABCG2 421C>A	CC	CA	AA,82,7,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,ABCB1 3435C>T	CC	CT	TT,84,7,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,"... severe toxicities and SNPs at ABCG2 34G>A, ABCG2 421C>A and ABCB1 3435C>T (Table 3–5). Statisticall...",87,160,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...4 Association between genetic polymorphisms ABCG2 421C>A and toxicit,104,57,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,Variant allele of ABCG2 34G>A caused apical plasma membrane dislocalizatio...,139,25,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...th skin rash or diarrhea and indicated that ABCG2 421C>A was statistically significantly associated ...,141,116,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...e unable to confirm the association between ABCG2 421C>A and diarrhea. Akasaka et al. also reported ...,141,543,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...ed that the allele frequency of the variant ABCG2 421C>A was higher and not associated with diarrhea...,141,640,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,...ht be lower allele frequency of the variant ABCG2 421C>A in Caucasian populations compared with two ...,143,83,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
421C>A,"...ssociation between genetic polymorphisms of ABCG2 421C>A and toxicities, although ABCG2 16702G>A was...",143,690,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,ABCB1 3435C>T has been significantly associated with red...,145,7,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,ABCB1 3435C>T has been significantly associated with red...,145,7,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...ever, the determination of polymorphisms of ABCB1 3435C>T would not be useful for predicting moderat...",145,204,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...ever, the determination of polymorphisms of ABCB1 3435C>T would not be useful for predicting moderat...",145,204,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
34G>A,"In summary, our study suggested that ABCG2 34G>A might be the predictor of skin toxicity in g...",147,44,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...ug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Geno...",165,111,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
3435C>T,"...ug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Geno...",165,111,Nagoya_J_Med_Sci_2012_Feb_74(1-2)_133-140.txt
2T>C,...peptide repeat domains (shaded boxes). The c.1194+2T>C and c.1194+3A>C splice-site mutations result ...,91,526,Nat_Commun_2014_Aug_7_5_4398.txt
3A>C,...omains (shaded boxes). The c.1194+2T>C and c.1194+3A>C splice-site mutations result in an in-frame d...,91,542,Nat_Commun_2014_Aug_7_5_4398.txt
3C>T,c.1687-3C>T	rs76650154	 	 	No effect	5	 ,176,8,Nat_Commun_2014_Aug_7_5_4398.txt
38913144A>G,"...sense change in SCN11A, c.3551T>C, p.V1184A (chr3:38913144A>G, hg19), was the most likely candidate ...",20,1214,Nat_Commun_2015_Dec_8_6_10049.txt
3A>G,"...gous for changes in in-tron 12 (c.993+1G>A, c.993+3A>G) that are predicted to affect splicing (Table...",20,216,Nat_Commun_2015_Jun_16_6_7092.txt
1G>A,...t DYNC2LI1 is markedly reduced in R01-013A (c.993+1G>A; p.Leu117Val) and R07-628A (p.Trp124Ter; p.Le...,20,1342,Nat_Commun_2015_Jun_16_6_7092.txt
13	C>T,"3, K2	Pat	13	C>T	0	0	0.0008	2.57	Novel	—",197,11,Nat_Commun_2015_Nov_2_6_8718.txt
16	G>A,"4–5, K3	Mat	16	G>A	0	0	0.0008	2.63	Novel	—",199,13,Nat_Commun_2015_Nov_2_6_8718.txt
118	T>C,"6, K4	Pat	118	T>C	0	0	0	2.12	Novel	—",202,11,Nat_Commun_2015_Nov_2_6_8718.txt
7A>G, p.S3G	7A>G	1	1/99 US FTLD-ALS	0/1038 US controls0/657 AU...,121,8,Nat_Commun_2016_Apr_15_7_11253.txt
542C>T, p.T181I	542C>T	6	1/283 JA SALS	0/514 JA controls0/967 AU c...,129,10,Nat_Commun_2016_Apr_15_7_11253.txt
-308G>A,"... InterLymph consortium, the variant allele for TNF-308G>A (rs1800629) and a TNF/LTA haplotype locate...",21,352,Nat_Genet_2010_Aug_18_42(8)_661-664.txt
3A>G,BBS	12620/V.15	N. European	c.2322+3A>G		0/440	0/356	BBS1: M390R hom,137,35,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
3A>G,BBS	12620/V.15	N. European	c.2322+3A>G		0/440	0/356	BBS1: M390R hom,137,35,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
3A>G,BBS	12620/V.15	N. European	c.2322+3A>G		0/440	0/356	BBS1: M390R hom,137,35,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
3A>G,BBS	13881/VI.24	N. European	c.2322+3A>G		0/440	0/356	BBS2:L209fsX229 hom,138,36,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
3A>G,BBS	13881/VI.24	N. European	c.2322+3A>G		0/440	0/356	BBS2:L209fsX229 hom,138,36,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
3A>G,BBS	13881/VI.24	N. European	c.2322+3A>G		0/440	0/356	BBS2:L209fsX229 hom,138,36,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
2 A>G,NPHP+	A34-II1	Portuguese	P209L	c.2758-2 A>G	0/440	0/440	0/356	0/356,153,39,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
3C>G,NPHP+	F514	N. European	W150R	c.3264-3C>G	0/440	0/440	0/356	0/356,155,37,Nat_Genet_2011_Mar_23_43(3)_189-196.txt
23508437A>G,"...h mutations in this element, 6 had the same chr10:23508437A>G mutation as part of a shared extended ...",27,518,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508305A>G,"...us chr10:23508363A>G mutation, a homozygous chr10:23508305A>G mutation and compound heterozygous chr...",27,774,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508305A>G,"...us chr10:23508363A>G mutation, a homozygous chr10:23508305A>G mutation and compound heterozygous chr...",27,774,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
23508446A>C,"...305A>G, 23508363A>G, 23508365A>G, 23508437A>G and 23508446A>C on chromosome 10 respectively)",98,946,Nat_Genet_2014_Jan_10_46(1)_61-64.txt
1664C>T,1	13	1664C>T	Ser555Leu,91,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
363G>C,3	3	363G>C	Glu121Asp,95,5,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
626G>A,5	626G>A	Arg209Gln,96,3,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1195C>T,5a	10	Homozygous 1195C>T	Arg399Cys,99,18,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
497C>T,6	3	497C>T	Ala166Val,100,5,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,7	18	2221G>A	Gly741Arg,102,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,7	18	2221G>A	Gly741Arg,102,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
961C>T,9	7	961C>T	Arg321Trp,106,5,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,18	2221G>A	Gly741Arg,113,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,13	18	2221G>A	Gly741Arg,114,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,18	2221G>A	Gly741Arg,119,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2883+1G>T,24	2883+1G>T	Intron 24 5′ splice site lost,127,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2576T>C,22	2576T>C	Leu859Pro,129,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
506-1G>A,22	4	506-1G>A	Intron 3 3′ splice site lost,132,6,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1763C>T,23	14	1763C>T	Ala588Val,134,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1315G>A,26	10	1315G>A	Gly439Ser,140,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,27	18	Homozygous 2221G>A	Gly741Arg,142,18,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,27	18	Homozygous 2221G>A	Gly741Arg,142,18,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,27	18	Homozygous 2221G>A	Gly741Arg,142,18,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2037+1G>A,29	16	2037+1G>A	Intron 16 5′ splice site lost,145,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
3053G>A,26	3053G>A	Arg1018Gln,146,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,18	2221G>A	Gly741Arg,148,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
1315G>A,34	10	1315G>A	Gly439Ser,155,7,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2883+1G>T,24	2883+1G>T	Intron 24 5′ splice site lost,156,4,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,35	18	Homozygous 2221G>A	Gly741Arg,157,18,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
2221G>A,35	18	Homozygous 2221G>A	Gly741Arg,157,18,Nephrol_Dial_Transplant_2013_Jun_17_28(6)_1533-1542.txt
16C>T,...da K Sakai H Hamanoue H Mizuguchi T Shimizu Y  A –16C>T substitution in the 5′ UTR of the puratrophi...,113,68,Neurogenetics_2010_Oct_28_11(4)_409-415.txt
16C>T,...da K Sakai H Hamanoue H Mizuguchi T Shimizu Y  A –16C>T substitution in the 5′ UTR of the puratrophi...,113,68,Neurogenetics_2010_Oct_28_11(4)_409-415.txt
3G>C,"...r splice site in intron 2 of the GYG1 gene (c.143+3G>C, p.Asp3Glufs*4), either in homozygous (in the...",542,525,Neurol_Genet_2015_Sep_24_1(3)_e21.txt
1-14A > G,... transcribed from constructs carrying mutation IVS1-14A > G. (B) Splicing pattern of LIPC minigenes ...,146,517,Nucleic_Acids_Res_2007_Oct_18_35(19)_6399-6413.txt
514 C > T,...used to test the hypothesis that the positions of 514 C > T and 231 G > A transitions were each dist...,55,388,Nucleic_Acids_Res_2007_Sep_22_35(17)_5717-5728.txt
9A->G,"...s, restoring the base pairs in the intronic stem (9A->G+9U->C)",56,725,Nucleic_Acids_Res_2012_Oct_30_40(19)_9876-9886.txt
7505T>C,"...utations were the tRNASer(UCN) 7445A>G, 7472insC, 7505T>C, 7510T>C and 7511T>C, tRNAHis 12201T>C and...",8,927,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7510T>C,"...were the tRNASer(UCN) 7445A>G, 7472insC, 7505T>C, 7510T>C and 7511T>C, tRNAHis 12201T>C and tRNAIle ...",8,936,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
8344A>G,...rsor of tRNASer(UCN) (16) or the MERRF-associated 8344A>G mutation in tRNALys gene (40). The imprope...,98,955,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7511T>C,"...ess-associated tRNASer(UCN) 7445A>G, 7472insC and 7511T>C mutations (16,18,41)",98,1634,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
8344A>G,... those in cells carrying MERRF-associated tRNALys 8344A>G and MELAS-associated tRNALeu(UUR) 3243A>G ...,100,304,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
3243A>G,"...tRNALys 8344A>G and MELAS-associated tRNALeu(UUR) 3243A>G mutations (42,43). Alternatively, the redu...",100,346,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7510T>C,...c hearing impairment in a Spanish family with the 7510T>C mutation in the mitochondrial tRNASer(UCN)...,125,204,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
7505T>C,...ciated with the novel mitochondrial tRNASer(UCN)  7505T>C mutation in a Han Chinese family Mol. Gene...,127,184,Nucleic_Acids_Res_2014_Aug_1_42(12)_8039-8048.txt
80A>G,...05-02551ArticleThe Reduced Folate Carrier (RFC-1) 80A>G Polymorphism and Maternal Risk of Having a C...,3,136,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...ate carrierSLC19A1RFC-1RFC1 A80G polymorphismRFC1 80A>G polymorphismDown Syndromematernal riskmeta-a...,5,62,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...ate carrierSLC19A1RFC-1RFC1 A80G polymorphismRFC1 80A>G polymorphismDown Syndromematernal riskmeta-a...,5,62,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
677C>T,...tion with maternal risk in combination with MTHFR 677C>T or MTHFR 1298A>C polymorphisms [19]. Subseq...,14,480,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,"...alone or combined [25,26,27]. Moreover, the RFC-1 80A>G polymorphism has been associated with reduce...",14,939,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...used to examine the association between the RFC-1 80A>G polymorphism and maternal risk of birth of a...,97,346,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...mates with 95% CI (fixed effects model) for RFC-1 80A>G recessive genetic model is shown in Figure 2...,99,111,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...ta-analysis suggest a possible role for the RFC-1 80A>G polymorphism in modulating maternal risk for...,141,76,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
80A>G,...ms known to be in linkage disequilibrium with the 80A>G one have been associated with an increased r...,141,799,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
66A>G,16. Amorim M.R.  Lima M.A.   MTRR 66A>G polymorphism as maternal risk factor for Dow...,175,35,Nutrients_2013_Jul_5_5(7)_2551-2563.txt
1047H>H,"...dentified. These were the missense mutation A>AG, 1047H>H/R in codon 3140, and the silent mutation C...",26,348,Oncol_Lett_2014_Jun_7_7(6)_2019-2022.txt
11614913 T>C,...[192-193]. Tian Tian et al. showed that the SNP rs11614913 T>C in the pre-miRNA region of miR-196a2 ...,203,197,Oncoscience_2014_Nov_15_1(11)_674-705.txt
1G>A,"...he other one severe (c.1361A>G, c.550C>T or c.648+1G>A) [18]. This is a common situation in non-leth...",209,148,Orphanet_J_Rare_Dis_2009_Feb_21_4_6.txt
34-1G>C,...ct compound heterozygous constellations (R277X/IVS34-1G>C and R277X/R1511X) in the thyroglobulin (TG...,573,150,Orphanet_J_Rare_Dis_2010_Jun_10_5_17.txt
34-1G>C,...ct compound heterozygous constellations (R277X/IVS34-1G>C and R277X/R1511X) in the thyroglobulin (TG...,573,150,Orphanet_J_Rare_Dis_2010_Jun_10_5_17.txt
1G > A,c.15053-1G > A	IVS69	Ex70 splice defect	+	1	Present study,132,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
1G > T,RP1558	p.R1549X/c.1328 + 1G > T	1933	USH2	43	Severe and progressive since 2...,342,26,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2T > G,RP1667*	p.C759F/c.11548 + 2T > G	1954	USH2	15	Mild and slightly progressive	...,350,27,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
52T > C,c.1328 + 52T > C	IVS7	-	3,378,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
32G > T,c.4627 + 32G > T	IVS21	UV2	1,382,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
18A > G,c.8681 + 18A > G	IVS43	UV2	1,392,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
118A > G,c.8681 + 118A > G	IVS43	UV2	1,396,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
52G > T,c.9056-52G > T	IVS45	UV	1,398,8,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
128A > G,c.9958 + 128A > G	IVS50	-	4,404,10,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
123T > C,c.10388-123T > C	IVS52	UV2	1,406,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
36G > C,c.14343 + 36G > C	IVS65	UV2	1,412,11,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
1153G > A,c.15298-1153G > A(g.798209G > A) d	IVS71	UV2	1,416,9,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2A > G,"...n-Ashkenazi Jews. The splice-site variant c.12062-2A > G was detected in three patients, in homozygo...",473,512,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2A > G,"...n-Ashkenazi Jews. The splice-site variant c.12062-2A > G was detected in three patients, in homozygo...",473,512,Orphanet_J_Rare_Dis_2011_Oct_17_6_65.txt
2A>T,...d a novel heterozygous splice site mutation c.622-2A>T (g.30100162 T>A) in two patients (Figure 1). ...,75,205,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
2A>T,...d a novel heterozygous splice site mutation c.622-2A>T (g.30100162 T>A) in two patients (Figure 1). ...,75,205,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
2A>T,"... splice site mutation site (g.30100162 T>A, c.622-2A>T in violet brackets and a line) and its conser...",81,207,Orphanet_J_Rare_Dis_2013_Aug_16_8_125.txt
1G>C,... third unrelated NPC patient presented the c.2795+1G>C/c.3493G>A (p.V1165M) genotype. This study was...,44,446,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
1G>C,... third unrelated NPC patient presented the c.2795+1G>C/c.3493G>A (p.V1165M) genotype. This study was...,44,446,Orphanet_J_Rare_Dis_2013_Feb_21_8_34.txt
2A>G,"... increased lipid	Low	UD	Dt, Cd, Mb, Me	Homo c.516-2A>G",51,139,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
2A>G,"... increased lipid	Low	UD	Dt, Cd, Mb, Me	Homo c.516-2A>G",51,139,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
2A>G,...20	Increased lipid	NA	NA	At 1y: normal	Homo c.516-2A>G,52,82,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
2A>G,...RF	10	6y 6 m	NA	NA	NA	CT brain: normal	Homo c.516-2A>G,56,133,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
11T>G,"...ystic changes in Dt, BG and central WM	Homo c.324-11T>G",66,172,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
11T>G,"... Scp, Dt, Me, WM tracts of spinal cord	Homo c.324-11T>G",75,215,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
2A>G,...T mutation or the c.324-11T>G mutation. The c.516-2A>G mutation segregated in two different Indian G...,160,949,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
2A>G,"...CT, c.575G>A (p.Arg192Gln), c.751+5G>A. and c.752-2A>G)",163,192,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
2A>G,...d play the violin. The splice site mutation c.752-2A>G was found in a patient (case 37) of Australia...,167,1244,Orphanet_J_Rare_Dis_2013_Jul_5_8_96.txt
571G>A,...ductase. We report two sisters homozygous for the 571G>A (E191K) DHCR24 mutation. Comparison of the ...,3,2096,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
307C>T,...91K]	c.[571G>A] + [571G>A] p.[E191K] + [E191K]	c.[307C>T] + [307C>T] p.[R103C] + [R103C]	c.[281G>A] ...,45,97,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
307C>T,...91K]	c.[571G>A] + [571G>A] p.[E191K] + [E191K]	c.[307C>T] + [307C>T] p.[R103C] + [R103C]	c.[281G>A] ...,45,97,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
1412A>C,...03C]	c.[281G>A] + [1438G>A] p.[R94H] + [E480K]	c.[1412A>C] + [881A > C;918G>C] p.[Y471S] + [N294T; K...,45,181,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
1412A>C,...03C]	c.[281G>A] + [1438G>A] p.[R94H] + [E480K]	c.[1412A>C] + [881A > C;918G>C] p.[Y471S] + [N294T; K...,45,181,Orphanet_J_Rare_Dis_2014_Jun_25_9_94.txt
1G>C,"5		37,6	4		c.1065+1G>C heterozygous	IVS7+1G>C ds	Splice site mutatio...",42,19,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
1G>T,"6		25,4	3	1	c.1065+1G>T heterozygous	IVS7+1G>T ds	Splice site mutatio...",43,20,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
1G>A,"10		57,0			c.2022+1G>A heterozygous	IVS13+1G>A ds	Splice site mutati...",48,19,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
1G>A,"10		57,0			c.2022+1G>A heterozygous	IVS13+1G>A ds	Splice site mutati...",48,19,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
2T>G,"12		30,0	2	1	c.2565+2T>G heterozygous	IVS17+2T>G ds	Splice site mutati...",54,21,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
2T>G,"20		1,7			c.4303+2T>G heterozygous	IVS25+2T>G ds	Splice site mutati...",67,18,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
25+2T>G,"20		1,7			c.4303+2T>G heterozygous	IVS25+2T>G ds	Splice site mutation",67,39,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
2A>G,"27		24,9	1	2	c.6908-2A>G heterozygous	IVS42-2A>G	Splice site mutation",85,21,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
42-2A>G,"27		24,9	1	2	c.6908-2A>G heterozygous	IVS42-2A>G	Splice site mutation",85,42,Orphanet_J_Rare_Dis_2015_Oct_15_10_134.txt
110G>C,(NM_005340.5)	2	c.[110G>C];[110G>C]	p.[Arg37Pro];[Arg37Pro],189,30,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
110G>C,(NM_005340.5)	2	c.[110G>C];[110G>C]	p.[Arg37Pro];[Arg37Pro],189,30,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
134T>A,(NM_030962.3)	1	c.[134T>A];[c.134T>A]	p..[Ile45Asn];[Ile45Asn],255,21,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1656G>T,SETX (NM_015046.5): c.[1656G>T(;)1658C>T,307,24,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1658C>T,SETX (NM_015046.5): c.[1656G>T(;)1658C>T,307,34,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
1658C>T,The mutation c.[1656G>T(;)1658C>T] in SETX gene was detected. It was not det...,310,27,Orphanet_J_Rare_Dis_2016_Aug_22_11(1)_118.txt
208T>C,"...rporation, Ann Arbor, MI, USA). A point mutation (208T>C) in the middle region of exon 3 (Genbank ac...",54,291,Pharmacogenomics_J_2012_Feb_20_12(1)_30-44.txt
31 G>A,"...2D6 detected by RETINA were as follows (Table 1): 31 G>A, 77 G>A, 100 C>T,124 G>A, 137_138 insT, 883...",27,73,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
124 G>A,"...ere as follows (Table 1): 31 G>A, 77 G>A, 100 C>T,124 G>A, 137_138 insT, 883 G>C, 1023 C>T,1659 G>A,...",27,97,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
124 G>A,"...ere as follows (Table 1): 31 G>A, 77 G>A, 100 C>T,124 G>A, 137_138 insT, 883 G>C, 1023 C>T,1659 G>A,...",27,97,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"..., 77 G>A, 100 C>T,124 G>A, 137_138 insT, 883 G>C, 1023 C>T,1659 G>A, 1707 delT, 1716 G>A, 1758 G>T, ...",27,129,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1659 G>A,"... 100 C>T,124 G>A, 137_138 insT, 883 G>C, 1023 C>T,1659 G>A, 1707 delT, 1716 G>A, 1758 G>T, 1863_1864...",27,138,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1758 G>T,"... 883 G>C, 1023 C>T,1659 G>A, 1707 delT, 1716 G>A, 1758 G>T, 1863_1864ins(TTTCGCCCC)2,1846 G>A, 1973_...",27,169,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"...3_2574 insC, 2587_2590 delGACT, 2615_2617 delAAG, 2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, ...",27,324,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"...3_2574 insC, 2587_2590 delGACT, 2615_2617 delAAG, 2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, ...",27,324,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2935 A>C,"...C, 2587_2590 delGACT, 2615_2617 delAAG, 2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, ...",27,334,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2935 A>C,"...C, 2587_2590 delGACT, 2615_2617 delAAG, 2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, ...",27,334,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2988 G>A,"..., 2615_2617 delAAG, 2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, 3259_3260 insGT,4125...",27,354,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3183 G>A,"...7 delAAG, 2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, 3259_3260 insGT,4125_4133 dup ...",27,364,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3201 C>T,"...2850 C>T, 2935 A>C, 2950 G>C, 2988 G>A, 3183 G>A, 3201 C>T, 3259_3260 insGT,4125_4133 dup GTGCCCACT,...",27,374,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2988 G>A,"...g alleles were included in the genotyping assays: 2988 G>A (CYP2D6*41), 2850 C>T (CYP2D6*2), 2615_26...",34,63,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"...d in the genotyping assays: 2988 G>A (CYP2D6*41), 2850 C>T (CYP2D6*2), 2615_2617 delAAG (CYP2D6*9), ...",34,85,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...ins(TTTCGCCCC)2 (CYP2D6*40), 1846 G>A (CYP2D6*4), 1023 C>T (CYP2D6*17), 100 C>T (CYP2D6*10), 31 G>A ...",34,195,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846G>A,"...C>T SNP, 13 (27%) had a100C>T SNP, 10 (21%) had a 1846G>A SNP, 9 (19%) had a 1023 C>T SNP, 9 (19%) h...",58,373,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846G>A,"...C>T SNP, 13 (27%) had a100C>T SNP, 10 (21%) had a 1846G>A SNP, 9 (19%) had a 1023 C>T SNP, 9 (19%) h...",58,373,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3183 G>A,"... G>A SNP, 2 (4%) had a 1659 G>A SNP, 2 (4%) had a 3183 G>A SNP, 1 (2%) had a 77 G>A SNP, 1 (2%) had ...",58,534,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
77 G>A,"... G>A SNP, 2 (4%) had a 3183 G>A SNP, 1 (2%) had a 77 G>A SNP, 1 (2%) had a 1863_1864ins(TTTCGCCCC)2 ...",58,561,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100C>T,...G variant. Representative data of the 1846G>A and 100C>T SNP assays of the RETINA system for all 48 ...,58,701,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,"...er, only 9 were availablecommerciallyvia TaqMan® (31 G>A, 100C>T, 1023 C>T, 1846G>A, 1863_1864ins(TT...",60,255,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...availablecommerciallyvia TaqMan® (31 G>A, 100C>T, 1023 C>T, 1846G>A, 1863_1864ins(TTTCGCCCC)2, 2615_...",60,271,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...availablecommerciallyvia TaqMan® (31 G>A, 100C>T, 1023 C>T, 1846G>A, 1863_1864ins(TTTCGCCCC)2, 2615_...",60,271,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
31 G>A,"...overed by the RETINA system in our study, only 11(31 G>A, 100 C>T, 883 G>C, 1023 C>T, 1707 delT, 175...",73,289,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
883 G>C,"...INA system in our study, only 11(31 G>A, 100 C>T, 883 G>C, 1023 C>T, 1707 delT, 1758 G>T, 1846 G>A,2...",73,306,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"...m in our study, only 11(31 G>A, 100 C>T, 883 G>C, 1023 C>T, 1707 delT, 1758 G>T, 1846 G>A,2549 delA,...",73,315,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850C>T,"...entified to be polymorphic: 29 samples (58%)had a 2850C>T SNP, 16 samples (32%) had a 1846G>A SNP, 1...",80,115,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2291G>A,"...(8%) had a 1707delT variant, 3 samples (6%) had a 2291G>A SNP, 2 samples (4%) had a 1023 C>T SNP, 2 ...",80,329,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100 C>T,"...carry a heterozygous 1846 G>A SNP, a heterozygous 100 C>T SNP, and a heterozygous variant of the CYP...",86,166,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100 C>T,"...carry a heterozygous 1846 G>A SNP, a heterozygous 100 C>T SNP, and a heterozygous variant of the CYP...",86,166,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
77 G>A,"...4 insC [CYP2D6*21], 2587_2590 delGACT [CYP2D6*38],77 G>A[CYP2D6*43],1716 G>A [CYP2D6*45], 77 G>A and...",99,1715,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1716 G>A,"...7 G>A[CYP2D6*43],1716 G>A [CYP2D6*45], 77 G>A and 1716 G>A [CYP2D6*46],3259_3260 insGT [CYP2D6*42], ...",99,1766,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
3201 C>T,"...1716 G>A [CYP2D6*46],3259_3260 insGT [CYP2D6*42], 3201 C>T [CYP2D6*56], and 2291 G>A [CYP2D6*59]). F...",99,1816,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2291 G>A,"...3260 insGT [CYP2D6*42], 3201 C>T [CYP2D6*56], and 2291 G>A [CYP2D6*59]). For the RETINA assays for w...",99,1842,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1846 G>A,Examination of heterozygous 1846 G>A alleles by Sanger Sequencing in liver sam...,117,29,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1758 G>T,"*8	1758 G>T, 2850 C>T",142,4,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*11	883 G>C, 2850 C>T",145,14,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"*17	1023 C>T, 2850 C>T",148,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1023 C>T,"*17	1023 C>T, 2850 C>T",148,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*35	31 G>A, 2850 C>T",154,13,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
100 C>T,"*36	100 C>T, exon 9 conversion with CYP2D7",155,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*41	2850 C>T, 2988 G>A",158,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*41	2850 C>T, 2988 G>A",158,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2988 G>A,"*41	2850 C>T, 2988 G>A",158,15,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*45	1716 G>A, 2850 C>T",162,15,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
77 G>A,"*46	77 G>A, 1716 G>A, 2850 C>T",163,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2291 G>A,"*59	2291 G>A, 2850 C>T",165,5,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*59	2291 G>A, 2850 C>T",165,15,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*59	2291 G>A, 2850 C>T",165,15,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
2850 C>T,"*59	2291 G>A, 2850 C>T",165,15,Pharmacogenomics_J_2014_Dec_1_14(6)_564-572.txt
1545 C>T,... schizophrenia subjects: V. Association of CYP1A2 1545 C>T polymorphism Pharmacogenomics J 2007 7 5 ...,156,170,Pharmgenomics_Pers_Med_2014_Oct_13_7_317-328.txt
720006	G->T,P5c1	chrII: 720006	G->T,57,13,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
545020	C-> A,chrV: 545020	C-> A,72,8,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
25655	G-> A,chrXIII: 25655	G-> A,78,11,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
381852	G-> A,chrXIV: 381852	G-> A,84,10,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
299460	C-> A,S8c2	chrXIV: 299460	C-> A,88,14,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
897313	G-> A,chrIV: 897313	G-> A,94,9,PLoS_Biol_2015_May_26_13(5)_e1002155.txt
188 D>V,"... Methods, S7A Fig.). As a result, we identified 3,188 D>V genes compared with 1,352 V>D genes (Fig. ...",115,428,PLoS_Comput_Biol_2015_Jan_23_11(1)_e1004032.txt
181G>A,...B) c.58+181G is evolutionarily conserved and c.58+181G>A disrupts a consensus binding sequence for t...,61,382,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
181G>A,...B) c.58+181G is evolutionarily conserved and c.58+181G>A disrupts a consensus binding sequence for t...,61,382,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
181G>A,"...Nsplice, GeneSplicer, Net2Gene) predict that c.58+181G>A does not affect splicing of the adjacent sp...",67,1187,PLoS_Genet_2011_Sep_29_7(9)_e1002307.txt
151C>T,"...60A>C (MAF = 3.5%, tagging the haplotype-560A>C, −151C>T, *181A>G) and −310G>A (MAF = 16%), associat...",121,855,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
310G>A,"...ging the haplotype-560A>C, −151C>T, *181A>G) and −310G>A (MAF = 16%), associated with minor increase...",121,877,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
560A>C,"...nts in the promoter and coding regions of APOA1 (−560A>C MAF = 3.5%, tagging the haplotype-560A>C, −...",172,76,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
-560A>C,"...f APOA1 (−560A>C MAF = 3.5%, tagging the haplotype-560A>C, −151C>T, *181A>G, and −310G>A MAF = 16%) ...",172,116,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
-560A>C,"...f APOA1 (−560A>C MAF = 3.5%, tagging the haplotype-560A>C, −151C>T, *181A>G, and −310G>A MAF = 16%) ...",172,116,PLoS_Genet_2012_Nov_29_8(11)_e1003063.txt
2278C>T,"...P3C selectively amplify the mutated (maternal) c. 2278C>T allele (Figure 2C). As expected, the mutan...",164,530,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,...ATRIP. The father has a WT sequence at this site. 2278C>T generates a primary stop codon predicting ...,263,295,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
2278C>T,...ATRIP. The father has a WT sequence at this site. 2278C>T generates a primary stop codon predicting ...,263,295,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
3477G>T,...19-8BI. RT-PCR sequencing revealed a heterozygous 3477G>T mutational change in both patients causing...,275,182,PLoS_Genet_2012_Nov_8_8(11)_e1002945.txt
67334934 G>T,...ion on the peaks for T and G are the T or G at g. 67334934 G>T. (F) Summary of the detection of diff...,26,1680,PLoS_Genet_2013_Jan_24_9(1)_e1003183.txt
21U>G,"...nth to adenosine (21U>A transgenes) or guanosine (21U>G transgenes), such that the transgenes encode...",238,548,PLoS_Genet_2013_Mar_14_9(3)_e1003392.txt
21U>G,"...nth to adenosine (21U>A transgenes) or guanosine (21U>G transgenes), such that the transgenes encode...",238,548,PLoS_Genet_2013_Mar_14_9(3)_e1003392.txt
0	G>C,Chr14:60974363	----	0.002	0	G>C	----	3.77,82,28,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
0	G>C,Chr14:60974363	----	0.002	0	G>C	----	3.77,82,28,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
0	G>T,Chr14:60977954	rs139302405	0.002	0	G>T	Ser242Ile	5.19,112,35,PLoS_Genet_2014_May_29_10(5)_e1004372.txt
600 C>A,"...ee J , Kim CH , Lee S  (2014 ) The polymorphism (−600 C>A) of CpG methylation site at the promoter r...",1233,62,PLoS_Genet_2014_Nov_6_10(11)_e1004735.txt
17704	C>T,Q97Stop	17704	C>T	n/a	n/a	Severe	2.4	n/a	n/a	n/a,34,9,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17761	C>A,R116R	17761	C>A	5–7	3–6	Mild/Moderate	2.0	96±5	96±8	I,35,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17778	G>T,Q121H	17778	G>T	n/a	18	Mild	7.0	26±3	110±15	II,36,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17756	G>T,G114V	17756	G>T	2	<1–1	Moderate/Severe	62.6	n/a	n/a	n/a,44,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17783	C>G,S123C	17783	C>G	n/a	15	Mild	69.5	n/a	n/a	n/a,45,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17756	G>C,G114A	17756	G>C	4–5	5–13	Mild/Moderate	71.3	n/a	n/a	n/a,46,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17704	C>G,Q97E	17704	C>G	<1	<1	Severe	75.3	63.5±5.8	5.9±2	n/a,47,6,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17704	C>A,Q97K	17704	C>A	n/a	<1	Severe	83.8	60±0.2	2.9±1	n/a,48,6,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
17756	G>A,G114E	17756	G>A	8	4–7	Mild/Moderate	93.1	n/a	n/a	n/a,50,7,PLoS_Genet_2016_May_26_12(5)_e1006082.txt
676T>C,"...stigation were selected. Four promoter variants (−676T>C, −472T>C, −469C>G, −276C>T), and the non-sy...",47,205,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
276C>T,"...ur promoter variants (−676T>C, −472T>C, −469C>G, −276C>T), and the non-synonymous (ns) substitution ...",47,232,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
469C>G,"...The other investigated COLEC11 variants −472T>C, −469C>G, −276C>T were not associated with urinary s...",65,1300,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
276C>T,"...d COLEC11 haplotypes including −472T>C, −469C>G, −276C>T and +48912G>A are summarized in Table 2. Si...",99,87,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
276C>T,"...d COLEC11 haplotypes including −472T>C, −469C>G, −276C>T and +48912G>A are summarized in Table 2. Si...",99,87,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
48912G>A,"...plotypes including −472T>C, −469C>G, −276C>T and +48912G>A are summarized in Table 2. Six haplotypes...",99,99,PLoS_Negl_Trop_Dis_2015_Mar_25_9(3)_e0003647.txt
871G>A,"...haroen C , Nuchprayoon I  (2005 ) G6PD Viangchan (871G>A) is the most common G6PD-deficient variant ...",269,59,PLoS_Negl_Trop_Dis_2015_Mar_6_9(3)_e0003602.txt
4741G>C,"...iated with higher CRP levels for SNPs 1919A>T and 4741G>C, but associated with lower CRP levels for ...",9,698,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"...>C, but associated with lower CRP levels for SNPs 2667G>C and 3872C>T. SNP 2667G>C was individually ...",9,753,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,...ciated with lower CRP levels for SNPs 2667G>C and 3872C>T. SNP 2667G>C was individually associated w...,9,765,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,"...SNP 2667G>C, Casas et al.,[19] which included SNP 3014G>A, also examined associations with cardiovas...",17,432,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1440C>T,"...tagSNPs polymorphic in EAs, included a triallelic 1440C>T>A (rs3091244) and a commonly studied rare ...",36,497,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"...1440C>T>A (rs3091244) and a commonly studied rare 2667G>C. (2.) Additionally, we conducted a compreh...",36,547,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4362G>C,"...ional SNPs with low minor allele frequency (MAF) [4362G>C and 5606G>T]. (3.) Finally, the Internatio...",36,808,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4362G>C,"...ional SNPs with low minor allele frequency (MAF) [4362G>C and 5606G>T]. (3.) Finally, the Internatio...",36,808,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,...vious LD analyses[9] showed that SNPs 3872C>T and 5237A>G together serve as a proxy so these two SNP...,36,1156,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1919A>T,...ol women and men (Table 3). The minor alleles for 1919A>T and 3014G>A were in high pairwise LD (r2>0...,49,799,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1919A>T,...ol women and men (Table 3). The minor alleles for 1919A>T and 3014G>A were in high pairwise LD (r2>0...,49,799,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"...e in high pairwise LD (r2>0.95), whereas 2667G>C, 3872C>T, 4741G>C, and 5237A>G were not in high LD ...",49,872,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,"...(r2>0.95), whereas 2667G>C, 3872C>T, 4741G>C, and 5237A>G were not in high LD (r2<0.30)",49,894,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1919A>T,1919A>T	rs1417938,76,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,2667G>C	rs1800947,82,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4741G>C,4741G>C	rs3093068,100,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,"...men and men (Table 4). Under the same model, SNPs 2667G>C and 3872C>T were associated with 22–37% lo...",130,525,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
4741G>C,"... associated with 22–37% lower CRP levels, whereas 4741G>C was associated with ∼40% higher CRP levels...",130,599,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1919A>T,... was associated with ∼40% higher CRP levels. SNPs 1919A>T and 3014G>A were associated with approxima...,130,656,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,...ted with ∼40% higher CRP levels. SNPs 1919A>T and 3014G>A were associated with approximately 20% hig...,130,668,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
1919A>T,1919A>T	236/466	0.90 (0.70–1.14)	0.37	1.22	0.009	2...,135,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
2667G>C,2667G>C	241/482	1.57 (1.01–2.44)	0.047	0.63	0.01	2...,136,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
5237A>G,5237A>G	241/476	0.93 (0.72–1.19)	0.56	0.98	0.86	24...,140,1,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3014G>A,"...% (Table 5). H1 with minor alleles of 1919A>T and 3014G>A and major alleles of all others, was the m...",148,111,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
-717A>G,...was in high LD with another commonly reported SNP -717A>G (rs2794521),199,62,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
-717A>G,...was in high LD with another commonly reported SNP -717A>G (rs2794521),199,62,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
-717A>G,...was in high LD with another commonly reported SNP -717A>G (rs2794521),199,62,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"... with CRP levels in the Physicians' Health Study, 3872C>T individually was associated with lower CRP...",203,797,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3872C>T,"...ctivity, and CRP levels.[17] The major alleles of 3872C>T and 5237A>G together serve as a proxy for ...",205,425,PLoS_ONE_2008_Jan_2_3(1)_e1395.txt
3787730 A>G,...am and downstream. Only one SNP in KCNE1 (LQT5; rs3787730 A>G; frequency allele A: 31.7%; β≈−1.6 ms/...,71,470,PLoS_One_2009_Jul_9_4(7)_e6138.txt
17A>T,"...genotyping assays, the probes for the mutations CD17A>T and CD24T>A were redesigned (MSAW method iii...",89,74,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
24T>A,"... initial set, the shorter probes for genotyping CD24T>A had a calculated Tm that was about 3°C lower...",89,226,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
24T>A,...he wild-type probe. Shorter probes for mutation CD24T>A resulted in heterozygote ratios of about 0.5...,89,444,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
24T>A,...he wild-type probe. Shorter probes for mutation CD24T>A resulted in heterozygote ratios of about 0.5...,89,444,PLoS_ONE_2009_Mar_11_4(3)_e4808.txt
258+2T>C,"... a very low, but correct residual splicing of the 258+2T>C SBDS transcript[11]–[13]. To date, there ...",17,864,PLoS_One_2009_Sep_17_4(9)_e7084.txt
1555A>G,... Fig 1A). Fig 1B depicts the homoplasmic mutation 1555A>G detected in the mitochondrial MTRNR1 gene ...,28,902,PLoS_One_2010_Jul_26_5(7)_e11804.txt
71G>A,....0011804.g001Figure 1 APEX detection of the W24X (71G>A) mutation in GJB2 and the 1555A>G mutation i...,30,71,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1555A>G,...tion of the W24X (71G>A) mutation in GJB2 and the 1555A>G mutation in MTRNR1,30,103,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2-2A>G,... in SLC26A4; two others carried splice variant IVS2-2A>G (of unknown clinical significance) in the p...,33,864,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2-2A>G,GJB2; R127H*	2	SLC26A4; V609G/SLC26A5; IVS2-2A>G**	1,43,47,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1555A>G,... gene. A third individual was homoplasmic for the 1555A>G mutation of the MTRNR1 gene that encodes t...,62,289,PLoS_One_2010_Jul_26_5(7)_e11804.txt
919-2A>G,...nts. The array identified one SLC26A4 homozygous (919-2A>G/919-2A>G) and two compound heterozygous g...,69,1283,PLoS_One_2010_Jul_26_5(7)_e11804.txt
1-2A>G,"...r 16% of Pendred disease-causing alleles [21], IVS1-2A>G is a rare splice variant, the clinical sign...",69,1507,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2-2A>G,...s). Four individuals were heterozygous for the IVS2-2A>G variant in SLC26A5. Similar to IVS1-2A>G in...,69,2563,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2-2A>G,...s). Four individuals were heterozygous for the IVS2-2A>G variant in SLC26A5. Similar to IVS1-2A>G in...,69,2563,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2-2A>G,...stük K Zordania R Joost K  2009 Splice variant IVS2-2A>G in the SLC26A5 (Prestin) gene in five Eston...,113,74,PLoS_One_2010_Jul_26_5(7)_e11804.txt
2-2A>G,...stük K Zordania R Joost K  2009 Splice variant IVS2-2A>G in the SLC26A5 (Prestin) gene in five Eston...,113,74,PLoS_One_2010_Jul_26_5(7)_e11804.txt
47A>G,"...males. However, two novel intronic variants, c.52-47A>G and c.105-179G>T, were identified in FMR1 (T...",66,153,PLoS_One_2010_Mar_5_5(3)_e9476.txt
179G>T,Intron 2	c.105-179G>T	0.01	1.06	1/51,71,16,PLoS_One_2010_Mar_5_5(3)_e9476.txt
179G>T,Intron 2	c.105-179G>T	0.01	1.06	1/51,71,16,PLoS_One_2010_Mar_5_5(3)_e9476.txt
639 A>G,BB1	British	639 A>G	N102S	1	1	8,37,13,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,Q	American	639 A>G	N102S	1	1	8,39,12,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,Q	American	639 A>G	N102S	1	1	8,39,12,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,Q	American	639 A>G	N102S	1	1	8,39,12,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,Y	German	639 A>G	N102S	1	1	8,41,10,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,Y	German	639 A>G	N102S	1	1	8,41,10,PLoS_One_2010_May_21_5(5)_e10760.txt
639 A>G,1	Irish	639 A>G	N102S	1	1	10,42,9,PLoS_One_2010_May_21_5(5)_e10760.txt
689 A>G,F105	Spanish?-Canadian	689 A>G	R119G	1	1	7,56,24,PLoS_One_2010_May_21_5(5)_e10760.txt
695 C>G,2	Egyptian	695 C>G	L121V	1	1	10,58,12,PLoS_One_2010_May_21_5(5)_e10760.txt
999 T>G,F1	Finnish	999 T>G	V122G	1	1	this report,62,12,PLoS_One_2010_May_21_5(5)_e10760.txt
999 T>G,F1	Finnish	999 T>G	V122G	1	1	this report,62,12,PLoS_One_2010_May_21_5(5)_e10760.txt
858 C>T,F115	Scottish	858 C>T	T175I	1	2	7,65,15,PLoS_One_2010_May_21_5(5)_e10760.txt
858 C>T,J	Hungarian-American	858 C>T	T175I	1	2	9,66,22,PLoS_One_2010_May_21_5(5)_e10760.txt
858 C>T,J	Hungarian-American	858 C>T	T175I	1	2	9,66,22,PLoS_One_2010_May_21_5(5)_e10760.txt
863 G>C,T	American	863 G>C	G177R	1	2	8,67,12,PLoS_One_2010_May_21_5(5)_e10760.txt
863 G>C,T	American	863 G>C	G177R	1	2	8,67,12,PLoS_One_2010_May_21_5(5)_e10760.txt
863 G>A,Z	Kosovar	863 G>A	G177R	1	2	9,69,11,PLoS_One_2010_May_21_5(5)_e10760.txt
863 G>A,Z	Kosovar	863 G>A	G177R	1	2	9,69,11,PLoS_One_2010_May_21_5(5)_e10760.txt
3425C>G,ALMS1 mutation*	c.[8938C>T]	c.[3425C>G]	c.[3425C>G]	c. [2164A>T],25,32,PLoS_One_2011_Apr_26_6(4)_e19081.txt
3425C>G,+[8938C>T]	+[3425C>G]	+[3425C>G]	+[11313_11316delTAGA],26,15,PLoS_One_2011_Apr_26_6(4)_e19081.txt
3425C>G,+[8938C>T]	+[3425C>G]	+[3425C>G]	+[11313_11316delTAGA],26,15,PLoS_One_2011_Apr_26_6(4)_e19081.txt
-866G>A,...Related Metabolic Traits: Focus on the Functional -866G>A Promoter Variant (rs659366). J Obes doi:10...,236,159,PLoS_One_2011_Dec_27_6(12)_e29650.txt
-866G>A,...Related Metabolic Traits: Focus on the Functional -866G>A Promoter Variant (rs659366). J Obes doi:10...,236,159,PLoS_One_2011_Dec_27_6(12)_e29650.txt
590C>T,"...between the polymorphisms of IL-4 gene promoter (−590C>T), IL-13 coding region (R130Q) and IL-16 gen...",229,197,PLoS_One_2011_Feb_28_6(2)_e16522.txt
84G>A,... Dong X    2010 Lack of association between nNOS −84G>A polymorphism and risk of infantile hypertrop...,158,96,PLoS_One_2011_Jul_15_6(7)_e22035.txt
84G>A,... Dong X    2010 Lack of association between nNOS −84G>A polymorphism and risk of infantile hypertrop...,158,96,PLoS_One_2011_Jul_15_6(7)_e22035.txt
77G>A,"...6G) and a variant in the 5′ untranslated region (−77G>A) have been found in the Soat1 gene, and indi...",82,1194,PLoS_One_2011_Oct_14_6(10)_e25344.txt
5G>C,5	Atypical	c.5210+5G>C		Splice site	Exon 23 skipping	Deterioration o...,64,19,PLoS_One_2011_Sep_13_6(9)_e24511.txt
5G>C,5	Atypical	c.5210+5G>C		Splice site	Exon 23 skipping	Deterioration o...,64,19,PLoS_One_2011_Sep_13_6(9)_e24511.txt
5G>C,...ults are shown in Table S3. One variation (c.5210+5G>C) was predicted as a loss of strength of nativ...,70,363,PLoS_One_2011_Sep_13_6(9)_e24511.txt
5G>C,"...plice site variation, c.5210+5G>C. For the c.5210+5G>C variation, exons 22 and 23 of CHD7 were intro...",170,99,PLoS_One_2011_Sep_13_6(9)_e24511.txt
5G>C,"...plice site variation, c.5210+5G>C. For the c.5210+5G>C variation, exons 22 and 23 of CHD7 were intro...",170,99,PLoS_One_2011_Sep_13_6(9)_e24511.txt
5G>C,"...plice site variation, c.5210+5G>C. For the c.5210+5G>C variation, exons 22 and 23 of CHD7 were intro...",170,99,PLoS_One_2011_Sep_13_6(9)_e24511.txt
7G>A,"...rapping analysis of splice site variation, c.5405-7G>A. For the c.5405-7G>A variation, exon 26 of CH...",176,68,PLoS_One_2011_Sep_13_6(9)_e24511.txt
3243 A>G,...etes due to defects in mitochondrial DNA (mtDNA). 3243 A>G is the mutation most frequently associate...,5,425,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243 A>G,...etes due to defects in mitochondrial DNA (mtDNA). 3243 A>G is the mutation most frequently associate...,5,425,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...D [1], [3]. Besides the frequently reported mtDNA 3243A>G mutation, whose functional significance ha...",8,678,PLoS_One_2012_Apr_19_7(4)_e34956.txt
293T>C,6	HVII	293T>C					-,55,8,PLoS_One_2012_Apr_19_7(4)_e34956.txt
15530 T>C,CYB	15530 T>C	syn				-,57,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14582A>G,ND6	14582A>G	V31A	N	T/1	Benign	-,69,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
16048G>A,HVI	16048G>A					-,70,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
10685G>A,ND4L	10685G>A	syn				-,73,7,PLoS_One_2012_Apr_19_7(4)_e34956.txt
16526G>A,HVI	16526G>A					-,75,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
951G>A,15	RNR1	951G>A					-,76,9,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14502T>C,ND6	14502T>C	I58V	C	T/0.36	Benign	-,80,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
16354C>T,HVI	16354C>T					-,81,6,PLoS_One_2012_Apr_19_7(4)_e34956.txt
5300C>T,"...plex I (46%) (ND1: 4024A>G, 4086C>T; ND2:5093T>C, 5300C>T; ND3: 10373G>A; ND4: 11253T>C, 11447G>A, 1...",92,707,PLoS_One_2012_Apr_19_7(4)_e34956.txt
10373G>A,"...ND1: 4024A>G, 4086C>T; ND2:5093T>C, 5300C>T; ND3: 10373G>A; ND4: 11253T>C, 11447G>A, 11928A>G; ND4L:...",92,721,PLoS_One_2012_Apr_19_7(4)_e34956.txt
11253T>C,"...086C>T; ND2:5093T>C, 5300C>T; ND3: 10373G>A; ND4: 11253T>C, 11447G>A, 11928A>G; ND4L:10685G>A; ND5:1...",92,736,PLoS_One_2012_Apr_19_7(4)_e34956.txt
11253T>C,"...086C>T; ND2:5093T>C, 5300C>T; ND3: 10373G>A; ND4: 11253T>C, 11447G>A, 11928A>G; ND4L:10685G>A; ND5:1...",92,736,PLoS_One_2012_Apr_19_7(4)_e34956.txt
11928A>G,"... 5300C>T; ND3: 10373G>A; ND4: 11253T>C, 11447G>A, 11928A>G; ND4L:10685G>A; ND5:12346C>T, 13135G>A, 1...",92,756,PLoS_One_2012_Apr_19_7(4)_e34956.txt
10685G>A,"...10373G>A; ND4: 11253T>C, 11447G>A, 11928A>G; ND4L:10685G>A; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14...",92,771,PLoS_One_2012_Apr_19_7(4)_e34956.txt
13135G>A,"... 11447G>A, 11928A>G; ND4L:10685G>A; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A...",92,795,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14502T>C,"...; ND5:12346C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A>G), in complex-IV (15%) (CO2:7762...",92,829,PLoS_One_2012_Apr_19_7(4)_e34956.txt
14582A>G,"...6C>T, 13135G>A, 14002A>G; ND6:14365C>T, 14502T>C, 14582A>G), in complex-IV (15%) (CO2:7762G>A; CO3:9...",92,839,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9935T>C,"...), in complex-IV (15%) (CO2:7762G>A; CO3:9803A>G, 9935T>C, 9947G>A, 9548G>A) of the respiratory chai...",92,897,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9935T>C,"...), in complex-IV (15%) (CO2:7762G>A; CO3:9803A>G, 9935T>C, 9947G>A, 9548G>A) of the respiratory chai...",92,897,PLoS_One_2012_Apr_19_7(4)_e34956.txt
9935T>C,"...), in complex-IV (15%) (CO2:7762G>A; CO3:9803A>G, 9935T>C, 9947G>A, 9548G>A) of the respiratory chai...",92,897,PLoS_One_2012_Apr_19_7(4)_e34956.txt
15530T>C,...y chain enzymes followed by complex III (3%) (CYB:15530T>C) and complex V (3%) (ATP8:8562C>G). Withi...,92,991,PLoS_One_2012_Apr_19_7(4)_e34956.txt
385A>G,"...48G>A, 16137A>G, 16354C>T, 16526G>A; HVII:293T>C, 385A>G), followed by RNRs (951G>A, 960delC) and tR...",92,1190,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,"...RNRs (951G>A, 960delC) and tRNAs (TV:1664G>A; TL1:3243A>G) both 6%, and by the NC7 region (3%) (8289...",92,1261,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,...sis of MIDD usually focuses on the search for the 3243A>G mutation in selected diabetic patients aff...,117,88,PLoS_One_2012_Apr_19_7(4)_e34956.txt
3243A>G,...sis of MIDD usually focuses on the search for the 3243A>G mutation in selected diabetic patients aff...,117,88,PLoS_One_2012_Apr_19_7(4)_e34956.txt
8562C>G,.... Only one of the four novel suspected mutations (8562C>G) detected in our population caused an amin...,117,864,PLoS_One_2012_Apr_19_7(4)_e34956.txt
8562C>G,.... Only one of the four novel suspected mutations (8562C>G) detected in our population caused an amin...,117,864,PLoS_One_2012_Apr_19_7(4)_e34956.txt
8562C>G,.... Only one of the four novel suspected mutations (8562C>G) detected in our population caused an amin...,117,864,PLoS_One_2012_Apr_19_7(4)_e34956.txt
8562C>G,.... Only one of the four novel suspected mutations (8562C>G) detected in our population caused an amin...,117,864,PLoS_One_2012_Apr_19_7(4)_e34956.txt
11573156 C>G,"...e functionality of two PLA2G2A non-coding SNPs, rs11573156 C>G and rs3767221 T>G where the rare alle...",7,274,PLoS_One_2012_Jul_17_7(7)_e41139.txt
11573156 C>G,"...e functionality of two PLA2G2A non-coding SNPs, rs11573156 C>G and rs3767221 T>G where the rare alle...",7,274,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T>G,"...two PLA2G2A non-coding SNPs, rs11573156 C>G and rs3767221 T>G where the rare alleles have been previ...",7,293,PLoS_One_2012_Jul_17_7(7)_e41139.txt
11573156 C>G,...ividuals homozygous for the common C allele for rs11573156 C>G (NC_000001.10:g20306146G>C) in the 5′...,24,386,PLoS_One_2012_Jul_17_7(7)_e41139.txt
11573156 C>G,...ividuals homozygous for the common C allele for rs11573156 C>G (NC_000001.10:g20306146G>C) in the 5′...,24,386,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T>G,"...levels (p = 1.9×10−14). For the second variant, rs3767221 T>G (NC_000001.10:g20301781A>C) in the 3′U...",24,567,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T>G,Rs3767221 T>G is Associated with Altered PLA2G2A Pro...,41,3,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T >G,... 4 Luciferase Assay Activity Analysis Comparing rs3767221 T >G,44,90,PLoS_One_2012_Jul_17_7(7)_e41139.txt
11573156 C>G,Rs11573156 C>G is Associated with Alternative Splici...,52,3,PLoS_One_2012_Jul_17_7(7)_e41139.txt
11573156 C >G,... 6 Luciferase Assay Activity Analysis Comparing rs11573156 C >G,55,90,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T>G,There is strong evidence to suggest that rs3767221 T>G in the 3′UTR of PLA2G2A is also functi...,88,44,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T>G,There is strong evidence to suggest that rs3767221 T>G in the 3′UTR of PLA2G2A is also functi...,88,44,PLoS_One_2012_Jul_17_7(7)_e41139.txt
3767221 T>G,There is strong evidence to suggest that rs3767221 T>G in the 3′UTR of PLA2G2A is also functi...,88,44,PLoS_One_2012_Jul_17_7(7)_e41139.txt
11573156 C>G,The effects of rs11573156 C>G on gene expression was assessed using...,159,18,PLoS_One_2012_Jul_17_7(7)_e41139.txt
11573156 C>G,The effects of rs11573156 C>G on gene expression was assessed using...,159,18,PLoS_One_2012_Jul_17_7(7)_e41139.txt
325C>T,212	340	no	n.a.	MT	exon1	325C>T	Q109X	exon1	325C>T	Q109X,26,26,PLoS_One_2012_Mar_20_7(3)_e33667.txt
325C>T,212	340	no	n.a.	MT	exon1	325C>T	Q109X	exon1	325C>T	Q109X,26,45,PLoS_One_2012_Mar_20_7(3)_e33667.txt
4A>G,262	586	yes	n.a.	n.a.	intron5	IVS5 −4A>G	?	-	-	-,31,37,PLoS_One_2012_Mar_20_7(3)_e33667.txt
4A>G,262	586	yes	n.a.	n.a.	intron5	IVS5 −4A>G	?	-	-	-,31,37,PLoS_One_2012_Mar_20_7(3)_e33667.txt
4A>G,162*	131	yes	n.a.	n.a.	intron 5	IVS5 −4A>G	?	-	-	-,32,39,PLoS_One_2012_Mar_20_7(3)_e33667.txt
4A>G,...entified in the examined PCD patients were: IVS5 −4A>G and 3′UTR+(195–205)del. No SNPs were reported...,67,88,PLoS_One_2012_Mar_20_7(3)_e33667.txt
5-4A>G,"...sed on the above observations, we assumed that IVS5-4A>G did not represent a causative PCD mutation....",67,1157,PLoS_One_2012_Mar_20_7(3)_e33667.txt
5-4A>G,"...sed on the above observations, we assumed that IVS5-4A>G did not represent a causative PCD mutation....",67,1157,PLoS_One_2012_Mar_20_7(3)_e33667.txt
52A>G,"...as not pursued further, given that a heterozygous 52A>G was found in only one patient with no other ...",127,943,PLoS_One_2012_Mar_20_7(3)_e33667.txt
52A>G,"...as not pursued further, given that a heterozygous 52A>G was found in only one patient with no other ...",127,943,PLoS_One_2012_Mar_20_7(3)_e33667.txt
325C>T,Number of chromosomes with 325C>T (Q109X)		1	0	2	0	3,173,28,PLoS_One_2012_Mar_20_7(3)_e33667.txt
1068G>A,Number of chromosomes with 1068G>A (W356X)		0	0	1	0	1,174,28,PLoS_One_2012_Mar_20_7(3)_e33667.txt
677C>T,"...ylation (χ2 = 8.82, p = 0.003) and maternal MTHFR 677C>T genotype with IGF2 methylation (χ2 = 2.77, ...",5,1878,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677C>T,"...ylation (χ2 = 8.82, p = 0.003) and maternal MTHFR 677C>T genotype with IGF2 methylation (χ2 = 2.77, ...",5,1878,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677C>T,...ne report suggests that maternal and infant MTHFR 677C>T does not affect cord blood methylation of t...,12,931,PLoS_One_2012_Mar_30_7(3)_e33290.txt
80G>A,"...), FOLH1 1561C>T (rs202676), CβS 644 bp ins, RFC1 80G>A (rs1051266) and SHMT 1420C>T (rs1979277)) we...",37,215,PLoS_One_2012_Mar_30_7(3)_e33290.txt
80G>A,"...), FOLH1 1561C>T (rs202676), CβS 644 bp ins, RFC1 80G>A (rs1051266) and SHMT 1420C>T (rs1979277)) we...",37,215,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1420C>T,"..., CβS 644 bp ins, RFC1 80G>A (rs1051266) and SHMT 1420C>T (rs1979277)) were determined using standar...",37,242,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1420C>T,"..., CβS 644 bp ins, RFC1 80G>A (rs1051266) and SHMT 1420C>T (rs1979277)) were determined using standar...",37,242,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66 G>A,Multipleł	Global	Infant MTRR 66 G>A*	117	−0.033	0.015	0.026	0.083	0.014	0.018	−...,82,30,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66 G>A,Univariate	IGF2 Site 3	Infant MTRR 66 G>A*	382	−0.706	0.498	0.157	0.005	0.497	0.156	−...,88,36,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677 C>T,Maternal MTHFR 677 C>T‡		1.286	0.478	0.008		0.460	0.006	0.214,95,18,PLoS_One_2012_Mar_30_7(3)_e33290.txt
1561C>T,Univariate	IGFBP3 Site 2	Maternal GCPII 1561C>T*	121	0.889	0.353	0.013	0.051	0.378	0.020	0...,98,41,PLoS_One_2012_Mar_30_7(3)_e33290.txt
80G>A,"RFC1 80G>A	IGFBP3 Site 4	94	6.98	6.33, 8.01	158	7.50	6....",131,6,PLoS_One_2012_Mar_30_7(3)_e33290.txt
80G>A,"RFC1 80G>A	IGFBP3 Site 4	94	6.98	6.33, 8.01	158	7.50	6....",131,6,PLoS_One_2012_Mar_30_7(3)_e33290.txt
80G>A,"RFC1 80G>A	IGFBP3 Site 4	94	6.98	6.33, 8.01	158	7.50	6....",131,6,PLoS_One_2012_Mar_30_7(3)_e33290.txt
677C>T,"MTHFR 677C>T	IGF2 Site 2	51	50.46	48.37, 53.91	80	51.74	...",135,7,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,...et al (2010) [59] reported no effects of the MTRR 66G>A variant on p16INK4A hypermethylation in the ...,157,2540,PLoS_One_2012_Mar_30_7(3)_e33290.txt
66G>A,"...as inversely associated with carriage of the MTRR 66G>A variant [60]. In the present study, both vit...",157,2774,PLoS_One_2012_Mar_30_7(3)_e33290.txt
11187870 G>C,... another unreported potentially functional SNP (rs11187870 G>C) of PLCE1 in a hospital-based case-co...,6,315,PLoS_One_2012_Mar_6_7(3)_e31932.txt
2274223A>G,"...e reported a shared susceptible locus at 10q23 (rs2274223A>G, exon 26) in the PLCE1 gene associated ...",19,479,PLoS_One_2012_Mar_6_7(3)_e31932.txt
2274223A>G,"...not shown). As a result, we genotyped two SNPs (rs2274223A>G and rs11187870G>C) of PLCE1 using genom...",28,874,PLoS_One_2012_Mar_6_7(3)_e31932.txt
3331G>A,"... (rs5742938, c. −21+639G>A; and rs13404927, c.699+3331G>A), one in MLH1 (rs13320360, c.546-191T>C), ...",204,1129,PLoS_One_2012_May_18_7(5)_e36962.txt
191T>C,"...7, c.699+3331G>A), one in MLH1 (rs13320360, c.546-191T>C), and one in MLH3 (rs28756991, Arg797His, c...",204,1170,PLoS_One_2012_May_18_7(5)_e36962.txt
2A>G,"...und heterozygous c.802-8_810del17insGC and c.1091-2A>G mutations of the CYP4V2 gene, known as geneti...",5,1458,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,"...7insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_810del17insGC, c.1091-2A>G	c.802-8_81...",76,147,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,"...17insGC, c.1091-2A>G	c.802-8_810del17insGC	c.1091-2A>G	c.802-8_810del17insGC	–	–	c.802-8_810del17ins...",76,216,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,"...17insGC, c.1091-2A>G	c.802-8_810del17insGC	c.1091-2A>G	c.802-8_810del17insGC	–	–	c.802-8_810del17ins...",76,216,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,....802-8_810del17insGC	c.802-8_810del17insGC	c.1091-2A>G,76,320,PLoS_One_2012_May_31_7(5)_e33673.txt
7C>T,...n the fourth generation. Intronic variation c.802-7C>T is non-pathogenic,96,385,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,...l analysis of exome sequencing showed that c.1091-2A>G in CYP4V2 was first carried by the 3 patients...,109,212,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,"...the mutations identified in this pedigree, c.1091-2A>G of CYP4V2 was predicted to disrupt the splici...",111,57,PLoS_One_2012_May_31_7(5)_e33673.txt
2A>G,"...the mutations identified in this pedigree, c.1091-2A>G of CYP4V2 was predicted to disrupt the splici...",111,57,PLoS_One_2012_May_31_7(5)_e33673.txt
2298881C>A,"Three ERCC1 functional SNPs (rs2298881C>A, rs3212986C>A and rs11615G>A) and two X...",11,32,PLoS_One_2012_Nov_15_7(11)_e49308.txt
3212961A>C,"... between the ERCC1 rs11615T>C, rs3212986C>A and rs3212961A>C polymorphisms and cancer risk [16], onl...",176,1015,PLoS_One_2012_Nov_15_7(11)_e49308.txt
11615T>C,"...sk of gastric cancer, both of which studied the rs11615T>C only in a relatively small Italy populati...",176,1166,PLoS_One_2012_Nov_15_7(11)_e49308.txt
2R > S,"... conditions, when the matrix fulfills the formula 2R > S+T and T > R >P> S, the game can be defined ...",53,320,PLoS_One_2012_Nov_7_7(11)_e48794.txt
2578C>A,"...olymorphisms that may influence VEGF expression: −2578C>A (rs699947), −1154G>A (rs1570360), −634G>C ...",16,1033,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"...002Table 2 The frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphisms between...",42,81,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"... The frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphisms between control s...",42,91,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,"...cies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T polymorphisms between control subjects and ...",42,103,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,VEGF −2578C>A,44,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,VEGF 936C>T,62,6,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"...o evaluate the frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T and KDR −604T>C (rs20...",70,232,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,"... the frequencies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T and KDR −604T>C (rs2071559), 11...",70,242,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,"...cies of the VEGF −2578C>A, −1154G>A, −634G>C, and 936C>T and KDR −604T>C (rs2071559), 1192G>A (rs230...",70,254,PLoS_One_2012_Oct_12_7(10)_e47158.txt
604T>C,"...e.0047158.t003Table 3 The frequencies of the KDR −604T>C, 1192G>A, and 1719T>A polymorphisms between...",72,70,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1719T>A,"... The frequencies of the KDR −604T>C, 1192G>A, and 1719T>A polymorphisms between control subjects and...",72,91,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,VEGF −2578C>A,101,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,VEGF −1154G>A,107,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,VEGF −1154G>A,107,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,VEGF −634G>C,113,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,VEGF −634G>C,113,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1719T>A,KDR 1719T>A,144,5,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,VEGF −634G>C,192,7,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1192G>A,KDR 1192G>A,210,5,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1719T>A,KDR 1719T>A,216,5,PLoS_One_2012_Oct_12_7(10)_e47158.txt
2578C>A,"We used following primers: VEGF −2578C>A polymorphism, forward 5′-GGA TGG GGC TGA C...",227,34,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1154G>A,"...bp (C allele) or 326 bp (A allele) product; VEGF −1154G>A polymorphism, forward 5′-CGC GTG TCT CTG G...",227,214,PLoS_One_2012_Oct_12_7(10)_e47158.txt
936C>T,"...TCG-3′, that amplifies a 204 bp product; and VEGF 936C>T polymorphism, forward 5′-AAG GAA GAG GAG AC...",227,527,PLoS_One_2012_Oct_12_7(10)_e47158.txt
634G>C,The VEGF −2578C>A and −634G>C polymorphisms were identified by digesting ...,229,24,PLoS_One_2012_Oct_12_7(10)_e47158.txt
1192G>A,"...>C, and 936C>T polymorphisms and the KDR −604T>C, 1192G>A, and 1719T>A polymorphisms is shown in Tab...",244,268,PLoS_One_2012_Oct_12_7(10)_e47158.txt
50G>A,....K146E; c.1440A>G resulting in p.P480P; and c.552+50G>A) in the Chinese population [24] and of the v...,19,210,PLoS_One_2013_Aug_15_8(8)_e71096.txt
14C>T,"...stic callus formation. The causative mutation, c.-14C>T in the 5'-untranslated region of IFITM5, was...",7,562,PLoS_One_2013_Aug_20_8(8)_e72337.txt
14C>T,"...stic callus formation. The causative mutation, c.-14C>T in the 5'-untranslated region of IFITM5, was...",7,562,PLoS_One_2013_Aug_20_8(8)_e72337.txt
14C>T,"...ine. Recently, a recurrent mutation in IFITM5 (c.-14C>T) has been found to be responsible for OI typ...",16,495,PLoS_One_2013_Aug_20_8(8)_e72337.txt
14C>T,"...r sequencing, we identified the same mutation (c.-14C>T) in proband 4 (Figure 3). Furthermore, it wa...",69,961,PLoS_One_2013_Aug_20_8(8)_e72337.txt
1308530 T>C,...e entire study cohort was found for the SNP BICF2P1308530 T>C at g.22785650 bp for the T allele (p =...,98,452,PLoS_One_2013_Aug_7_8(8)_e70903.txt
-826C>T,TNFA-308 and NFKBIA (-826C>T and 3’UTRA>G) polymorphisms may play role ...,21,22,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-826 C>T,"...sequences as described previously [32,33]. NFKBIA -826 C>T and 3’UTR A>G polymorphisms were genotype...",42,405,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,...n each case). When genotypic distribution of TNFA -308 G>A polymorphism was compared between cases a...,90,188,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-826 C>T,"...No associations of NFKB1 -94 ins/del, and NFKBIA (-826 C>T and 3’UTR A>G) polymorphisms were observe...",90,583,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,"...sion analysis showed no significant effect of TNFA-308 G>A, NFKB1 -94ATTG ins/del, NFKBIA (-826 C>T ...",125,89,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-826 C>T,NFKBIA -826 C>T polymorphism,140,8,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,TNFA-308 G>A polymorphism,174,6,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-826 C>T,NFKBIA -826 C>T polymorphism,180,9,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-826 C>T,NFKBIA -826 C>T polymorphis,209,8,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-826 C>T,...e disequilibrium (LD) analysis showed that NFKBIA -826 C>T and 3’UTR A>G polymorphisms were in moder...,254,57,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,"Combined risk genotype analysis of TNFA-308 G>A, NFKB1 -94ATTG ins/del and NFKBIA (-826 C...",264,40,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,The MAF of TNFA -308 G>A polymorphism in present study was 7.1% wh...,292,17,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,...dies did not find independent association of TNFA -308 G>A polymorphism with susceptibility to gastr...,293,578,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,...dies did not find independent association of TNFA -308 G>A polymorphism with susceptibility to gastr...,293,578,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-826C>T,"...iation of two functional polymorphisms in NFKBIA (-826C>T and 3’UTRA>G) with ESCC susceptibility, ho...",295,1006,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308 G>A,"...ary, our results suggest independent role of TNFA -308 G>A polymorphism and combined effect of TNFA ...",311,58,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-308G>A,"...Sachan R , Mittal B  (2009 ) Association of TNFA (-308G>A) and IL-10 (-819C>T) promoter polymorphism...",339,73,PLoS_One_2013_Dec_4_8(12)_e81999.txt
12-19G>A,... Mittal B  (2011 ) CASP8 -652 6N del and CASP8 IVS12-19G>A gene polymorphisms and susceptibility/pro...,380,98,PLoS_One_2013_Dec_4_8(12)_e81999.txt
-31G>C,...11 ) Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophage...,381,115,PLoS_One_2013_Dec_4_8(12)_e81999.txt
7+2T>G,IVS7+2T>G	c.441+2T>G	D	skipping of 62 bp at the3′-end...,61,4,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>A,IVS8+2T>Ac	c.547+2T>A	D	skipping of exon 8	r.[442_547del]	mono-alle...,62,18,PLoS_One_2013_Feb_22_8(2)_e57173.txt
16+1G>T,IVS16+1G>T	c.4986+1G>T	D	retention of 65 bp at the5′-...,63,4,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,IVS16−1G>A	c.4987−1G>A	A	skipping of exon 17	r.[4987_507...,64,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,IVS16−1G>A	c.4987−1G>A	A	skipping of exon 17	r.[4987_5074del]	mono-a...,64,19,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,IVS5−2A>Gd	c.476−2A>G	A	skipping of exons 6;up-regulation of Δexons...,69,18,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,IVS21−1G>Af*	c.8755−1G>A	A	skipping of exon 22; skipping of exon22+51 ...,71,21,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4A>G,IVS9−4A>G	c.594−4A>G	A	none	r.[ = ]	bi-allelic	none	p. ...,95,6,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>A,"... been already analyzed in previous studies (c.547+2T>A in BRCA1, and c.476−2A>G, c.7008−2A>T, c.8755...",125,104,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>T,"...dies (c.547+2T>A in BRCA1, and c.476−2A>G, c.7008−2A>T, c.8755−1G>A and c.8954−1_8955delGTTinsAA in ...",125,142,PLoS_One_2013_Feb_22_8(2)_e57173.txt
441+2T>G,"...2], [43]–[45] and 6 not previously characterized (441+2T>G, c.4986+1G>T, c.4987−1G>A, c.5278−2delA, ...",125,257,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>T,"... 6 not previously characterized (441+2T>G, c.4986+1G>T, c.4987−1G>A, c.5278−2delA, c.5332+1G>A in BR...",125,274,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...1G>A, c.5278−2delA, c.5332+1G>A in BRCA1and c.475+1G>A in BRCA2). In particular, BRCA1 c.547+2T>A, c...",125,337,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...1G>A, c.5278−2delA, c.5332+1G>A in BRCA1and c.475+1G>A in BRCA2). In particular, BRCA1 c.547+2T>A, c...",125,337,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>A,"... c.475+1G>A in BRCA2). In particular, BRCA1 c.547+2T>A, c.4987−1G>A and c.5332+1G>A caused the loss ...",125,380,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2T>A,"... c.475+1G>A in BRCA2). In particular, BRCA1 c.547+2T>A, c.4987−1G>A and c.5332+1G>A caused the loss ...",125,380,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...and 21, respectively (Fig. 1A–C), and BRCA2 c.475+1G>A resulted in the loss of exon 5 (Fig. 1D). In ...",125,505,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...at the 5′-end of exon 21) (Fig. 1H), BRCA2 c.8755−1G>A (one lacking exon 22 and another exon 22 plus...",125,1166,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,"...are reported in Table S2. In 2 cases, BRCA2 c.476−2A>G and c.8755−1G>A, cDNA sequence analyses revea...",135,406,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,"...Table S2. In 2 cases, BRCA2 c.476−2A>G and c.8755−1G>A, cDNA sequence analyses revealed maintenance ...",135,422,PLoS_One_2013_Feb_22_8(2)_e57173.txt
11T>G,c.213−11T>G	YES	−100%; S (C)	−100%; S (C)			−4.1%; S (C)...,161,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4A>G,c.594−4A>G	NO	0.0%; NS (C)	+1.5; NS (C)	−1.6%; NS (C)	+1...,163,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
4A>G,c.594−4A>G	NO	0.0%; NS (C)	+1.5; NS (C)	−1.6%; NS (C)	+1...,163,7,PLoS_One_2013_Feb_22_8(2)_e57173.txt
5G>A,c.4986+5G>A	YES	−100%; S (C)	−100%; S (C)	−100%; S (C)		−...,166,8,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,...(BRCA1 c.5278−2delA and BRCA2 c.7008−2A>T; c.8755−1G>A; c.8954−1_8955delGTTinsAA) of more than one a...,176,924,PLoS_One_2013_Feb_22_8(2)_e57173.txt
1G>A,...(BRCA1 c.5278−2delA and BRCA2 c.7008−2A>T; c.8755−1G>A; c.8954−1_8955delGTTinsAA) of more than one a...,176,924,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,"... above, we detected 2 such mutations (BRCA2 c.476−2A>G and c.8755−1G>A). However, quantitative analy...",181,1154,PLoS_One_2013_Feb_22_8(2)_e57173.txt
2A>G,"... above, we detected 2 such mutations (BRCA2 c.476−2A>G and c.8755−1G>A). However, quantitative analy...",181,1154,PLoS_One_2013_Feb_22_8(2)_e57173.txt
-1 Ser->Ala,"..., Tsirigotis D , et al (2008 ) Muscle-specific IRS-1 Ser->Ala transgenic mice are protected from fat...",115,92,PLoS_One_2013_Jan_10_8(1)_e53557.txt
8+27G>A,"...eu), c.3999G>T (p.Leu1333Leu), IVS8+26A>G, and IVS8+27G>A), in the ATP7B gene were observed by scree...",73,227,PLoS_One_2013_Jul_2_8(7)_e66526.txt
-11377 C>G,The common SNP -11377 C>G (rs266729) is located in the promoter r...,27,16,PLoS_One_2013_Jun_24_8(6)_e66808.txt
276G>T,"...between single-nucleotide polymorphisms (+45T>G, +276G>T, −11377C>G, −11391G>A) of adiponectin gene ...",201,128,PLoS_One_2013_Jun_24_8(6)_e66808.txt
11377C>G,"...ingle-nucleotide polymorphisms (+45T>G, +276G>T, −11377C>G, −11391G>A) of adiponectin gene and type ...",201,137,PLoS_One_2013_Jun_24_8(6)_e66808.txt
11377C>G,"...ingle-nucleotide polymorphisms (+45T>G, +276G>T, −11377C>G, −11391G>A) of adiponectin gene and type ...",201,137,PLoS_One_2013_Jun_24_8(6)_e66808.txt
-238G>A,"... , Liu L , Gao T  (2007 ) TNF-alpha gene promoter -238G>A and -308G>A polymorphisms alter risk of ps...",180,75,PLoS_One_2013_May_23_8(5)_e64376.txt
1515	S>F,Left Lateral Occipital Gyrus	48	72	−3.20	13.08	1515	S>F,95,48,PLoS_One_2013_May_3_8(5)_e63220.txt
1554	N>R,...rontal Gyrus/Temporal Pole	35.8	−23.5	−16.1	13.35	1554	N>R,100,66,PLoS_One_2013_May_3_8(5)_e63220.txt
411	N>R,...ight Middle Occipital Gyrus	−16.7	91.5	16.5	12.23	411	N>R,107,52,PLoS_One_2013_May_3_8(5)_e63220.txt
8590T>C,"..., Aherrahrou Z , et al (2005 ) Association of the 8590T>C polymorphism of CYP4A11 with hypertension ...",217,91,PLoS_One_2013_Nov_21_8(11)_e80072.txt
125 G>A,"...A and FY*B, differ by a single base substitution (125 G>A) resulting in the replacement at residue 4...",17,97,PLoS_One_2014_Apr_7_9(4)_e93782.txt
-33T>C,"...esulting in the absence of DARC antigens on RBCs (-33T>C; FyES, erythrocyte-silent) [30]. Although m...",17,479,PLoS_One_2014_Apr_7_9(4)_e93782.txt
125G>A,"...DARC, comprising polymorphic positions −33T>C and 125G>A, was amplified by PCR using the forward pri...",36,1426,PLoS_One_2014_Apr_7_9(4)_e93782.txt
1G>A,"27	MSH2/Intron 13, c.2210+1G>A	Pathogenic, skipping of exon	Normal	Lost	Lost...",118,27,PLoS_One_2014_Apr_7_9(4)_e94170.txt
14G>A,"368	MLH1/Intron 13, c.1558+14G>A; PMS2/Intron 11, c.2006 +6 G>A	MLH1, probabl...",129,28,PLoS_One_2014_Apr_7_9(4)_e94170.txt
803G>A,"...hogenic SNVs (Table 2), the missense mutation, c. 803G>A, of PMCA4 gene had the highest pathogenic p...",63,75,PLoS_One_2014_Aug_13_9(8)_e104790.txt
803G>A,"We evaluated the impact of the mutation, c. 803G>A (p.R268Q), on PMCA4 protein structure (Fig....",78,45,PLoS_One_2014_Aug_13_9(8)_e104790.txt
-418 G>C,...nical Research DesignNo Correlation between TIMP2 -418 G>C Polymorphism and Increased Risk of Cancer...,3,649,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,... evaluate the potential association between TIMP2 -418 G>C polymorphism and cancer risk,8,394,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,...ted no evidence of significant risk between TIMP2 -418 G>C polymorphism and cancer risk in any of th...,14,195,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,The present meta-analysis suggests that the TIMP2 -418 G>C polymorphism may not be involved in predi...,17,51,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,...tigate the possible association between the TIMP2 -418 G>C polymorphism and cancer susceptibility in...,26,189,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,...tigate the possible association between the TIMP2 -418 G>C polymorphism and cancer susceptibility in...,26,189,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,...a-analysis to evaluate the overall association of -418 G>C polymorphism in risk/resistance to the de...,26,749,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,"...valuate the strength of association between TIMP2 -418 G>C polymorphism and cancer risk, pooled ORs ...",39,64,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,...0088184.t001Table 1 Main characteristics of TIMP2 -418 G>C polymorphism included in this meta-analys...,45,72,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,...88184.t002Table 2 Genotypic distribution of TIMP2 -418 G>C gene polymorphism,59,74,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,...88184.t002Table 2 Genotypic distribution of TIMP2 -418 G>C gene polymorphism,59,74,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,Association of TIMP2 -418 G>C polymorphism and overall cancer susceptib...,87,22,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,Association of TIMP2 -418 G>C polymorphism and overall cancer susceptib...,87,22,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,... ORs on overall cancer risk associated with TIMP2 -418 G>C gene polymorphism,93,109,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,...study investigating the association between TIMP2 -418 G>C gene polymorphism and overall cancer risk...,102,113,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,... in the meta-analysis. The results indicated that -418 G>C polymorphism is not significantly associa...,102,299,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,...ibute the susceptibility to cancer risk and TIMP2 -418 G>C analyzed variant do not influence individ...,102,855,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,...h the risk of cancer and suggested that the TIMP2 -418 G>C polymorphism did not contribute increased...,109,374,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,...h the risk of cancer and suggested that the TIMP2 -418 G>C polymorphism did not contribute increased...,109,374,PLoS_One_2014_Aug_19_9(8)_e88184.txt
-418 G>C,...h the risk of cancer and suggested that the TIMP2 -418 G>C polymorphism did not contribute increased...,109,374,PLoS_One_2014_Aug_19_9(8)_e88184.txt
886G>A,c.*886G>A	n/a (3'UTR)	319	M	—	—	0.4	rs146304341,77,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
979G>C,c.*979G>C	n/a (3'UTR)	73	M	0.1	—	0.13	rs182365313,78,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
979G>C,c.*979G>C	n/a (3'UTR)	73	M	0.1	—	0.13	rs182365313,78,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
1012G>C,c.*1012G>C	n/a (3'UTR)	67	—	0.1	—	0.13	rs139566390,79,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
699C>T,c.*699C>T	n/a	32	M	0.9	—	0.5	rs150572228,87,6,PLoS_One_2014_Aug_5_9(8)_e95453.txt
25G>A,"...n two patients each, and the intronic GATA4 c.909+25G>A that was found in 3 patients. We included th...",98,340,PLoS_One_2014_Aug_5_9(8)_e95453.txt
25G>A,"...n two patients each, and the intronic GATA4 c.909+25G>A that was found in 3 patients. We included th...",98,340,PLoS_One_2014_Aug_5_9(8)_e95453.txt
886G>A,...patients. The first patient carried both GATA4 c.*886G>A and TBX1 c.*1074G>A (both maternal in origi...,98,685,PLoS_One_2014_Aug_5_9(8)_e95453.txt
1074G>A,... patient carried both GATA4 c.*886G>A and TBX1 c.*1074G>A (both maternal in origin); the second carr...,98,704,PLoS_One_2014_Aug_5_9(8)_e95453.txt
2435C>T,"...d in two patients. The first carried BOP/SMYD1 c.*2435C>T (paternal), HAND2 c.75_76insGCCGCC, p.A25_...",98,1107,PLoS_One_2014_Aug_5_9(8)_e95453.txt
3+1G>A,...amily with progressive childhood cataracts and IVS3+1G>A CRYBA3/A1 mutations . Mol Vis 16 :2347 –53 ...,129,121,PLoS_One_2014_Dec_17_9(12)_e115406.txt
10K> Pis,...d in the following order: Pis-1≈Pis-V10K≈Pis-F1K/V10K> Pis-F2K/V10K> Pis-F6K/V10K,154,1007,PLoS_One_2014_Dec_4_9(12)_e114453.txt
5G>A,...and to explore the aberrant transcript from c.615+5G>A in the same CD infant,8,493,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...and to explore the aberrant transcript from c.615+5G>A in the same CD infant,8,493,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,"...es supporting the splice-site nature of the c.615+5G>A mutation, and the novel c.1064G>A variation, ...",14,219,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,"...he abnormal mRNA molecule from the mutation c.615+5G>A was not detected yet, making it obscure how t...",21,349,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,"...long with the possible splice-site mutation c.615+5G>A. In this paper, by using an agc1Δ yeast model...",23,184,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,"...ons, i.e. c.851_854delGTAT, c.1638_1660dup, c.615+5G>A and IVS16ins3kb, were screened by PCR/LA-PCR ...",30,169,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...n the left illustrated the screening of the c.615+5G>A mutation by mean of a PCR-RFLP approach. The ...,106,72,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...n the left illustrated the screening of the c.615+5G>A mutation by mean of a PCR-RFLP approach. The ...,106,72,PLoS_One_2014_Feb_21_9(2)_e89267.txt
5G>A,...ation for intron 6 retention in cDNA due to c.615+5G>A in SLC25A13 gene. The retention may lead to p...,134,730,PLoS_One_2014_Feb_21_9(2)_e89267.txt
3435C>T,"...unctional effect of ABCB1 1236C>T, 2677G>T/A, and 3435C>T [27]. The variant haplotypes 1236T-2677A-3...",157,528,PLoS_One_2014_Feb_25_9(2)_e89622.txt
10C>A,...91383391	G	G/T	0.017**	0.025	0.44	0.024	0.56	C	c.-10C>A		5′-ÚTR	1,91,67,PLoS_One_2014_Jul_14_9(7)_e102065.txt
129C>T,...4542378	G	G/A	0.480	0.490	0.80	0.492	0.81	C	c.945+129C>T		intron,96,66,PLoS_One_2014_Jul_14_9(7)_e102065.txt
1-10 C>A,"...ions, as well as one rare variant in the 5′-UTR (c1-10 C>A). The latter was present in 5 patients, a...",117,636,PLoS_One_2014_Jul_14_9(7)_e102065.txt
829C>T,"...gs in ALL treatment, has been associated with SNP 829C>T near the miR-24 binding site in the 3′UTR o...",20,346,PLoS_One_2014_Mar_10_9(3)_e91261.txt
829C>T,"...gs in ALL treatment, has been associated with SNP 829C>T near the miR-24 binding site in the 3′UTR o...",20,346,PLoS_One_2014_Mar_10_9(3)_e91261.txt
94C>A,"...A , Yusoff R , et al (2012 ) Polymorphism of ITPA 94C>A and risk of adverse effects among patients w...",255,99,PLoS_One_2014_Mar_10_9(3)_e91261.txt
3176352 G>C,...OncologyCancer PreventionCancer Risk Factorsp21 rs3176352 G>C and p73 rs1801173 C>T Polymorphisms Ar...,3,401,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,...ionCancer Risk Factorsp21 rs3176352 G>C and p73 rs1801173 C>T Polymorphisms Are Associated with an I...,3,423,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,"...k of ESCC. After Bonferroni correction, for p21 rs3176352 G>C, the pcorrect was still significant. F...",14,350,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,p21 rs3176352 G>C and p73 rs1801173 C>T SNPs are associated with increased ris...,17,29,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,p21 rs3176352 G>C and p73 rs1801173 C>T SNPs are associated with increased ris...,17,29,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,"...rates of repeated analyses were 100% except p21 rs3176352 G>C (158/160, 98.75%). For all SNPs, minor...",51,405,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,...ed SNPs	p21 rs2395655 G>A	p21 rs1059234 C>T	p21 rs3176352 G>C	p21 rs1801270 C>A	p21 rs762623 C>A	p53...,72,58,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,...ed SNPs	p21 rs2395655 G>A	p21 rs1059234 C>T	p21 rs3176352 G>C	p21 rs1801270 C>A	p21 rs762623 C>A	p53...,72,58,PLoS_One_2014_May_12_9(5)_e96958.txt
1042522 G>C,...6352 G>C	p21 rs1801270 C>A	p21 rs762623 C>A	p53 rs1042522 G>C	TP53BP1 rs560191 G>C	p73 rs1801173C>T,72,111,PLoS_One_2014_May_12_9(5)_e96958.txt
1042522 G>C,...6352 G>C	p21 rs1801270 C>A	p21 rs762623 C>A	p53 rs1042522 G>C	TP53BP1 rs560191 G>C	p73 rs1801173C>T,72,111,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,"c MAF: minor allele frequency, p73 rs1801173 C>T MAF is in CHB+JPT population",91,38,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,"c MAF: minor allele frequency, p73 rs1801173 C>T MAF is in CHB+JPT population",91,38,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,p73 rs1801173 C>T,152,7,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,p21 rs3176352 G>C and p73 rs1801173 C>T combinations				...,159,7,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,p21 rs3176352 G>C and p73 rs1801173 C>T combinations				...,159,7,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,"...rmed to correct the p value (pcorrect); for p21 rs3176352 G>C, the pcorrect = 0.096 for CC vs. GG af...",165,313,PLoS_One_2014_May_12_9(5)_e96958.txt
1059234 C>T,"...alyses revealed that the p21 rs2395655 G>A, p21 rs1059234 C>T, p21 rs762623 C>A and p53 rs1042522 G>...",169,392,PLoS_One_2014_May_12_9(5)_e96958.txt
762623 C>A,"...t the p21 rs2395655 G>A, p21 rs1059234 C>T, p21 rs762623 C>A and p53 rs1042522 G>C polymorphisms wer...",169,411,PLoS_One_2014_May_12_9(5)_e96958.txt
1042522 G>C,"...>A, p21 rs1059234 C>T, p21 rs762623 C>A and p53 rs1042522 G>C polymorphisms were not associated with...",169,432,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,"..., adjusted p = 0.0192 for CC vs. GG/GC. For p73 rs1801173 C>T, the pcorrect = 0.202 for CT vs. CC af...",169,684,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,To evaluate the effects of p21 rs3176352 G>C genotypes on ESCC risk according to di...,174,34,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,To evaluate the effects of p21 rs3176352 G>C genotypes on ESCC risk according to di...,174,34,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,To evaluate the effects of p21 rs3176352 G>C genotypes on ESCC risk according to di...,174,34,PLoS_One_2014_May_12_9(5)_e96958.txt
3176352 G>C,... increased risk of ESCC associated with the p21 rs3176352 G>C polymorphism was evident among all sub...,174,246,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,... decreased risk of ESCC associated with the p73 rs1801173 C>T polymorphism was evident among older p...,174,427,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,... decreased risk of ESCC associated with the p73 rs1801173 C>T polymorphism was evident among older p...,174,427,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,... decreased risk of ESCC associated with the p73 rs1801173 C>T polymorphism was evident among older p...,174,427,PLoS_One_2014_May_12_9(5)_e96958.txt
1801173 C>T,... decreased risk of ESCC associated with the p73 rs1801173 C>T polymorphism was evident among older p...,174,427,PLoS_One_2014_May_12_9(5)_e96958.txt
11614913 T>C,"...iu S , Yin J , Wang L , et al (2013 ) MiR-196a2 rs11614913 T>C polymorphism and risk of esophageal c...",231,73,PLoS_One_2014_May_12_9(5)_e96958.txt
3212948 G>C,"Overall, this meta-analysis suggests that ERCC1 rs3212948 G>C, but not others, is a lung cancer risk...",20,51,PLoS_One_2014_May_19_9(5)_e97616.txt
3212948 G>C,"Overall, this meta-analysis suggests that ERCC1 rs3212948 G>C, but not others, is a lung cancer risk...",20,51,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T>C,Zhou	2005	mixed	USA	Caucasian	PB	TaqMan	rs11615 T>C	0.541	1752	1358,52,43,PLoS_One_2014_May_19_9(5)_e97616.txt
3212986 C>A,rs3212986 C>A	0.088,58,10,PLoS_One_2014_May_19_9(5)_e97616.txt
3212948 G>C,rs3212948 G>C	0.171,61,10,PLoS_One_2014_May_19_9(5)_e97616.txt
3212961 A>C,rs3212961 A>C	0.515,64,10,PLoS_One_2014_May_19_9(5)_e97616.txt
3212948 G>C,Jones	2011	mixed	USA	Caucasian	PB	TaqMan	rs3212948 G>C	0.848	427	737,68,44,PLoS_One_2014_May_19_9(5)_e97616.txt
3212986 C>A,Kang	2011	mixed	China	Chinese	HB	PCR-RFLP	rs3212986 C>A	0.018	200	200,72,45,PLoS_One_2014_May_19_9(5)_e97616.txt
3212986 C>A,Kang	2011	mixed	China	Chinese	HB	PCR-RFLP	rs3212986 C>A	0.018	200	200,72,45,PLoS_One_2014_May_19_9(5)_e97616.txt
2298881 C>A,rs2298881 C>A	0.350,75,10,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T >C,...ma	2012	mixed	European	Caucasian	HB	HumanHap300	rs11615 T >C	0.185	2679	4226,77,54,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T>C,rs11615 T>,94,3,PLoS_One_2014_May_19_9(5)_e97616.txt
11615 T>C,rs11615 T>,94,3,PLoS_One_2014_May_19_9(5)_e97616.txt
3212948 G>C,ERCC1 3212948 G>C polymorphis,143,7,PLoS_One_2014_May_19_9(5)_e97616.txt
3212948 G>C,ERCC1 3212948 G>C polymorphis,143,7,PLoS_One_2014_May_19_9(5)_e97616.txt
2298881 C>A,ERCC1 rs2298881 C>A polymorphis,146,9,PLoS_One_2014_May_19_9(5)_e97616.txt
2298881 C>A,ERCC1 rs2298881 C>A polymorphis,146,9,PLoS_One_2014_May_19_9(5)_e97616.txt
-1123G>C,"... , et al (2007 ) The PTPN22 promoter polymorphism -1123G>C association cannot be distinguished from ...",189,104,PLoS_One_2014_May_9_9(5)_e96943.txt
-1123G > C,"... J, Li H, Gu D, Du W, Xue F, et al. (2012) PTPN22 -1123G > C polymorphism is associated with suscept...",192,56,PLoS_One_2014_May_9_9(5)_e96943.txt
2243250 C>T,...ating a correlation between IL-4 polymorphisms (rs2243250 C>T) and susceptibility to HBV infection [...,158,652,PLoS_One_2014_Oct_8_9(10)_e110061.txt
489C>A,RP-0911	adRP + AMD	LORD	C1QTNF5 c. 489C>A; p.Ser163Arg (NM_015645.3)	Hayward C et al....,106,36,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
489C>A,RP-0911	adRP + AMD	LORD	C1QTNF5 c. 489C>A; p.Ser163Arg (NM_015645.3)	Hayward C et al....,106,36,PLoS_One_2015_Jul_21_10(7)_e0133624.txt
2159G>A,"...s (SNPs) for CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T), two for CYP2B6 (516 G>T and...",57,212,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
516 G>T,"..., -163C>A, 2159G>A, and 5347C>T), two for CYP2B6 (516 G>T and 785 A>G), and four for CYP2E1 (-1293G>...",57,251,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
785 A>G,"...159G>A, and 5347C>T), two for CYP2B6 (516 G>T and 785 A>G), and four for CYP2E1 (-1293G>C, -352A>G, ...",57,263,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
785 A>G,"...159G>A, and 5347C>T), two for CYP2B6 (516 G>T and 785 A>G), and four for CYP2E1 (-1293G>C, -352A>G, ...",57,263,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-1293G>C,"...YP2B6 (516 G>T and 785 A>G), and four for CYP2E1 (-1293G>C, -352A>G, -333T>A, and 7632T>A) were dete...",57,294,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
7632T>A,"... four for CYP2E1 (-1293G>C, -352A>G, -333T>A, and 7632T>A) were detected and the frequencies were 11...",57,326,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
5347C>T,"...CYP1A2 (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T) were used in a correlation analysis. Sign...",94,185,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-163C>A,-163C>A,103,2,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-163C>A,-163C>A,103,2,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-3113A>G,-3113A>G,111,2,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-352A>G,-352A>G,140,2,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
7632T>A,"...ferent from that of CYP1A2. For SNPs -1293G>C and 7632T>A of CYP2E1, the Vmax and CLint of both the ...",146,333,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-352A>G,"...d/or CLint of CYP2E1 -333TT (-333T>A) and -352AA (-352A>G) genotypes were also observed. However, fo...",146,569,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-3860G>A,"...ike wild-type [14]. In the present study, 5 SNPs (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T)...",161,1135,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-3860G>A,"...ike wild-type [14]. In the present study, 5 SNPs (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T)...",161,1135,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-3860G>A,"...ike wild-type [14]. In the present study, 5 SNPs (-3860G>A, -3113G>A, -163C>A, 2159G>A, and 5347C>T)...",161,1135,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-3860G>A,...2 activities in HLM were rather interesting. SNPs -3860G>A and -3113G>A are located in the distal en...,161,2106,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-3860G>A,...2 activities in HLM were rather interesting. SNPs -3860G>A and -3113G>A are located in the distal en...,161,2106,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-163C>A,"...e distal enhancer region of the CYP1A2 gene. Both -163C>A and 2159G>A are intronic mutations, wherea...",161,2195,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-3860G>A,"...nymous variant in exon 7 of CYP1A2 [34]. Although -3860G>A, -3113G>A, and -163C>A are considered to ...",161,2314,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
516G>T,"...H, K262R, respectively) [16,35]. In addition, SNP 516G>T can also lead to incorrect splicing of the ...",163,151,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-1293G>C,"... [13]. None of the 4 SNPs assessed in this study (-1293G>C, -352A>G, -333T>A, and 7632T>A) had an ef...",167,206,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
7632T>A,"...ed in this study (-1293G>C, -352A>G, -333T>A, and 7632T>A) had an effect on CYP2E1 activity. However...",167,238,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-1293G>C,...correlated with the Vmax and CLint of CYP2E1 SNPs -1293G>C and 7632T>A wild-type homozygote and vari...,167,370,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-1293G>C,...correlated with the Vmax and CLint of CYP2E1 SNPs -1293G>C and 7632T>A wild-type homozygote and vari...,167,370,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
7632T>A,...th the Vmax and CLint of CYP2E1 SNPs -1293G>C and 7632T>A wild-type homozygote and variant heterozyg...,167,383,PLoS_One_2015_Jun_5_10(6)_e0128547.txt
-12140G>A,"...omoter single-nucleotide polymorphisms (SNPs) (SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-1137...",7,1077,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...nucleotide polymorphisms (SNPs) (SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G) with NSC...",7,1091,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12410G>A,...ciation of two adiponectin gene promoter SNPs (SNP-12410G>A and SNP-11377C>G) with NSCLC risk in a H...,19,82,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12410G>A,...ciation of two adiponectin gene promoter SNPs (SNP-12410G>A and SNP-11377C>G) with NSCLC risk in a H...,19,82,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,...iponectin gene promoter SNPs (SNP-12410G>A and SNP-11377C>G) with NSCLC risk in a Han Chinese popula...,19,99,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,...dded two other adiponectin gene promoter SNPs (SNP-11426A>G and SNP-11391G>A) to evaluate the associ...,19,427,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...se four adiponectin gene promoter SNPs, namely,SNP-12140G>A (rs266730), SNP-11426A>G (rs16861194), S...",19,539,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...method. Four adiponectin promoter SNPs, namely SNP-12140G>A (rs266730), SNP-11426A>G (rs16861194), S...",29,148,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"1.2 Association of adiponectin gene promoterSNP-12140G>A, SNP-11426A>G, SNP-11391G>A, and SNP-113...",51,48,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"1.2 Association of adiponectin gene promoterSNP-12140G>A, SNP-11426A>G, SNP-11391G>A, and SNP-113...",51,48,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...rSNP-12140G>A, SNP-11426A>G, SNP-11391G>A, and SNP-11377C>G with NSCL",51,94,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"The allele and genotype frequencies for SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-1137...",52,44,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ele and genotype frequencies for SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G in the NS...",52,58,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ele and genotype frequencies for SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G in the NS...",52,58,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11391G>A,"...pe frequencies for SNP-12140G>A, SNP-11426A>G, SNP-11391G>A and SNP-11377C>G in the NSCLC and contro...",52,72,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...d control groups. The genotype frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G were in H...",52,275,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...d control groups. The genotype frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G were in H...",52,275,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ps. The genotype frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G were in HWE for the NSC...",52,289,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G were in HWE for the NSCLC and control gr...",52,306,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...owever, the allele and genotype frequencies of SNP-12140G>A were significantly different in the NSCL...",52,422,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...011 and 0.046, respectively). The G allele for SNP-12140G>A occurred at a significantly higher frequ...",52,550,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...rison of genotypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between NSCL...",54,97,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...rison of genotypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between NSCL...",54,97,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between NSCLC and control ...",54,111,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between NSCLC and control ...",54,111,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,SNP-12140G>A	A/A(freq)	A/G(freq)	G/G(freq)		A(freq)	G...,56,4,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,SNP-11377C>G	C/C(freq)	C/G(freq)	G/G(freq)		C(freq)	G...,62,4,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...f inheritance analysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>",65,61,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,...3 Different inheritance models analysis of the SNP-12140G>A in adiponectin gene promoter between NSC...,68,90,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,...3 Different inheritance models analysis of the SNP-12140G>A in adiponectin gene promoter between NSC...,68,90,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,...4 Different inheritance models analysis of the SNP-11426A>G in adiponectin gene promoter between NSC...,81,90,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...analysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>",107,97,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,...mated frequencies of SNP-12140G>A-SNP-11426A>G-SNP-11377C>G haplotypes with frequencies of more than...,108,424,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,SNP-12140G>A	SNP-11426A>G	SNP-11377C>G	NSCLC[n(%)]	Control[n(%)]	P value	P valu...,111,30,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"... frequencies forSNP-12140G>A, SNP-11426A>G and SNP-11377C>G between pathologic stages I+II and III+I...",121,103,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between pathologic stages ...",123,111,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between pathologic stages ...",123,111,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ypic and allelic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between pathologic stages ...",123,111,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...ic distribution of SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between pathologic stages I+II and III+I...",123,125,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,SNP-11426A>G	A/A(freq)	A/G(freq)	G/G(freq)		A(freq)	G...,128,4,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...6 Association analysis of adiponectin promoter SNP-12140G>A, SNP-11426A>G, and SNP-11377C>G with ade...",134,53,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...ectin promoter SNP-12140G>A, SNP-11426A>G, and SNP-11377C>G with adenocarcinoma (AC) and squamous ce...",134,85,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...ectin promoter SNP-12140G>A, SNP-11426A>G, and SNP-11377C>G with adenocarcinoma (AC) and squamous ce...",134,85,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...ces in the allele and genotype frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between A...",135,83,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ele and genotype frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between AC and SCC(Tabl...",135,97,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ele and genotype frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between AC and SCC(Tabl...",135,97,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...frequencies for SNP-12140G>A, SNP-11426A>G and SNP-11377C>G between AC and SCC(Table 8)",135,114,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ysis of the adiponectin promoter SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between adenocarcinoma (AC...",137,108,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...ysis of the adiponectin promoter SNP-12140G>A, SNP-11426A>G, SNP-11377C>G between adenocarcinoma (AC...",137,108,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"In 2009, Laumen et al. found that SNP-11426A>G, SNP-11391G>Aand SNP-11377C>G within the...",153,38,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...t al. found that SNP-11426A>G, SNP-11391G>Aand SNP-11377C>G within the adiponectin promoter were reg...",153,68,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,...or for NSCLC[23] and that individuals with the SNP-12140G>A GG genotype have increased risk for NSCL...,153,494,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,...or for NSCLC[23] and that individuals with the SNP-12140G>A GG genotype have increased risk for NSCL...,153,494,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,...or for NSCLC[23] and that individuals with the SNP-12140G>A GG genotype have increased risk for NSCL...,153,494,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...e, e.g.,SNP-12140G>A maybe more important than SNP-11377C>G in the Chinese population. Based on thes...",153,1842,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...e, e.g.,SNP-12140G>A maybe more important than SNP-11377C>G in the Chinese population. Based on thes...",153,1842,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,".... Based on these results, we hypothesized that SNP-12140G>A may influence adiponectin promoter activ...",153,1927,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,...uture. It was an interesting finding that only SNP-12140G>A was associated with NSCLC in our study. ...,153,2346,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11426A>G,"...just was partly in linkage disequilibrium with SNP-11426A>G and SNP-11377C>G. Therefore, we assumed ...",153,2480,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...n linkage disequilibrium with SNP-11426A>G and SNP-11377C>G. Therefore, we assumed this could be pos...",153,2497,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,...ible one of causes of the divergence that only SNP-12140G>A associated with NSCLC in this Han Chines...,153,2598,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...n Chinese population, but not SNP-11426A>G and SNP-11377C>G",153,2690,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...ectin by subcutaneous adipose tissue [3].Thus, SNP-12140G>A may be merely a susceptibility factor fo...",155,878,PLoS_One_2015_May_27_10(5)_e0127751.txt
-12140G>A,"...study. The statistical power for the effect of SNP-12140G>A was calculated using PS software [28],an...",157,180,PLoS_One_2015_May_27_10(5)_e0127751.txt
-11377C>G,"...nectin promoter SNP-12140G>A, SNP-11426A>G and SNP-11377C>G and NSCLC in a Han Chinese population an...",160,109,PLoS_One_2015_May_27_10(5)_e0127751.txt
97V>A,"...n one RCUD patient. Thus, the mutation led to the 97V>A amino-acid change in the protein sequence. S...",157,139,PLoS_One_2015_May_8_10(5)_e0126555.txt
3140A>G,H1047R	3140A>G	112	11.1,66,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
1624G>A,E542K	1624G>A	38	3.8,68,7,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3140A>G,"H1047R,E542K	3140A>G,1624G>A	2	0.2",70,14,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3140A>G,"H1047R,E542K	3140A>G,1624G>A	2	0.2",70,14,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
1624G>A,"H1047R,E542K	3140A>G,1624G>A	2	0.2",70,22,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
1624G>A,"H1047R,E542K	3140A>G,1624G>A	2	0.2",70,22,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3139C>T,H1047Y	3139C>T	1	0.1,72,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3139C>T,H1047Y	3139C>T	1	0.1,72,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3142T>C,H1047H	3142T>C	1	0.1,73,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3197C>T,A1066V	3197C>T hom	1	0.1,77,8,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3140A>G,"A1020T, H1047R, A1066T	3058G>A, 3140A>G, 3196G	1	0.1",78,33,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
3140A>G,"A1020T, H1047R, A1066T	3058G>A, 3140A>G, 3196G	1	0.1",78,33,PLoS_One_2015_Oct_9_10(10)_e0140293.txt
-511 C>T,"...). The presence of >1, ‘T’ (minor) allele of IL1B -511 C>T in a genotype seemed to provide protectio...",9,1772,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,"...ences in association statuses were seen for IL1A +4845 G>T, IL1B -511 C>T, IL1RN 86bp VNTR and IL1RN...",9,2828,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...carrying IL1B -511 C>T, IL1RN 86bp VNTR or IL1RN +8006 T>C polymorphisms seemed to enjoy significant...",9,3344,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-3954 C>T,"...845 G>T (rs17561), IL1B-1903 C>T (rs1143627), IL1B-3954 C>T (rs1143634), IL1B-5887 C>T(rs1143633), I...",17,235,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-3954 C>T,"...845 G>T (rs17561), IL1B-1903 C>T (rs1143627), IL1B-3954 C>T (rs1143634), IL1B-5887 C>T(rs1143633), I...",17,235,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
9589 A>T,"...887 C>T(rs1143633), IL1B-511 C>T (rs16944), IL1RN+9589 A>T (rs454078), IL1RN+8006 T>C (rs419598), IL...",17,314,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511 C>T,...The T (minor) allele and the TT genotype for IL1B -511 C>T polymorphism showed a promising trend tow...,51,607,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511 C>T,...The T (minor) allele and the TT genotype for IL1B -511 C>T polymorphism showed a promising trend tow...,51,607,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
111000 T>C,"...ing, published study for 3 IL1RN gene SNPs, viz. +111000 T>C, +8061 C>T and +9589 A>T, they were exc...",56,994,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
9589 A>T,"...IL1RN gene SNPs, viz. +111000 T>C, +8061 C>T and +9589 A>T, they were excluded from quantitative syn...",56,1021,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
9589 A>T,"...IL1RN gene SNPs, viz. +111000 T>C, +8061 C>T and +9589 A>T, they were excluded from quantitative syn...",56,1021,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-889 C>T,Interleukin-1 SNPs included- IL1A-889 C>T (rs1800587); IL1A+4845 G>T (rs17561); IL1...,86,34,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-5887 C>T,...4845 G>T (rs17561); IL1B -511 C>T (rs16944); IL1B -5887 C>T (rs1143633); IL1B -3954 C>T (rs1143634);...,86,111,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,...1143627); IL1RN 86bp VNTR (PMID 14563376); IL1RN +8006 T>C (rs419598),86,230,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,Two variants of IL1A gene viz. -889 C>T and +4845 G>T were selected for meta-analysis. We inclu...,91,46,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-889 C>T,"...27–0.57). No significant association with CAD for -889 C>T was detected either, for EA and NIA in ou...",91,589,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-889 C>T,"...27–0.57). No significant association with CAD for -889 C>T was detected either, for EA and NIA in ou...",91,589,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-889 C>T,"...27–0.57). No significant association with CAD for -889 C>T was detected either, for EA and NIA in ou...",91,589,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,+4845 G>T (rs17561),105,2,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-3954 C>T,-3954 C>T (rs1143634),134,1,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,+8006 T>C (rs419598),162,2,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-889 C>T,a Dominant genetic model: TT+CT vs. CC for A-889 C>T; TT+GT vs. GG for A+4845 G>T; TT+CT vs. C...,175,45,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511 C>T,...T; TT+GT vs. GG for A+4845 G>T; TT+CT vs. CC for B-511 C>T; TT+CT vs. CC for B-1903 C>T; TT+CT vs. C...,175,102,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903 C>T,...>T; TT+CT vs. CC for B-511 C>T; TT+CT vs. CC for B-1903 C>T; TT+CT vs. CC for B-3954 C>T; TT+CT vs. ...,175,130,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,... other allele than allele 2); CC+CT vs. TT for RN+8006 T>C,175,290,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,... other allele than allele 2); CC+CT vs. TT for RN+8006 T>C,175,290,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-889 C>T,b Recessive genetic model: TT vs. CT+CC for A-889 C>T; TT vs. CT+GG for A+4845 G>T; TT vs. CT+C...,177,46,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...l: TT vs. CT+CC for A-889 C>T; TT vs. CT+GG for A+4845 G>T; TT vs. CT+CC for B-511 C>T; TT vs. CT+CC...,177,75,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903 C>T,...>T; TT vs. CT+CC for B-511 C>T; TT vs. CT+CC for B-1903 C>T; TT vs. CT+CC for B-3954 C>T; TT vs. CT+...,177,131,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-5887 C>T,...T; TT vs. CT+CC for B-3954 C>T; TT vs. CT+CC for B-5887 C>T; 2/2 vs. X/2+X/X for RN 86bp VNTR; CC vs...,177,189,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,...vs. X/2+X/X for RN 86bp VNTR; CC vs. CT+TT for RN+8006 T>C,177,254,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...lele C for A-889 C>T; Allele T vs. Allele G for A+4845 G>T; Allele T vs. Allele C for B-511 C>T; All...,179,91,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903 C>T,...llele C for B-511 C>T; Allele T vs. Allele C for B-1903 C>T; Allele T vs. Allele C for B-3954 C>T; A...,179,165,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903 C>T,...llele C for B-511 C>T; Allele T vs. Allele C for B-1903 C>T; Allele T vs. Allele C for B-3954 C>T; A...,179,165,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511 C>T,...st plots depicting meta-analysis results for IL1B -511 C>T (rs16944) polymorphism,186,94,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-3954 C>T,"...0.71 for -1903 C>T, p value range = 0.44–0.92 for -3954 C>T and p value range = 0.65–0.72 for -5887 ...",189,632,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...Ps viz. B-511 C>T, B-3954 C>T, RN86bp VNTR and RN+8006 T>C, qualified for publication bias assessmen...",202,330,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-3954 C>T,"...all three funnel plots for IL1B -511 C>T and IL1B -3954 C>T, polymorphisms, whereas S6 Fig displays ...",202,618,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-3954 C>T,"...of ≥ 5 studies). Only three SNPs viz. B-511 C>T, B-3954 C>T, RN86bp VNTR qualified for the same. The...",205,209,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-889 C>T,...ary angioplasty (PTCA) has also been reported for -889 C>T which probably testifies its lack of asso...,211,545,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...terners) has reported significant association of +4845 G>T with CAD in a relatively small sample siz...,213,93,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...terners) has reported significant association of +4845 G>T with CAD in a relatively small sample siz...,213,93,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,...terners) has reported significant association of +4845 G>T with CAD in a relatively small sample siz...,213,93,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-3954 C>T,"...ts for all 4 IL1B SNPs (i.e. -511 C>T, -1903 C>T, -3954 C>T and -5887 C>T), in the present case-cont...",218,87,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511 C>T,...nds suggesting possible association were seen for -511 C>T. Congruent with the results of our case-c...,218,274,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511 C>T,"... of our case-control study, subgroup analysis for -511 C>T hinted associations for certain ancestral...",218,360,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903 C>T,"Lack of associations for -1903 C>T, -3954 C>T and -5887 C>T with CAD, as se...",220,26,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-3954 C>T,"Lack of associations for -1903 C>T, -3954 C>T and -5887 C>T with CAD, as seen in our c...",220,37,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-5887 C>T,"Lack of associations for -1903 C>T, -3954 C>T and -5887 C>T with CAD, as seen in our case-control st...",220,51,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
111000 T>C,"...phisms (i.e. +9589 A>T, +8006 T>C, +8061 C>T and +111000 T>C) in our present case-control study. Ass...",225,207,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,"...s although validated the lack of association for +8006 T>C in the pooled analysis, but discovered si...",227,67,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
4845 G>T,"...residing in the IL-1 gene cluster (i.e. for IL1A +4845 G>T, IL1B -511 C>T, IL1RN +8006 T>C and IL1RN...",229,326,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511 C>T,"... IL-1 gene cluster (i.e. for IL1A +4845 G>T, IL1B -511 C>T, IL1RN +8006 T>C and IL1RN 86bp VNTR) whi...",229,341,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511C>T,...Ps hinting association with the disease (i.e. IL1B-511C>T and ILIRN 86bp VNTR) have previously been ...,231,418,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-511 C>T,"...cestral groups were seen for IL1A +4845 G>T, IL1B -511 C>T, IL1RN 86bp VNTR and IL1RN +8006 T>C. The...",236,337,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-889 C>T,...st plots depicting meta-analysis results for IL1A -889 C>T (rs1800587) polymorphism,254,63,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903C>T,...st plots depicting meta-analysis results for IL1B -1903C>T (rs1143627) polymorphism,275,63,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903C>T,...st plots depicting meta-analysis results for IL1B -1903C>T (rs1143627) polymorphism,275,63,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-1903C>T,...st plots depicting meta-analysis results for IL1B -1903C>T (rs1143627) polymorphism,275,63,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-3954 C>T,...er’s estimates for dominant genetic model of IL1B -3954 C>T polymorphism. Panel E: Begg’s funnel plo...,283,608,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,...’s estimates for dominant genetic model of IL1RN +8006 T>C polymorphism. Panel E: Begg’s funnel plot...,290,616,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
8006 T>C,...’s estimates for dominant genetic model of IL1RN +8006 T>C polymorphism. Panel E: Begg’s funnel plot...,290,616,PLoS_One_2016_Apr_14_11(4)_e0153480.txt
-938C>A,...OrganellesCell MembranesMembrane ProteinsThe BCL2 -938C>A Promoter Polymorphism Is Associated with R...,3,1215,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,"...unctional single nucleotide polymorphism (SNP) c.-938C>A (rs2279115), located in the promoter region...",7,721,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,"...ive effects of polymorphisms, among them the BCL2 -938C>A polymorphism, in a preliminary study compr...",19,82,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,"...ive effects of polymorphisms, among them the BCL2 -938C>A polymorphism, in a preliminary study compr...",19,82,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,"...evaluate the time to loosening, dependent on BCL2 -938C>A genotype. The impact of age, BMI, and BCL2...",29,554,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,Clinical characteristics and BCL2 -938C>A genotype,32,35,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,...inical characteristics were analyzed dependent on -938C>A genotypes in both groups. None of the vari...,33,766,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,... variables was significantly associated with BCL2 -938C>A genotypes. To control for differences in c...,33,861,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,... variables was significantly associated with BCL2 -938C>A genotypes. To control for differences in c...,33,861,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,...notypes to further analyze the impact of the BCL2 -938C>A polymorphism on aseptic loosening. Median ...,84,160,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,.... Despite correcting for these variables the BCL2 -938C>A polymorphism remained a significant factor...,94,515,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,...>A genotype. (B) patients (n = 234) based on BCL2 -938C>A CC+CA and AA genotype,97,181,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,BCL2 -938C>A,108,6,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,...ients. Our goal was to determine whether the BCL2 -938C>A polymorphism influences the course and occ...,120,573,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,"...ll these players interact with regard to the BCL2 -938C>A genotype on the cellular level. Therefore,...",124,1681,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C>A,"In summary, our work revealed the BCL2 -938C>A polymorphism as a putative molecular marke...",126,40,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
938C>A,...ype of the regulatory BCL2 promoter polymorphism (938C>A) is associated with a favorable outcome in ...,166,63,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
-938C > A,BCL-2 (-938C > A) polymorphism is associated with breast ...,177,8,PLoS_One_2016_Feb_16_11(2)_e0149528.txt
2-2A>G,"...ivity: CYP21A2 deletion, large gene conversion, IV2-2A>G, p.G110Efs, exon 6 cluster (p.I236N, p.V237...",57,356,PLoS_One_2016_Feb_5_11(2)_e0148548.txt
2	G > A,zy2	G > A	TTC ACA TGA ATT GTC	406Wstop,56,3,PLoS_One_2016_Jun_14_11(6)_e0157537.txt
7	G > A,nde-4/fntb-1	zy7	G > A	ATG CTT AAA GAG TAC	E321K,62,16,PLoS_One_2016_Jun_14_11(6)_e0157537.txt
21	C > T,zy21	C > T	ATG GAA TGA GAA GGC	R305stop,64,3,PLoS_One_2016_Jun_14_11(6)_e0157537.txt
4T>C,7. HFE	chr6:26091336	c.340+4T>C	Splicing	rs2071303	46	33	-,88,28,PLoS_One_2016_May_16_11(5)_e0155421.txt
2A>G,....pone.0155421.g005Fig 5 Novel LMNA mutation c.357-2A>G (p.N120Lfs*5),127,66,PLoS_One_2016_May_16_11(5)_e0155421.txt
2A>G,...als (>60 years old). We found only the LMNA c.357-2A>G variant completely segregated with the phenot...,146,402,PLoS_One_2016_May_16_11(5)_e0155421.txt
1G>T,"...tide in the same splice acceptor site, LMNA c.357-1G>T was reported in three patients with arrhythmi...",157,232,PLoS_One_2016_May_16_11(5)_e0155421.txt
1G>T,"...,32]. In a cohort of 324 DCM patients, LMNA c.357-1G>T was detected in one family that consisted of ...",157,345,PLoS_One_2016_May_16_11(5)_e0155421.txt
1G>T,"...ions (PVCs), and a pacemaker/ICD [31]. LMNA c.357-1G>T also was found in one French patient with spo...",157,640,PLoS_One_2016_May_16_11(5)_e0155421.txt
1G>T,"...e at the same splice site, we expected LMNA c.357-1G>T and LMNA c.357-2A>G to both produce the same ...",161,236,PLoS_One_2016_May_16_11(5)_e0155421.txt
2A>G,"... site, we expected LMNA c.357-1G>T and LMNA c.357-2A>G to both produce the same aberrant products th...",161,256,PLoS_One_2016_May_16_11(5)_e0155421.txt
1G>T,"...ld be subject to NMD. However, for the LMNA c.357-1G>T, RNA studies showed skipping of exon 2 in the...",161,362,PLoS_One_2016_May_16_11(5)_e0155421.txt
1G>T,"...ld be subject to NMD. However, for the LMNA c.357-1G>T, RNA studies showed skipping of exon 2 in the...",161,362,PLoS_One_2016_May_16_11(5)_e0155421.txt
1805G>T,"... all subjects combined, 2 SNPs in TLR1 (−2192T>C, 1805G>T) were significantly associated with Td (Ta...",114,53,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C,"...ssociated with Td (Table 2), and one SNP in TLR2 (597T>C) was significantly associated with BOP (Tab...",114,132,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
2192T>C,All samples	Td	TLR1	rs5743595	−2192T>C	-	C	Add	1.27	0.001a,118,32,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
7202G>A,rs5743551	−7202G>A	-	A	Add	-0.95	0.002,120,15,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
7202G>A,rs5743551	−7202G>A	-	A	Add	-0.95	0.002,120,15,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
7202G>A,rs5743551	−7202G>A	-	A	Add	-0.95	0.002,120,15,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,rs5743618	1805G>T	Ser602Ile	G	Add	-1.11	0.001a,121,14,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1401G>A,TLR6	rs5743795	−1401G>A	-	A	Add	1.39	0.004,122,19,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1401G>A,TLR6	rs5743795	−1401G>A	-	A	Add	1.39	0.004,122,19,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1401G>A,TLR6	rs5743795	−1401G>A	-	A	Add	1.39	0.004,122,19,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
7202G>A,Td	TLR1	rs5743551	−7202G>A	-	A	Add	-1.57	0.001a,125,21,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,rs5743618	1805G>T	Ser602Ile	G	Add	-1.56	<0.001a,126,14,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,African American	Td	TLR1	rs5743618	1805G>T	Ser602Ile	G	Add	-1.72	0.009,127,36,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
28A>G, 	 	 	rs5744077	28A>G	Met10Val	G	Add	-1.22	0.008,134,17,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
15607A>G,REC	TLR2	rs1898830	−15607A>G	-	G	Add	12.92	0.006,146,22,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1174G>A,BOP	TLR9	rs352139	+1174G>A	-	A	Dom	20.57	0.004,148,21,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1635G>A,rs352140	1635G>A	Pro545Pro	A	Add	-12.98	0.006,149,13,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
4224C>T,African American	REC	TLR6	rs2381289	4224C>T	-	T	Dom	19.66	0.005,150,37,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C, 	BOP	TLR2	rs3804099	597T>C	Asn199Asn	T	Dom	14.70	0.004,151,22,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
7202G>A,...er stimulation with TLR1/2 ligand Pam3CSK4 [62]. −7202G>A and 1805G>T were functionally relevant in ...,170,775,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
7202G>A,...er stimulation with TLR1/2 ligand Pam3CSK4 [62]. −7202G>A and 1805G>T were functionally relevant in ...,170,775,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,"...on with TLR1/2 ligand Pam3CSK4 [62]. −7202G>A and 1805G>T were functionally relevant in sepsis, tube...",170,787,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C,"Most previous studies did not include 597T>C [12,19,22,23]. One study, conducted in 2 No...",174,39,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C,"...ymous SNP (Asn199Asn), the molecular mechanism of 597T>C is not clear. The 597T allele may have a ro...",174,242,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
597T>C,...lar symbiotic bacterium Wolbachia. It may be that 597T>C is in LD with a highly polymorphic (GT)n di...,174,512,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
4224C>T,"...s [74]. In addition, −502T>C is in strong LD with 4224C>T (S3 Table), located in the 3′-UTR. It is w...",176,867,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,"...significant SNPs in this study, 3 (TLR1 −7202G>A, 1805G>T; TLR6 −502T>C) were associated with HIV st...",178,1362,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1805G>T,"...significant SNPs in this study, 3 (TLR1 −7202G>A, 1805G>T; TLR6 −502T>C) were associated with HIV st...",178,1362,PLoS_One_2016_Oct_11_11(10)_e0164075.txt
1-13T>G,... UL and LL + axial + respiratory insufficiency	IVS1-13T>G IVS1-13T>G	c.2173C>T	779	Yes	39	Y	Y,108,75,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1G>A,3	F	26	HyperCKemia	IVS1-13T>G	c.1889-1G>A	779	No	-	N	N,109,38,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1-13T>G,...weakness UL and LL + respiratory insufficiency	IVS1-13T>G	c.1637A>G	391	Yes	24	Y	Y,118,68,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1-13T>G,19	M	14	HyperCKemia	IVS1-13T>G	c.573C>A	660	No	-	N	N,125,24,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1-13T>G,21	F	35	Proximal weakness LL	IVS1-13T>G	c.1A>T	355	Yes	29	N	N,127,33,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1-13T>G,21	F	35	Proximal weakness LL	IVS1-13T>G	c.1A>T	355	Yes	29	N	N,127,33,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1G>A,22	F	40	Proximal weakness LL	IVS1-13T>G	c.1889-1G>A	831	No	-	N	Y,128,48,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
5G>A,...s LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	907	Yes	45	N	N,129,75,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
5G>A,...s LL + respiratory insufficiency	c.1781G>A	c.1194+5G>A	907	Yes	45	N	N,129,75,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
1-13T>G,...ss UL + LL + axial + respiratory insufficiency	IVS1-13T>G	c.2481+102_2646+31del	430	Yes	57	N	Y,130,74,PLoS_One_2016_Oct_6_11(10)_e0163493.txt
409	C>M,"MMSE	27.29±2.31	25.68±2.68	19.33±3.82	201.32*	2, 409	C>M>A",152,50,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...ecall	21.47±4.06	17.15±4.39	10.91±3.71	111.87*	2, 409	C>M>A",153,67,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...d recall	7.26±2.00	3.49±2.92	0.29±0.92	152.14*	2, 409	C>M>A",154,62,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...d recall	7.26±2.00	3.49±2.92	0.29±0.92	152.14*	2, 409	C>M>A",154,62,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
358	C>M,"... ㅇ, ㅅ	26.35±11.01	20.41±9.78	13.83±8.95	27.51*	2, 358	C>M>A",159,57,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
358	C>M,"... ㅇ, ㅅ	26.35±11.01	20.41±9.78	13.83±8.95	27.51*	2, 358	C>M>A",159,57,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
358	C>M,"... ㅇ, ㅅ	26.35±11.01	20.41±9.78	13.83±8.95	27.51*	2, 358	C>M>A",159,57,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
358	C>M,"... ㅇ, ㅅ	26.35±11.01	20.41±9.78	13.83±8.95	27.51*	2, 358	C>M>A",159,57,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...an-forward	6.07±1.51	5.63±1.40	4.91±1.45	6.44*	2, 409	C>M>A",163,59,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...-backward	4.10±1.15	3.56±0.97	2.92±0.95	25.23*	2, 409	C>M>A",164,61,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"... score	14.43±1.32	13.37±1.58	8.91±2.54	230.62*	2, 409	C>M>A",194,56,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"Recall	1.87±0.85	1.20±0.84	0.26±0.51	77.30*	2, 409	C>M>A",208,48,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...g speed	12.24±4.31	10.47±4.03	6.35±3.40	38.78*	2, 409	C>M>A",231,60,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
409	C>M,"...Score	49.84±9.59	43.48±7.81	29.06±7.17	168.37*	2, 409	C>M>A",232,57,PLoS_One_2016_Sep_26_11(9)_e0163792.txt
77C->G,...s W  Borns K  Windhagen A  Schwinzer R   2006 The 77C->G mutation in the human CD45 (PTPRC) gene lea...,240,65,PLoS_Pathog_2011_Dec_8_7(12)_e1002432.txt
1075A>C,"...39G>A, CYP2C19 +681G>A, +636G>A, CYP2C9 +430С>T, +1075A>C). Genotype frequencies of polymorphisms in...",3,1589,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
636G > A,...and the Chinese. The difference between CYP2C19 + 636G > A genotype frequencies among the Yakuts and...,32,192,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
430C > T,...nt. The comparison of the frequencies of CYP2C9 + 430C > T genotypes found a statistically significa...,32,422,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
430C > T,...nt. The comparison of the frequencies of CYP2C9 + 430C > T genotypes found a statistically significa...,32,422,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
681G > A,...f minor alleles of polymorphisms in the CYP2C19 + 681G > A and CYP2C9 + 430C > T in the sample we st...,35,656,Res_Pharm_Sci_2016_May-Jun_11(3)_259-264.txt
2643 C>G,...wed the presence of the homozygous c2772 A>G and c2643 C>G polymorphisms. ABCA3 sequencing showed a ...,42,184,Respir_Res_2011_Aug_25_12(1)_115.txt
2643 C>G,...wed the presence of the homozygous c2772 A>G and c2643 C>G polymorphisms. ABCA3 sequencing showed a ...,42,184,Respir_Res_2011_Aug_25_12(1)_115.txt
1G > A,"Intron 1C, c.-5 + 1G > A. Splicing site variant, causing no expressi...",78,20,Respir_Res_2014_Oct_7_15(1)_125.txt
1G > A,"Interestingly, mutations c.-5 + 1G > A and c.-5 + 2dupT triggered the elimination ...",183,33,Respir_Res_2014_Oct_7_15(1)_125.txt
1G > A,"Interestingly, mutations c.-5 + 1G > A and c.-5 + 2dupT triggered the elimination ...",183,33,Respir_Res_2014_Oct_7_15(1)_125.txt
1G > A,...2 transcript was significantly enriched in c.-5 + 1G > A (83.0% vs. 51.3% in wt) although other thre...,183,311,Respir_Res_2014_Oct_7_15(1)_125.txt
-33T>C,"... FY*B/FY*B in 158 (39.50%) samples. The mutation (-33T>C), which occurs in the GATA-box erythroid pr...",114,147,Rev_Bras_Hematol_Hemoter_2011_33(1)_21-25.txt
-181A>G,...ArticleAssociation of Matrix Metalloproteinase-7 (-181A>G) Polymorphism with Risk of Esophageal Squa...,3,264,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,Carriers for the MMP-7 (-181A>G) GG were associated with an increased risk...,10,25,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,Carriers for the MMP-7 (-181A>G) GG were associated with an increased risk...,10,25,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,Carriers for the MMP-7 (-181A>G) GG were associated with an increased risk...,10,25,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,The MMP-7 polymorphism (–181A>G) was genotyped in subjects by polymerase ch...,31,26,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,...ference. Observed genotype frequencies for MMP-7 (-181A>G) polymorphism (rs17878362) in controls wer...,34,665,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,Association of genetic variant of MMP-7 (-181A>G) polymorphism with susceptibility to E,42,42,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,"...7). In the present study, when we used the MMP 7 (-181A>G) AA genotype as reference, we found that i...",43,270,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,"...7). In the present study, when we used the MMP 7 (-181A>G) AA genotype as reference, we found that i...",43,270,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,"...7). In the present study, when we used the MMP 7 (-181A>G) AA genotype as reference, we found that i...",43,270,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,"... reference, we found that individuals with MMP-7 (-181A>G) GG genotype were significantly associated...",43,343,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,Table 5 Interaction of MMP-7 (–181A>G) genotypes with smokin,57,32,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
181A>G,Table 5 Interaction of MMP-7 (–181A>G) genotypes with smokin,57,32,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,...ographical differences in the influence of MMP-7 (-181A>G) on the susceptibility of various cancers,62,887,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,...ort of genetic susceptibility of EC due to MMP-7 (-181A>G) gene polymorphism in the Kashmir valley. ...,72,298,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
-181A>G,".... In conclusion, our data suggest that the MMP-7 (-181A>G) gene polymorphism may influence the susce...",72,396,Saudi_J_Gastroenterol_2011_Sep-Oct_17(5)_301-306.txt
1G>T,... (C) Hexadecanedioate levels among SLCO1B1 (c.481+1G>T) LoF mutation carriers. (D) Deoxycarnitine le...,53,301,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
2T>A,"....975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933+2T>A), having both homozygous and heterozygous gen...",86,74,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
2T>A,"....975T>G), SLCO1B1 (c.481+1G>T), and LRRC69 (c.933+2T>A), having both homozygous and heterozygous gen...",86,74,Sci_Adv_2016_Aug_31_2(8)_e1600800.txt
8919 G > A,"ATM	c. 8919 G > A, W2845X (HT144)",184,8,Sci_Rep_2013_Dec_13_3_3494.txt
8919 G > A,"ATM	c. 8919 G > A, W2845X (HT144)",184,8,Sci_Rep_2013_Dec_13_3_3494.txt
2A>C,NR2E3	c.119-2A>C	 	8*10−6	arRP	Arab Muslim	MOL1266	1	Homozygou...,100,13,Sci_Rep_2015_Aug_26_5_13187.txt
6+1G>A,...essential splice site variant CFH 1:196648924 (IVS6+1G>A) or missense variant rs139360826 (R175P). I...,3,2887,Sci_Rep_2016_Aug_30_6_31531.txt
6+1G>A,"... database who did not carry the CFH C192F, CFH IVS6+1G>A, or CFH R175P variants based on sequencing....",32,871,Sci_Rep_2016_Aug_30_6_31531.txt
1G>A,"... activity. Most splice site variants, like IVS6 + 1G>A in Pedigree B, lead to haploinsufficiency as ...",37,952,Sci_Rep_2016_Aug_30_6_31531.txt
7868G>A,ARRP-49	c.[8422G>A];[7868G>A]	50/M	32	NA	NA	PD/ODW/RR	PD/ODW/RR,90,22,Sci_Rep_2016_Jan_20_6_19432.txt
7868G>A,ARRP-49	c.[8422G>A];[7868G>A]	50/M	32	NA	NA	PD/ODW/RR	PD/ODW/RR,90,22,Sci_Rep_2016_Jan_20_6_19432.txt
1418G>T,RP:S-18	c.[1418G>T];[2971C>T]	55/M	52	NA	NA	NA	NA,95,12,Sci_Rep_2016_Jan_20_6_19432.txt
1418G>T,RP:S-18	c.[1418G>T];[2971C>T]	55/M	52	NA	NA	NA	NA,95,12,Sci_Rep_2016_Jan_20_6_19432.txt
3024C>A,RP:S-48	c.[3024C>A]	20/F	15	R-a/b	R-a/b	PD/ODW	PD/ODW,99,12,Sci_Rep_2016_Jan_20_6_19432.txt
1 G>A,RP:S-40	15	c.2259+1 G>A	hom	–	splicing	novel	–	NA/NA,115,19,Sci_Rep_2016_Jan_20_6_19432.txt
417C > T,...lattice corneal dystrophy type I in patients with 417C > T (R124C) and 1762A > G (H572R) mutations i...,267,75,Sci_Rep_2016_Mar_31_6_23836.txt
1762A > G,...ophy type I in patients with 417C > T (R124C) and 1762A > G (H572R) mutations in TGFBI (BIGH3) . Mol...,267,96,Sci_Rep_2016_Mar_31_6_23836.txt
3+1G>A,RHD*DEL8 (IVS3+1G>A)	Splice site mutation	6,167,14,Sci_Rep_2016_Sep_1_6_32317.txt
118A>G,...h J   Meta-analysis of the relevance of the OPRM1 118A>G genetic variant for pain treatment Pain  20...,280,70,Scientifica_(Cairo)_2013_Apr_2_2013_415279.txt
-174G > C,...ontgomery H. E.  Sanders J.    Interleukin-6 gene -174G > C and -572G > C promoter polymorphisms are...,142,68,Stem_Cells_Int_2015_May_28_2015_498328.txt
-174G > C,...ontgomery H. E.  Sanders J.    Interleukin-6 gene -174G > C and -572G > C promoter polymorphisms are...,142,68,Stem_Cells_Int_2015_May_28_2015_498328.txt
-572G > C,....  Sanders J.    Interleukin-6 gene -174G > C and -572G > C promoter polymorphisms are strong predic...,142,82,Stem_Cells_Int_2015_May_28_2015_498328.txt
-857C>T,"...4061/2011/920584Research ArticleAssociation of TNF-857C>T, TNFRSF1A36A>G, and TNFRSF1B676T>G Polymor...",3,143,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,"...esearch ArticleAssociation of TNF-857C>T, TNFRSF1A36A>G, and TNFRSF1B676T>G Polymorphisms with Ische...",3,160,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,"...ciation of TNF-857C>T, TNFRSF1A36A>G, and TNFRSF1B676T>G Polymorphisms with Ischemic Stroke in a Gre...",3,179,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-857C>T,"...ndard salt extraction procedure. Polymorphisms TNF-857C>T  (rs1799724),  TNFRSF1A36A>G  (rs767455), ...",43,131,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-857C>T,"...cruited in each group (cases and controls) for TNF-857C>T, 272 subjects for TNFRSF1A36A>G, and 85 su...",46,656,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,"...ontrols) for TNF-857C>T, 272 subjects for TNFRSF1A36A>G, and 85 subjects in each group for TNFRSF1B6...",46,690,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,"...ontrols) for TNF-857C>T, 272 subjects for TNFRSF1A36A>G, and 85 subjects in each group for TNFRSF1B6...",46,690,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,"...SF1B are summarized in Table 2. Regarding TNFRSF1A36A>G, a statistically significant difference was ...",53,136,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,"...ation of  TNF-857C>T,  TNFRSF1A36A>G, and TNFRSF1B676T>G polymorphisms with ischemic stroke, under t...",58,99,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-857C>T,...ocated on chromosome 6p21 encodes TNF-α.  The  TNF-857C>T polymorphism is a functional polymorphism ...,60,59,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-857C>T,...ocated on chromosome 6p21 encodes TNF-α.  The  TNF-857C>T polymorphism is a functional polymorphism ...,60,59,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-857C>T,...ocated on chromosome 6p21 encodes TNF-α.  The  TNF-857C>T polymorphism is a functional polymorphism ...,60,59,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-308G>A,...rphism with Pereira et al. suggesting that the TNF-308G>A polymorphism may play a role in ischemic s...,60,368,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-308G>A,...rphism with Pereira et al. suggesting that the TNF-308G>A polymorphism may play a role in ischemic s...,60,368,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-308G>A,...rphism with Pereira et al. suggesting that the TNF-308G>A polymorphism may play a role in ischemic s...,60,368,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-857C>T,... to exclude this polymorphism and focus on the TNF-857C>T polymorphism. Our study exerted that this ...,62,299,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,...a gene located on chromosome 12p13.2. The TNFRSF1A36A>G polymorphism is a silent mutation in codon 1...,64,74,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-857C>T,...he power of our study is limited regarding the TNF-857C>T and the TNFRSF1A36A>G polymorphism. Regard...,70,237,Stroke_Res_Treat_2011_May_29_2011_920584.txt
36A>G,... limited regarding the TNF-857C>T and the TNFRSF1A36A>G polymorphism. Regarding the TNFRSF1B676T>G p...,70,261,Stroke_Res_Treat_2011_May_29_2011_920584.txt
676T>G,...n criteria and the significant result for TNFRSF1B676T>G polymorphism,70,593,Stroke_Res_Treat_2011_May_29_2011_920584.txt
-857C>T,Polymorphisms	TNF-857C>T	TNFRSF1A36A>G	TNFRSF1B676T>G,92,18,Stroke_Res_Treat_2011_May_29_2011_920584.txt
420 C>T,"The 420 C>T substitution of CYP2C9*2, the 1075 A>C sub...",15,5,Thromb_J_2008_Jun_17_6_7.txt
420 C>T,"The 420 C>T substitution of CYP2C9*2, the 1075 A>C sub...",15,5,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,"... number AY587020), we selected one SNP (rs9934438/1173 C>T) localized in the first intron of VKORC1,...",38,147,Thromb_J_2008_Jun_17_6_7.txt
1173 C>T,"...pe distributions of CYP2C9*2, CYP2C9*3 and VKORC1 1173 C>T polymorphisms in 212 patients from the Os...",50,57,Thromb_J_2008_Jun_17_6_7.txt
678 C>A,"...orted a new heterozygous MTHFR gene polymorphism (678 C>A), with an unusual melting point profile. A...",20,78,Turk_J_Haematol_2012_Jun_15_29(2)_204-205.txt
678 C>A,"...orted a new heterozygous MTHFR gene polymorphism (678 C>A), with an unusual melting point profile. A...",20,78,Turk_J_Haematol_2012_Jun_15_29(2)_204-205.txt
20209 C >T,9 Ozdag H  Egin Y  Akar N   Prothrombin gene 20209 C >T along with the first description of a h...,35,46,Turk_J_Haematol_2012_Jun_15_29(2)_204-205.txt
4 C >T,...ozygous polymorphism at the 3’ downstream region +4 C >T in the Turkish population Lab Hematol 2006 ...,35,148,Turk_J_Haematol_2012_Jun_15_29(2)_204-205.txt
226	R>K,226	R>K	L>F,91,1,Virol_J_2009_Nov_16_6_198.txt
271	A>V,271	A>V	A>T,95,1,Virol_J_2009_Nov_16_6_198.txt
327	N>D,327	N>D	S>F,99,1,Virol_J_2009_Nov_16_6_198.txt
361	A>E,361	A>E	A>S,103,1,Virol_J_2009_Nov_16_6_198.txt
383	I>M,383	I>M	no change,109,1,Virol_J_2009_Nov_16_6_198.txt
401	D>E,401	D>E	L>F,113,1,Virol_J_2009_Nov_16_6_198.txt
456	L>I,456	L>I	R>M,127,1,Virol_J_2009_Nov_16_6_198.txt
538	N>I,538	N>I	L>I,135,1,Virol_J_2009_Nov_16_6_198.txt
668	S>L,668	S>L	no change	S>L,143,1,Virol_J_2009_Nov_16_6_198.txt
702	V>I,702	V>I	I>T	no change,145,1,Virol_J_2009_Nov_16_6_198.txt
723	N>D,723	N>D	F>S	no change,149,1,Virol_J_2009_Nov_16_6_198.txt
379	R>K,379	R>K	no change,165,1,Virol_J_2009_Nov_16_6_198.txt
729		I>T,729		I>T	no change,183,1,Virol_J_2009_Nov_16_6_198.txt
413C>T,"...ants at 4 polymorphic sites, which were −465T>C, −413C>T, 314C>T and 939A>G in the HNMT gene, and th...",7,97,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
314C>T,"...4 polymorphic sites, which were −465T>C, −413C>T, 314C>T and 939A>G in the HNMT gene, and the functi...",7,105,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
939A>G,"...ic sites, which were −465T>C, −413C>T, 314C>T and 939A>G in the HNMT gene, and the functional effect...",7,116,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
939A>G,...h non-atopic eczema (P = 0.004) and those of HNMT 939A>G polymorphism were significantly associated ...,10,225,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
413C>T,"...ps (P = 0.048). However, those of HNMT 654T>C and 413C>T polymorphisms were not. In addition, subjec...",10,350,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
939A>G,... with the homozygous AA or heterozygous AG of the 939A>G polymorphism showed significantly higher Ig...,10,452,World_Allergy_Organ_J_2012_Feb_17_5(Suppl_2)_S33a.txt
252 G>A,"...ic receptor gene (ADRB2; -47 T>C, 46 A>G, 79 C>G, 252 G>A, and 523 C>A) using a single-base extensio...",8,503,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,".... The haplotype of ADRB2 (GAA composed of 46 A>G, 252 G>A, and 523 C>A) was significantly associated...",11,186,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"...reover, in subjects with the AG or GG genotype at 46 A>G and haplotype [GAA] of ADRB2, the prevalenc...",11,326,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
-47 T>C,...d extension 5'-CXCGCAGAGCXCCGCCGTGGGTCCGCC-3' for -47 T>C; forward 5'-CAGGAAACAGCTATGACCGCACATAACGGG...,34,594,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
-47 T>C,...d extension 5'-CXCGCAGAGCXCCGCCGTGGGTCCGCC-3' for -47 T>C; forward 5'-CAGGAAACAGCTATGACCGCACATAACGGG...,34,594,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,"...and extension 5'-ACGTCRTGGTCCGGCGCATGGCTTC-3' for 46 A>G; forward 5'-TTCTTGCTGGCACCCAAT-3', reverse ...",34,744,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523 C>A,...and extension 5'-CTTGCCCATTCAGATGCACTGGTAC-3' for 523 C>A,34,1144,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
-47T>C,"...0 seconds. Melting processes were done at 55℃ for -47T>C, 46A>G, 79C>G, and 523C>A SNPs, at 50℃ for ...",36,308,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
79C>G,"...ing processes were done at 55℃ for -47T>C, 46A>G, 79C>G, and 523C>A SNPs, at 50℃ for 252G>A SNP for ...",36,323,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523C>A,"...es were done at 55℃ for -47T>C, 46A>G, 79C>G, and 523C>A SNPs, at 50℃ for 252G>A SNP for 1 minute. E...",36,334,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523 C>A,"...enotypes of 252 G>A, or the CA or AA genotypes of 523 C>A (p<0.05, respectively). However, the stati...",52,215,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523 C>A,"...enotypes of 252 G>A, or the CA or AA genotypes of 523 C>A (p<0.05, respectively). However, the stati...",52,215,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,"...sons. The results of power analysis were 0.56 for 252 G>A (effect size 0.11), and 0.61 for 523 C>A (...",52,393,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
252 G>A,"...sons. The results of power analysis were 0.56 for 252 G>A (effect size 0.11), and 0.61 for 523 C>A (...",52,393,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
523 C>A,"...0.56 for 252 G>A (effect size 0.11), and 0.61 for 523 C>A (effect size 0.15)",52,434,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
-47 T>C,"...egard to other ADRB2 SNPs, polymorphisms at ADRB2 -47 T>C located in the β upstream peptide were rep...",66,57,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
-47 T>C,"...egard to other ADRB2 SNPs, polymorphisms at ADRB2 -47 T>C located in the β upstream peptide were rep...",66,57,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
46 A>G,...est that workers with the AG/GG genotype of ADRB2 46 A>G are at a higher risk of generating wheat-sp...,68,1053,Yonsei_Med_J_2011_May_1_52(3)_488-494.txt
769C>T,c.[769C>T];[769C>T],98,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],102,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],104,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],104,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],106,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[47C>T],108,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
47C>T,c.[769C>T];[47C>T],110,13,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[21-43dup23],112,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[21-43dup23],112,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
769C>T,c.[769C>T];[769C>T],126,4,Zdr_Varst_2015_Mar_13_54(2)_112-118.txt
